Clinical Trials

• B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants
  ClinicalTrials.gov Identifier: NCT00488683 - Recruiting
  Meningococcal Disease
  
• B Type Natriuretic Peptide for the Management of Weaning
  ClinicalTrials.gov Identifier: NCT00473148 - Recruiting
  Respiratory Insufficiency; Duration of Weaning From Invasive Ventilation
  
• B-19 Parvovirus Vaccine Study
  ClinicalTrials.gov Identifier: NCT00379938 - Suspended
  Parvovirus B19 Infection
  
• B-Left HF: Biventricular Versus Left Univentricular Pacing With Implantable Cardiac Defibrillator (ICD) Back-Up in Heart Failure Patients
  ClinicalTrials.gov Identifier: NCT00187213 - Active, not recruiting
  Heart Failure; Ventricular Dysfunction; Heart Diseases
  
• B-Lymphocyte Immunotherapy in Islet Transplantation
  ClinicalTrials.gov Identifier: NCT00468442 - Recruiting
  Type 1 Diabetes Mellitus
  
• B-Lymphocyte Stimulator (BLyStm) To Treat Selective IgA Deficiency
  ClinicalTrials.gov Identifier: NCT00024934 - Completed
  
  
• B-Type Natriuretic Peptide for Acute Shortness of Breath EvaLuation (BASEL) Study - Private Practice
  ClinicalTrials.gov Identifier: NCT00130611 - Active, not recruiting
  Acute dyspnoea
  
• B-Type Natriuretic Peptide in the Non-Cardiac Pediatric Patient
  ClinicalTrials.gov Identifier: NCT00330811 - Active, not recruiting
  Pediatric
  
• B14 Meningococcal Carriage in Seine-Maritime Population: Prevalence Study and Search of Risk Factors
  ClinicalTrials.gov Identifier: NCT00465582 - Recruiting
  Meningococcal Infections
  
• B181 Metobes-III: Weight Loss Maintenance of a New Bioactive Compound (Metobes-Long)
  ClinicalTrials.gov Identifier: NCT00302263 - Completed
  Obesity
  
• B181: Stimulation of Thermogenesis by Bio-Active Food Ingredients
  ClinicalTrials.gov Identifier: NCT00302289 - Completed
  Obesity
  
• B195: Effect of Diet-Induced Energy Deficit and Body Fat Reduction on Inflammatory Markers in Obese Subjects
  ClinicalTrials.gov Identifier: NCT00302926 - Completed
  Obesity
  
• B2-Adrenergic Receptor Polymorphisms
  ClinicalTrials.gov Identifier: NCT00279786 - Recruiting
  Status Asthmaticus
  
• Back Pain Prevalence in Wheelchair Users and Associated Risk Factors
  ClinicalTrials.gov Identifier: NCT00477568 - Recruiting
  Back Pain
  
• Backup With Combivir or Single Dose (Sd) Truvada in Order to Avoid NNRTI Resistance After Sd Nevirapine for the PMTCT
  ClinicalTrials.gov Identifier: NCT00346567 - Recruiting
  HIV
  
• BacLite Rapid MRSA Clinical Performance
  ClinicalTrials.gov Identifier: NCT00541632 - Enrolling by invitation
  Methicillin Resistance
  
• Baclofen Effects on Smoking Urge and Withdrawl
  ClinicalTrials.gov Identifier: NCT00257894 - Recruiting
  Smoking; Tobacco - Use Disorder; Nicotine Dependence; Nicotine - Use Disorder
  
• Baclofen for the Treatment of Cocaine Dependence - 1
  ClinicalTrials.gov Identifier: NCT00082485 - Active, not recruiting
  Cocaine-Related Disorders
  
• Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00516503 - Not yet recruiting
  Neurotoxicity; Pain; Unspecified Adult Solid Tumor, Protocol Specific
  
• Bacteria Entering the Blood Stream From Tooth Extractions and Tooth Brushing
  ClinicalTrials.gov Identifier: NCT00454285 - Active, not recruiting
  Bacteremia
  
• Bacterial Contamination of Anaesthetists' Hands by Personal Mobile Phones Used in the Operating Theatre
  ClinicalTrials.gov Identifier: NCT00416936 - Completed
  Environmental Microbiology; Equipment Contamination; Personnel, Hospital
  
• Bacterial Control in Partial Thickness Burns Using Silver-Containing Wound Dressings
  ClinicalTrials.gov Identifier: NCT00343824 - Recruiting
  Burn Wounds - Partial Thickness (2nd Degree)
  
• Bacterial Interference for Prevention of Catheter-Associated UTI
  ClinicalTrials.gov Identifier: NCT00554996 - Not yet recruiting
  Catheter-Associated UTI
  
• Bacterial Pulmonary Infection in PICU
  ClinicalTrials.gov Identifier: NCT00271531 - Recruiting
  Bacterial Infection
  
• Bacterial Vaginosis Screening and Treatment to Reduce Infective Complications, Abortion and Preterm Delivery
  ClinicalTrials.gov Identifier: NCT00491270 - Not yet recruiting
  Vaginosis, Bacterial; Abortion, Spontaneous; Premature Birth
  
• Bacterial Vaginosis; A Randomized Trial to Reduce Recurrence
  ClinicalTrials.gov Identifier: NCT00542074 - Completed
  Bacterial Vaginosis
  
• Balance Control and Maturation in Normal and Deaf Children Aged from 6 to 14 Years Old
  ClinicalTrials.gov Identifier: NCT00140699 - Active, not recruiting
  Deaf children
  
• Balance Impairment and Falls Risk in People With Lower Limb Arthritis, and Can These be Improved With Exercise?
  ClinicalTrials.gov Identifier: NCT00527189 - Completed
  Arthritis
  
• Balance in Patients After Surgery for Torn Meniscus.
  ClinicalTrials.gov Identifier: NCT00256971 - Recruiting
  Torn Menisci
  
• Balance Recovery and Training on Fall Prevention in Stroke
  ClinicalTrials.gov Identifier: NCT00173992 - Not yet recruiting
  Stroke
  
• Balance Recovery and Training on Fall Prevention in Stroke
  ClinicalTrials.gov Identifier: NCT00166907 - Recruiting
  Stroke
  
• Balanced Anesthesia for Intubation of Premature Infants - a Randomized Intervention Study
  ClinicalTrials.gov Identifier: NCT00216944 - Recruiting
  Premature Birth
  
• Balloon Angioplasty Versus Xpert Stent in CLI Patients XXS Study
  ClinicalTrials.gov Identifier: NCT00546845 - Recruiting
  Cronic Limb Ishemia; Intervention
  
• Balloon Angioplasty vs. Cutting Balloon Angioplasty of Femoropopliteal Arteries- a Randomized Controlled Trial
  ClinicalTrials.gov Identifier: NCT00437905 - Terminated
  Peripheral Vascular Disease; Intermittent Claudication; Atherosclerosis; Angioplasty
  
• Balloon Prophylaxis of Aneurysmal Vasospasm
  ClinicalTrials.gov Identifier: NCT00282893 - Completed
  Aneurysm; Vasospasm
  
• Balloon Valvuloplasty Registry
  ClinicalTrials.gov Identifier: NCT00005199 - Completed
  Heart Diseases; Mitral Valve Stenosis; Aortic Valve Stenosis
  
• Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00408174 - Completed
  Inflammatory Bowel Disease; Ulcerative Colitis
  
• Banding Versus Propranolol for Primary Prophylaxis of Variceal Bleeding
  ClinicalTrials.gov Identifier: NCT00337740 - Recruiting
  Liver Cirrhosis; Esophageal Varices
  
• Bands in Peripheral Blood After Coronary Artery Bypass Grafting With and Without Cardiopulmonary Bypass
  ClinicalTrials.gov Identifier: NCT00563030 - Recruiting
  Neutrophils; Coronary Artery Bypass Graft Surgery; Inflammatory Response Syndrome, Systemic
  
• Bangkok Tenofovir Study
  ClinicalTrials.gov Identifier: NCT00119106 - Recruiting
  HIV Infections
  
• Bangladesh Vitamin E and Selenium Trial
  ClinicalTrials.gov Identifier: NCT00392561 - Recruiting
  Arsenical Skin Lesions
  
• Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation
  ClinicalTrials.gov Identifier: NCT00428233 - Recruiting
  Chronic Lymphocytic Leukemia
  
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00574132 - Recruiting
  Alzheimer's Disease
  
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00575055 - Recruiting
  Alzheimer's Disease
  
• Bardet-Biedl Syndrome Study: Clinical and Genetic Epidemiology Study in Adults
  ClinicalTrials.gov Identifier: NCT00213811 - Active, not recruiting
  Bardet-Biedl Syndrome; Orphan Diseases
  
• Bariatric Dose-Ranging Study With Dexmedetomidine
  ClinicalTrials.gov Identifier: NCT00363935 - Completed
  Abdominal Surgery Patients
  
• Bariatric Surgery for ESRD Patients vs Control
  ClinicalTrials.gov Identifier: NCT00580762 - Recruiting
  Obesity; ESRD
  
• Barley Protein and CVD
  ClinicalTrials.gov Identifier: NCT00334308 - Active, not recruiting
  Hypercholesterolemia; Cardiovascular Disease; Diet Therapy
  
• Barrett's Esophagus & Gastroesophageal Reflux Disease
  ClinicalTrials.gov Identifier: NCT00513331 - Recruiting
  Barrett's Esophagus; GERD
  
• Barrier Function and Production of Inflammatory Cytokines in the Rectal Mucosa in Patients With Septic Shock
  ClinicalTrials.gov Identifier: NCT00378586 - Not yet recruiting
  Septic Shock
  
• Barriers to Care for Harris County Cervical Cancer Patients or Patients With Precancerous Lesions (CIS)
  ClinicalTrials.gov Identifier: NCT00519272 - Recruiting
  Cervical Cancer
  
• Barriers to Effective Weight Loss in Overweight Adolescents
  ClinicalTrials.gov Identifier: NCT00562263 - Recruiting
  Overweight
  
• Barriers to Treatment in Obese Adolescents
  ClinicalTrials.gov Identifier: NCT00167830 - Active, not recruiting
  Obesity
  
• Basal Insulins - Pharmacodynamics
  ClinicalTrials.gov Identifier: NCT00566124 - Completed
  Diabetes
  
• Baseline Sexual Function, Cognitive Function, Body Composition and Muscle Parameters and Pharmacokinetics of Transdermal Testosterone Gel in Women with Hypopituitarism
  ClinicalTrials.gov Identifier: NCT00144404 - Recruiting
  Panhypopituitarism
  
• Baselines in Reproductive Disorders
  ClinicalTrials.gov Identifier: NCT00456274 - Recruiting
  Amenorrhea; Hypogonadotropic Hypogonadism; Kallmann's Syndrome
  
• BaSES Trial: Basel Starch Evaluation in Sepsis
  ClinicalTrials.gov Identifier: NCT00273728 - Recruiting
  Sepsis; Severe Sepsis; Septic Shock
  
• Basic Life Support Termination of Resuscitation Implementation Study
  ClinicalTrials.gov Identifier: NCT00370461 - Recruiting
  Cardiac Arrest
  
• Basic Mechanisms of Meditation and Cardiovascular Disease in Older Blacks
  ClinicalTrials.gov Identifier: NCT00010530 - Completed
  Cardiovascular Diseases
  
• BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes
  ClinicalTrials.gov Identifier: NCT00389402 - Recruiting
  HIV Infections
  
• Basiliximab for the Treatment of Acute Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00563108 - Recruiting
  Graft vs Host Disease; Hematopoietic Stem Cell Transplantation
  
• Basiliximab in Moderate to Severe Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00430898 - Recruiting
  Ulcerative Colitis
  
• BASTA Study on STI in HIV Infected Patients
  ClinicalTrials.gov Identifier: NCT00310245 - Completed
  HIV Infection
  
• Bathing persons with Alzheimer's disease aT Home (The BATH Study)
  ClinicalTrials.gov Identifier: NCT00062569 - Recruiting
  Alzheimer Disease
  
• Batracylin in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma
  ClinicalTrials.gov Identifier: NCT00450502 - Recruiting
  Lymphoma; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• BATTLE Program: BAY43-9006 in Patients With NSCLC
  ClinicalTrials.gov Identifier: NCT00411671 - Recruiting
  Lung Cancer
  
• BATTLE Program: Tarceva and Targretin in Patients With NSCLC
  ClinicalTrials.gov Identifier: NCT00411632 - Recruiting
  Lung Cancer
  
• BATTLE Program: Tarceva in Previously Treated Subjects With Advanced NSCLC
  ClinicalTrials.gov Identifier: NCT00410059 - Recruiting
  Lung Cancer
  
• BATTLE Program: Umbrella Protocol for Patients With NSCLC
  ClinicalTrials.gov Identifier: NCT00409968 - Recruiting
  Lung Cancer
  
• BATTLE Program: ZD6474 in Previously Treated Subjects With NSCLC
  ClinicalTrials.gov Identifier: NCT00410189 - Recruiting
  Lung Cancer
  
• Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus
  ClinicalTrials.gov Identifier: NCT00503347 - Recruiting
  Hepatitis C Virus; HIV Infections
  
• BAY 43-9006 (Sorafenib) and Bevacizumab (Avastin) To Treat Solid Tumors
  ClinicalTrials.gov Identifier: NCT00095459 - Recruiting
  Neoplasms
  
• BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00098254 - Recruiting
  
  
• BAY 43-9006 (Sorafenib) Versus Interferon Alpha-2a in Patients with Unresectable and/Or Metastatic Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00117637 - Completed
  Renal Cell Carcinoma; Neoplasm Metastasis
  
• BAY 43-9006 in Patients with Advanced Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00048919 - Completed
  Carcinoma, Hepatocellular
  
• BAY 43-9006 in Previously Untreated Patients With IIIB/IV NSCLC
  ClinicalTrials.gov Identifier: NCT00533585 - Recruiting
  Lung Cancer
  
• BAY 43-9006 in Treating Patients With Advanced Inoperable Liver Cancer
  ClinicalTrials.gov Identifier: NCT00058383 - No longer recruiting
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer
  
• BAY 43-9006 in Treating Patients With Imatinib Mesylate-Resistant Chronic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00085007 - Active, not recruiting
  chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; relapsing chronic myelogenous leukemia
  
• BAY 43-9006 in Treating Patients With Refractory Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00064350 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
  
• BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00040989 - Terminated
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• BAY 59-7939 in the Extended Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Elective Total Hip Replacement (RECORD 1)
  ClinicalTrials.gov Identifier: NCT00329628 - Completed
  Thromboembolism
  
• BAY 59-8862 in Treating Patients With Advanced Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00039169 - Active, not recruiting
  stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• BAY 59-8862 in Treating Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00054314 - Completed
  recurrent non-small cell lung cancer
  
• BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00039156 - Active, not recruiting
  recurrent grade III follicular large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; recurrent adult diffuse large cell lymphoma; ...
  
• BAY-43-9006 in Advanced, Metastatic Soft Tissue Sarcomas
  ClinicalTrials.gov Identifier: NCT00406601 - Recruiting
  Sarcoma, Soft Tissue
  
• BAY12-8039 5 Days Sinusitis vs Placebo
  ClinicalTrials.gov Identifier: NCT00492024 - Recruiting
  Respiratory Tract Infection; Bacterial Sinusitis
  
• BB-10901 in Treating Patients With Recurrent or Refractory Lung Cancer, Metastatic Carcinoid Tumor, or Other Solid Tumors
  ClinicalTrials.gov Identifier: NCT00074256 - Recruiting
  adult solid tumor; gastrointestinal carcinoid tumor; Neuroendocrine Carcinoma; Non-small cell lung cancer; pulmonary carcinoid tumor; ...
  
• BB-10901 in Treating Patients With Relapsed and/or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00346255 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00346385 - Suspended
  Cervical Cancer; Gastrointestinal Carcinoid Tumor; Lung Cancer; Sarcoma; Unspecified Adult Solid Tumor, Protocol Specific
  
• BBC ONE - British Bifurcation Coronary Study
  ClinicalTrials.gov Identifier: NCT00351260 - Recruiting
  Ischaemic Heart Disease; Stenosis; Angina
  
• BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)
  ClinicalTrials.gov Identifier: NCT00088530 - Recruiting
  Lymphoma, Non-Hodgkin
  
• BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery
  ClinicalTrials.gov Identifier: NCT00024362 - Active, not recruiting
  stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
  
• BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment
  ClinicalTrials.gov Identifier: NCT00014547 - Active, not recruiting
  extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer
  
• BC-DAISY: A Breast Cancer Decision Aid System
  ClinicalTrials.gov Identifier: NCT00347568 - Active, not recruiting
  Breast Cancer
  
• BCG Plus Interferon alfa 2b in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00004122 - Completed
  transitional cell carcinoma of the bladder; stage I bladder cancer; recurrent bladder cancer; Quality of Life
  
• BCG Vaccine and Morbidity from Malaria.
  ClinicalTrials.gov Identifier: NCT00131794 - Completed
  Malaria
  
• BCG Vaccine Oral Intradermal
  ClinicalTrials.gov Identifier: NCT00396370 - Suspended
  Tuberculosis
  
• BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00352079 - Recruiting
  Bladder Cancer
  
• BCG With or Without Mitomycin in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00023842 - Active, not recruiting
  stage 0 bladder cancer; recurrent bladder cancer; transitional cell carcinoma of the bladder
  
• Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00005032 - Active, not recruiting
  Recurrent Small Cell Lung Cancer
  
• BCX-1777 in Treating Patients With Refractory Cancer
  ClinicalTrials.gov Identifier: NCT00073944 - Active, not recruiting
  central nervous system cancer; female reproductive cancer; Gastrointestinal Cancer; hematopoietic and lymphoid cancer; skin tumor
  
• BCX-1777 in Treating Patients With Refractory Cutaneous T-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00061880 - Active, not recruiting
  Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
  
• BDNF Gene Polymorphism and Antidepressants Treatment
  ClinicalTrials.gov Identifier: NCT00308893 - Recruiting
  Depression
  
• Be SMART NIS, Moderate to Servere Asthma Patient Observation
  ClinicalTrials.gov Identifier: NCT00514787 - Recruiting
  Asthma
  
• BEAM+131I-Anti-B1 & Autologous Hematopoietic Stem Cell Transplant for Recurrent Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00574509 - Active, not recruiting
  Lymphoma
  
• BEATRICE Study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer.
  ClinicalTrials.gov Identifier: NCT00528567 - Recruiting
  Breast Cancer
  
• BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis
  ClinicalTrials.gov Identifier: NCT00545909 - Active, not recruiting
  Post-Menopausal Osteoporosis
  
• Beclomethasone in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00489203 - Recruiting
  Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon
  ClinicalTrials.gov Identifier: NCT00010283 - Active, not recruiting
  Leukemia; Testicular Cancer; ovarian epithelial cancer; Lymphoma; Breast Cancer; Multiple Myeloma; kidney tumor
  
• Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease
  ClinicalTrials.gov Identifier: NCT00043147 - Completed
  Graft Versus Host Disease
  
• Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss
  ClinicalTrials.gov Identifier: NCT00416143 - Recruiting
  Sudden Loss of Hearing
  
• Bedside Silo Versus Operative Closure for Gastroschisis
  ClinicalTrials.gov Identifier: NCT00404690 - Recruiting
  Gastroschisis
  
• Behavior and Driving Safety Study
  ClinicalTrials.gov Identifier: NCT00575679 - Not yet recruiting
  Alcoholic Intoxication
  
• Behavior and Naltrexone Treatment for Alcoholics
  ClinicalTrials.gov Identifier: NCT00000449 - Completed
  Alcoholism
  
• Behavior Change and Maintenance Intervention for HIV+ MSM Methamphetamine Users
  ClinicalTrials.gov Identifier: NCT00432926 - Recruiting
  HIV Infections; Substance Abuse; Sexually Transmitted Diseases
  
• Behavior Enhances Drug Reduction of Incontinence (BE-DRI)
  ClinicalTrials.gov Identifier: NCT00090584 - Completed
  Urinary Incontinence
  
• Behavior in Children with Attention Deficit Hyperactivity Disorder and in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00026546 - Active, not recruiting
  Attention Deficit Hyperactivity Disorder
  
• Behavior of Children Related to Numbness After Dental Local Anesthesia
  ClinicalTrials.gov Identifier: NCT00363207 - Recruiting
  Anesthesia, Local; Anesthesia, Dental
  
• Behavior Therapy for Children and Adolescents with Obsessive-Compulsive Disorder (OCD)
  ClinicalTrials.gov Identifier: NCT00000386 - Completed
  Obsessive-Compulsive Disorder
  
• Behavior Therapy for Families of Diabetic Adolescents
  ClinicalTrials.gov Identifier: NCT00358059 - Completed
  Type 1 Diabetes Mellitus
  
• Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00082732 - Active, not recruiting
  stage I prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate
  
• Behavioral & Nutritional Treatment to Help CF Preschoolers Grow
  ClinicalTrials.gov Identifier: NCT00241969 - Recruiting
  Cystic Fibrosis; Pancreatic Cystic Fibrosis
  
• Behavioral and Immunological Factors in Coronary Disease
  ClinicalTrials.gov Identifier: NCT00037284 - Active, not recruiting
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Depression
  
• Behavioral and Pharmacological Treatment for Insomnia
  ClinicalTrials.gov Identifier: NCT00042146 - Completed
  Sleep Initiation and Maintenance Disorders; Sleep Disorders, Intrinsic
  
• Behavioral and Physiological Effects of Visual Training
  ClinicalTrials.gov Identifier: NCT00526942 - Recruiting
  Healthy
  
• Behavioral Counseling for Alcohol Dependent Smokers (nicotine patch)
  ClinicalTrials.gov Identifier: NCT00004551 - Completed
  Alcoholism; Smoking
  
• Behavioral Economics of Human Drug Self-Administration
  ClinicalTrials.gov Identifier: NCT00005765 - Completed
  Drug Dependence
  
• Behavioral Effects of Obstructive Sleep Apnea in Children
  ClinicalTrials.gov Identifier: NCT00060723 - Active, not recruiting
  Sleep-Disordered Breathing; Sleep Apnea, Obstructive; ADHD
  
• Behavioral Factors in Coronary Heart Disease
  ClinicalTrials.gov Identifier: NCT00005314 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Coronary Disease; Metabolic Syndrome X
  
• Behavioral Health Services for Women Receiving Public Assistance
  ClinicalTrials.gov Identifier: NCT00057655 - Completed
  Mental Disorders
  
• Behavioral Indicators of Pain:Tool Development With Concurrent and Construct Validity
  ClinicalTrials.gov Identifier: NCT00208052 - Completed
  Pain
  
• Behavioral Insomnia Therapy for Fibromyalgia
  ClinicalTrials.gov Identifier: NCT00000397 - Completed
  Fibromyalgia; Insomnia
  
• Behavioral Insomnia Therapy in Primary Care
  ClinicalTrials.gov Identifier: NCT00105872 - Completed
  Insomnia
  
• Behavioral Insomnia Therapy With Chronic Fatigue Syndrome
  ClinicalTrials.gov Identifier: NCT00540254 - Recruiting
  Chronic Fatigue Syndrome; Behavioral Therapy Targeted to Sleep Problems
  
• Behavioral Intervention For BMT/SCT Survivors
  ClinicalTrials.gov Identifier: NCT00579917 - Recruiting
  Hodgkin's Disease; Leukemia; Multiple Myeloma; Non-Hodgkin's Lymphoma
  
• Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00164372 - Active, not recruiting
  HIV Infections; Hepatitis C
  
• Behavioral Intervention Trial for HIV-Infected Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00146445 - Active, not recruiting
  Peer Mentoring Intervention; Video & Discussion Intervention (comparison condition)
  
• Behavioral Interventions for Control of TB
  ClinicalTrials.gov Identifier: NCT00005739 - Completed
  Lung Diseases; Tuberculosis
  
• Behavioral Interventions for Control of Tuberculosis
  ClinicalTrials.gov Identifier: NCT00005742 - Completed
  Lung Diseases; Tuberculosis
  
• Behavioral Naltrexone Therapy (BNT) for Promoting Adherence to Oral Naltrexone (BNT-Oral) vs Extended Release Injectable Depot Naltrexone (Depot-BNT); a Randomized Trial. A Free Treatment for Opiate Abuse.
  ClinicalTrials.gov Identifier: NCT00577408 - Recruiting
  Opiate Dependence; Heroin Dependence
  
• Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence
  ClinicalTrials.gov Identifier: NCT00332228 - Active, not recruiting
  Opiate Dependence
  
• Behavioral Processes Underlying Reward Processing in Depression
  ClinicalTrials.gov Identifier: NCT00205933 - Completed
  Major Depressive Disorder; Bipolar Disorder
  
• Behavioral Self-Regulation
  ClinicalTrials.gov Identifier: NCT00488228 - Active, not recruiting
  Obesity
  
• Behavioral Sleep Intervention in Adult Family Homes
  ClinicalTrials.gov Identifier: NCT00393627 - Recruiting
  Dementia
  
• Behavioral Strategies for Weight Management
  ClinicalTrials.gov Identifier: NCT00575731 - Active, not recruiting
  Obesity
  
• Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence
  ClinicalTrials.gov Identifier: NCT00218075 - Active, not recruiting
  Cocaine Abuse; Cocaine-Related Disorders
  
• Behavioral Therapy Development for Methamphetamine Abuse
  ClinicalTrials.gov Identifier: NCT00252434 - Recruiting
  Depression; Drug Abuse; Sexually Transmitted Diseases
  
• Behavioral Therapy for Reduction in Smoking Craving
  ClinicalTrials.gov Identifier: NCT00449293 - Active, not recruiting
  Smoking Cessation; Tobacco Dependence
  
• Behavioral Therapy Plus Naltrexone for Alcoholism
  ClinicalTrials.gov Identifier: NCT00000456 - Completed
  Alcoholism
  
• Behavioral Treatment of Drug Abuse in SPMI Patients
  ClinicalTrials.gov Identifier: NCT00295139 - Recruiting
  Schizophrenia; Mood Disorders; Substance Dependence
  
• Behavioral Treatment of Fibromyalgia
  ClinicalTrials.gov Identifier: NCT00000398 - Completed
  Fibromyalgia
  
• Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
  ClinicalTrials.gov Identifier: NCT00050622 - Completed
  Attention Deficit Hyperactivity Disorder
  
• Behavioral Treatments for Acute Stress Disorder In Firefighters
  ClinicalTrials.gov Identifier: NCT00183508 - Active, not recruiting
  Stress Disorders, Post-Traumatic
  
• Behavioral Treatments for Chronic Pain
  ClinicalTrials.gov Identifier: NCT00371865 - Recruiting
  Intractable Pain
  
• Behavioral, Clinical and Basic Science Studies of Non-Occupational Post-Exposure Prophylaxis ("PEP-2")
  ClinicalTrials.gov Identifier: NCT00473018 - Completed
  HIV Infections
  
• Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (naltrexone/nicotine patch)
  ClinicalTrials.gov Identifier: NCT00000447 - Completed
  Alcoholism; Smoking
  
• Behavioural Intervention for Dysphagia in Acute Stroke
  ClinicalTrials.gov Identifier: NCT00257764 - Completed
  Dysphagia
  
• Behavioural Treatment of Hypertension
  ClinicalTrials.gov Identifier: NCT00247910 - Recruiting
  Hypertension
  
• Belatacept Evaluation of Nephroprotection and Efficacy as First-Line Immunosupression (BENEFIT)
  ClinicalTrials.gov Identifier: NCT00256750 - Active, not recruiting
  Kidney Transplantation; Chronic Kidney Failure
  
• Belatacept in Liver Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00555321 - Recruiting
  Immunosuppression in Solid Organ Transplant
  
• Belatacept Pharmacokinetic Trial in Renal Transplantation
  ClinicalTrials.gov Identifier: NCT00578448 - Not yet recruiting
  Renal Transplantation
  
• Belatacept Post Depletional Repopulation to Facilitate Tolerance
  ClinicalTrials.gov Identifier: NCT00565773 - Not yet recruiting
  Organ Transplantation
  
• Belatacept to Prevent Organ Rejection in Kidney Transplant Patients
  ClinicalTrials.gov Identifier: NCT00346151 - Recruiting
  Transplantation, Kidney; End-Stage Renal Disease
  
• Belgian Prospective Multicentre Registry on the Performance of the Smart Stent in the Superficial Femoral Artery According to the New Tasc II-Classification
  ClinicalTrials.gov Identifier: NCT00496041 - Recruiting
  Peripheral Vascular Disease
  
• BELIEVE Study: Nesiritide and Post Myocardial Infarction Left Ventricular Modeling
  ClinicalTrials.gov Identifier: NCT00252213 - Active, not recruiting
  Myocardial Infarction
  
• Belotecan (CKD-602) in Recurrent or Progressive Carcinoma of Uterine Cervix
  ClinicalTrials.gov Identifier: NCT00430144 - Recruiting
  Cervical Cancer
  
• Below Study - Balloonangioplasty or Stents with ReoPro for Prevention of Subacute Reocclusion in Arteries Below the Knee
  ClinicalTrials.gov Identifier: NCT00163254 - Active, not recruiting
  Patients above 18 years
  
• Beluga - Clinical Observations of Automatic Algorithms for Cardiac Pacing
  ClinicalTrials.gov Identifier: NCT00286858 - Recruiting
  Bradycardia; Sick Sinus Syndrome; Heart Block
  
• Bemiparin Randomized Trial on Bridging Oral Anticoagulants in Invasive Procedures (BERTA Study)
  ClinicalTrials.gov Identifier: NCT00484822 - Recruiting
  Long-Term Oral Anticoagulant Therapy
  
• Benazepril for Advanced Chronic Renal Insufficiency
  ClinicalTrials.gov Identifier: NCT00270426 - Terminated
  Chronic Kidney Failure
  
• Benchmarking Initiative to Reduce Bronchopulmonary Dysplasia
  ClinicalTrials.gov Identifier: NCT00067613 - Active, not recruiting
  Bronchopulmonary Dysplasia
  
• Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS)
  ClinicalTrials.gov Identifier: NCT00204620 - Completed
  Sarcoma, Soft Tissue
  
• Bendamustine and Bortezomib Combination Therapy in Indolent NHL
  ClinicalTrials.gov Identifier: NCT00426855 - Recruiting
  Lymphoma, Non-Hodgkin
  
• Bendamustine and Mitoxantrone in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00274963 - Recruiting
  Leukemia
  
• Bendamustine and Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00274989 - Recruiting
  Leukemia
  
• Bendamustine in Treating Patients With Rituximab-Refractory Indolent B-Cell Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00085033 - Completed
  adult non-Hodgkin's lymphoma; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Beneficial Bacteria to Prevent and Malnutrition and Diarrhea in Pakistinian Infants
  ClinicalTrials.gov Identifier: NCT00118872 - Recruiting
  Malnutrition; Diarrhea
  
• Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
  ClinicalTrials.gov Identifier: NCT00014989 - Active, not recruiting
  Cerebral Palsy; Intraventricular hemorrhage; Periventricular Leukomalacia; Pulmonary Edema; Abruptio Placentae
  
• Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array
  ClinicalTrials.gov Identifier: NCT00318318 - Active, not recruiting
  Healthy; Estrogen Replacement Therapy
  
• BENEFIT Extension Study
  ClinicalTrials.gov Identifier: NCT00544037 - Recruiting
  Multiple Sclerosis
  
• Benefit of a Collaborative Approach to Improve the Quality of Medicines Use in Elderly Inpatients
  ClinicalTrials.gov Identifier: NCT00279656 - Completed
  Frail Elderly Inpatient
  
• Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0)
  ClinicalTrials.gov Identifier: NCT00563862 - Terminated
  Nasopharyngeal Neoplasms; Carcinoma, Squamous Cell
  
• Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)
  ClinicalTrials.gov Identifier: NCT00563927 - Active, not recruiting
  Nasopharyngeal Neoplasms; Carcinoma, Squamous Cell
  
• Benefit of Adding Trastuzumab to Second Line Chemotherapy in Breast Cancer Patients Previously Treated with Trastuzumab.
  ClinicalTrials.gov Identifier: NCT00130507 - Suspended
  Breast Cancer
  
• Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer
  ClinicalTrials.gov Identifier: NCT00577057 - Not yet recruiting
  Nasopharyngeal Neoplasms
  
• Benefit of Immunoprophylaxis on Fibrosis to Reduce Viral Load After Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00538265 - Recruiting
  Liver Transplantation
  
• Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics
  ClinicalTrials.gov Identifier: NCT00181012 - Recruiting
  Cancer; Pain
  
• Benefit of Self-Monitoring of Anticoagulation Instrument
  ClinicalTrials.gov Identifier: NCT00506870 - Recruiting
  Mechanical Prosthetic Heart Valve Implantation; Patient Self Monitoring of Oral Anticoagulent Therapy
  
• Benefit of SeptiFast Multiplex PCR in the Etiologic Diagnosis and Therapeutic Approach for Onco-Hematology Patients Presenting Sepsis
  ClinicalTrials.gov Identifier: NCT00561639 - Not yet recruiting
  Hematologic Diseases; Sepsis
  
• Benefits and Risks of Newborn Screening for Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00014950 - Completed
  Cystic Fibrosis; Lung Disease; Pseudomonas Infections
  
• Benefits of 'Repeat Back' Protocols Within A Computer-Based Informed Consent Program
  ClinicalTrials.gov Identifier: NCT00288899 - Recruiting
  Surgery; Cholecystectomy, Laparoscopic; Prostatectomy; Arthroplasty, Replacement, Hip; Endarterectomy, Carotid
  
• Benefits of Applying Neuroprosthesis for Improving Reaching and Grasping Functions in Stroke Patients
  ClinicalTrials.gov Identifier: NCT00221078 - Active, not recruiting
  -Stroke
  
• Benefits of Applying Neuroprosthesis to Improve Grasping and Reaching in Spinal Cord Injury Patients
  ClinicalTrials.gov Identifier: NCT00221117 - Recruiting
  Spinal Cord Injuries
  
• Benefits of Exercise and Education for Individuals With Parkinson's Disease (BEEP)
  ClinicalTrials.gov Identifier: NCT00167453 - Completed
  Parkinson Disease
  
• Benefits of Lightweight Ambulatory Oxygen Systems for Individuals With Chronic Obstructive Pulmonary Disease (COPD) Who Need Supplemental Oxygen
  ClinicalTrials.gov Identifier: NCT00325754 - Active, not recruiting
  Pulmonary Disease, Chronic Obstructive
  
• Benefits of Switching Antidepressants Following Early Nonresponse
  ClinicalTrials.gov Identifier: NCT00519012 - Recruiting
  Depression
  
• Benefits of Tanning in Fibromyalgia Patients
  ClinicalTrials.gov Identifier: NCT00447083 - Completed
  Fibromyalgia Syndrome
  
• Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets
  ClinicalTrials.gov Identifier: NCT00442325 - Completed
  Coronary Arteriosclerosis; Diabetes Mellitus, Type 2; Cerebrovascular Accident; Dyslipidemia; Peripheral Vascular Disease
  
• Benfotiamine in Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00565318 - Not yet recruiting
  Diabetic Nephropathy
  
• Benign Prostatic Hyperplasia Trial With Avodart And Tamsulosin Combination Treatment
  ClinicalTrials.gov Identifier: NCT00090103 - Active, not recruiting
  Benign Prostatic Hyperplasia
  
• Benzamide Derivates as Treatment of Clozapine-Induced Hypersalivation
  ClinicalTrials.gov Identifier: NCT00534573 - Not yet recruiting
  Clozapine-Induced Hypersalivation
  
• Benzene Exposure as a Risk Factor for Hematological Cancer or Related Disorders or Lung Cancer in Chinese Workers
  ClinicalTrials.gov Identifier: NCT00516568 - Not yet recruiting
  Leukemia; Lung Cancer; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Benzocaine Gel Toothache Dose-Response Study
  ClinicalTrials.gov Identifier: NCT00474175 - Recruiting
  Toothache
  
• Benzoylphenylurea in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00010205 - Completed
  unspecified adult solid tumor, protocol specific
  
• Benzoylphenylurea in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00016354 - Completed
  unspecified adult solid tumor, protocol specific
  
• Berlin Deep Brain Stimulation Depression Study
  ClinicalTrials.gov Identifier: NCT00531726 - Recruiting
  Therapy Resistant Major Depression
  
• Beryllium Infliximab Study: Clinical Interventional Trial
  ClinicalTrials.gov Identifier: NCT00111917 - Recruiting
  Berylliosis; Beryllium Disease
  
• BEST (Burn Center Evaluation of Standard Therapies) Ventilator Mode Study-
  ClinicalTrials.gov Identifier: NCT00351741 - Recruiting
  Burns
  
• Best Bypass Surgery (BBS) Trial
  ClinicalTrials.gov Identifier: NCT00120991 - Active, not recruiting
  Heart Disease; Cardiovascular Disease
  
• Beta Alethine in Treating Patients With Low-Grade Lymphoma
  ClinicalTrials.gov Identifier: NCT00007839 - Active, not recruiting
  Lymphoma
  
• Beta Alethine in Treating Patients With Myeloma
  ClinicalTrials.gov Identifier: NCT00006466 - Active, not recruiting
  monoclonal gammopathy of undetermined significance; stage I multiple myeloma; stage II multiple myeloma; extramedullary plasmacytoma; ...
  
• Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00041379 - Active, not recruiting
  Waldenstrom's Macroglobulinemia
  
• Beta Blockade in Critical Injury
  ClinicalTrials.gov Identifier: NCT00356187 - Recruiting
  Trauma
  
• Beta Blocker for Chronic Wound Healing
  ClinicalTrials.gov Identifier: NCT00368602 - Recruiting
  Ulcer; Burns
  
• Beta Blockers Versus Variceal Band Ligation and Beta Blockers for Primary Prophylaxis of Variceal Bleeding
  ClinicalTrials.gov Identifier: NCT00409084 - Recruiting
  Esophageal Varices
  
• Beta Carotene From Natural Source for Patients With Non-Active Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00275418 - Recruiting
  Crohn's Disease
  
• Beta Cell Function in Women With Turner Syndrome
  ClinicalTrials.gov Identifier: NCT00419107 - Active, not recruiting
  Turner Syndrome
  
• Beta Cell Function Tests Over Time In Patients With T2dm Randomized To Metformin Or Rosiglitazone
  ClinicalTrials.gov Identifier: NCT00282945 - Terminated
  Type 2 Diabetes Mellitus
  
• Beta-2 Polymorphisms and Beta Receptor Selectivity
  ClinicalTrials.gov Identifier: NCT00214318 - Completed
  Heart Failure
  
• Beta-Blocker Before Extubation
  ClinicalTrials.gov Identifier: NCT00563238 - Recruiting
  Myocardial Ischemia
  
• Beta-Blocker Continuation Versus Interruption in Heart Failure Worsening
  ClinicalTrials.gov Identifier: NCT00162565 - Recruiting
  Heart Failure,Congestive; beta-Adrenergic Blockers
  
• Beta-Blocker Evaluation in Survival Trial (BEST)
  ClinicalTrials.gov Identifier: NCT00000560 - Completed
  Cardiovascular Diseases; Heart Diseases; Heart Failure, Congestive; Heart Failure
  
• Beta-Blocker Heart Attack Trial (BHAT)
  ClinicalTrials.gov Identifier: NCT00000492 - Completed
  Arrhythmia; Cardiovascular Diseases; Coronary Disease; Death, Sudden, Cardiac; Heart Diseases; Myocardial Infarction; Myocardial Ischemia; ...
  
• Beta-Carotene and Alpha-Tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients
  ClinicalTrials.gov Identifier: NCT00169845 - Active, not recruiting
  Neoplasms
  
• Beta-Cell Function and Sitagliptin Trial (BEST)
  ClinicalTrials.gov Identifier: NCT00420511 - Recruiting
  Type 2 Diabetes Mellitus
  
• Beta-CIT-SPECT and Neurophysiology in Depression
  ClinicalTrials.gov Identifier: NCT00145132 - Recruiting
  Depression
  
• Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00492167 - Recruiting
  Neuroblastoma
  
• beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00037011 - Active, not recruiting
  disseminated neuroblastoma; recurrent neuroblastoma
  
• Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00087009 - Recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma
  
• Beta-hCG + Erythropoietin in Acute Stroke
  ClinicalTrials.gov Identifier: NCT00362414 - Recruiting
  Acute Stroke
  
• Betaferon®/ Betaseron® (Interferon Beta-1b) in Patients With Chronic Viral Cardiomyopathy
  ClinicalTrials.gov Identifier: NCT00185250 - Completed
  Cardiomyopathies; Heart Diseases
  
• Betamethasone Dosing Interval - 12 or 24 Hours?
  ClinicalTrials.gov Identifier: NCT00453141 - Recruiting
  Preterm Delivery
  
• Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00206635 - Completed
  Multiple Sclerosis
  
• Betaseron Pregnancy Registry
  ClinicalTrials.gov Identifier: NCT00317564 - Recruiting
  Birth Defects; Pregnancy Complications; Multiple Sclerosis
  
• Better Adherence to Therapeutic Lifestyle Change Efforts Trial
  ClinicalTrials.gov Identifier: NCT00458874 - Recruiting
  Cardiovascular Disease
  
• Better Asthma Outcomes: Lowering Tobacco Smoke Exposure
  ClinicalTrials.gov Identifier: NCT00217958 - Active, not recruiting
  Lung Diseases; Asthma
  
• Better Days, Better Nights: Treatment for Sleep Difficulties
  ClinicalTrials.gov Identifier: NCT00338429 - Recruiting
  Sleep Onset Latency and/or Bedtime Resistance
  
• Better Pediatric Asthma Outcomes Through Chronic Care
  ClinicalTrials.gov Identifier: NCT00355069 - Active, not recruiting
  Asthma
  
• Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma
  ClinicalTrials.gov Identifier: NCT00137826 - Active, not recruiting
  Mesothelioma
  
• Bevacizumab + CHOP-Rituximab in Untreated Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00401817 - Recruiting
  Untreated Mantle Cell Lymphoma
  
• BEVACIZUMAB + LETROZOL vs LETROZOL as First Line Treatment in Postmenopausal Patients With Advanced or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00545077 - Not yet recruiting
  Breast Cancer
  
• Bevacizumab and Abraxane as Second-Line Therapy in Triple Negative Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00472693 - Recruiting
  Breast Cancer
  
• Bevacizumab and AZD2171 in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma
  ClinicalTrials.gov Identifier: NCT00458731 - Recruiting
  Lymphoma; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Bevacizumab and Bortezomib in Patients With Advanced Malignancy
  ClinicalTrials.gov Identifier: NCT00428545 - Recruiting
  Advanced Malignancy; Lymphoma; Myeloma; Solid Tumors
  
• Bevacizumab and Capecitabine as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00107315 - Recruiting
  recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer
  
• Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00578149 - Completed
  Non-Small Cell Lung Cancer
  
• Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00193219 - Recruiting
  Colon Cancer
  
• Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00077298 - Completed
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer
  
• Bevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00335829 - Recruiting
  Liver Cancer
  
• Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00423696 - Recruiting
  Colorectal Cancer
  
• Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00467142 - Recruiting
  Colorectal Cancer
  
• Bevacizumab and Combination Chemotherapy in Patients With Hematologic Cancers
  ClinicalTrials.gov Identifier: NCT00217425 - Recruiting
  anaplastic large cell lymphoma; stage I adult T-cell leukemia/lymphoma; stage II adult T-cell leukemia/lymphoma; ...
  
• Bevacizumab and Combination Chemotherapy in Treating Patients Who Have Undergone Surgery for Breast Cancer That Has Spread to the Lymph Nodes
  ClinicalTrials.gov Identifier: NCT00119262 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; Male Breast Cancer
  
• Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00544011 - Recruiting
  Colorectal Cancer
  
• Bevacizumab and Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00128674 - Recruiting
  stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• Bevacizumab and Docetaxel in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00541099 - Not yet recruiting
  Lung Cancer
  
• Bevacizumab and Docetaxel in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00504257 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00055861 - Completed
  recurrent breast cancer; stage IV breast cancer
  
• Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00445406 - Recruiting
  Breast Cancer
  
• Bevacizumab and Erlotinib Followed by Cisplatin or Carboplatin and Gemcitabine in Treating Patients With Newly Diagnosed or Recurrent Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00354549 - Recruiting
  Lung Cancer
  
• Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00287222 - Recruiting
  Hepatocellular Carcinoma
  
• Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site
  ClinicalTrials.gov Identifier: NCT00193622 - Active, not recruiting
  Neoplasms, Unknown Primary
  
• Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer
  ClinicalTrials.gov Identifier: NCT00365391 - Recruiting
  Liver Cancer
  
• Bevacizumab and Erlotinib in Treating Patients With Metastatic or Unresectable Biliary Tumors
  ClinicalTrials.gov Identifier: NCT00356889 - Recruiting
  Extrahepatic Bile Duct Cancer; Gallbladder Cancer
  
• Bevacizumab and Erlotinib in Treating Patients With Metastatic Pancreatic Cancer That Did Not Respond to Previous Treatment With Gemcitabine
  ClinicalTrials.gov Identifier: NCT00365144 - Recruiting
  Pancreatic Cancer
  
• Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00055913 - Active, not recruiting
  Head and Neck Cancer
  
• Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
  ClinicalTrials.gov Identifier: NCT00126542 - Active, not recruiting
  recurrent ovarian epithelial cancer; stage IV ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer
  
• Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00091026 - Recruiting
  adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
  
• Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00028834 - Completed
  stage III pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00126490 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00301990 - Recruiting
  Kidney Cancer
  
• Bevacizumab and Irinotecan in Treating Patients With Recurrent High-Grade Malignant Glioma That Progressed on Bevacizumab Alone
  ClinicalTrials.gov Identifier: NCT00393094 - Recruiting
  Brain and Central Nervous System Tumors
  
• Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas
  ClinicalTrials.gov Identifier: NCT00268359 - Active, not recruiting
  Adult Anaplastic Astrocytoma; Adult Anaplastic Oligodendroglioma; Adult Glioblastoma; Adult Gliosarcoma; Recurrent Adult Brain Tumor; ...
  
• Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, or Ependymoma
  ClinicalTrials.gov Identifier: NCT00381797 - Recruiting
  Brain and Central Nervous System Tumors
  
• Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
  ClinicalTrials.gov Identifier: NCT00433381 - Suspended
  Brain and Central Nervous System Tumors
  
• Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00305825 - Active, not recruiting
  Breast Cancer
  
• Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00072566 - Completed
  recurrent ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer
  
• Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00098787 - Recruiting
  recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer; adenocarcinoma of the colon; ...
  
• Bevacizumab and PEG-Interferon alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors
  ClinicalTrials.gov Identifier: NCT00055809 - Completed
  recurrent gastrointestinal carcinoid tumor; metastatic gastrointestinal carcinoid tumor; regional gastrointestinal carcinoid tumor
  
• Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00347399 - Recruiting
  Age Related Macular Degeneration
  
• Bevacizumab and Radiation Therapy for Sarcomas
  ClinicalTrials.gov Identifier: NCT00356031 - Recruiting
  Soft Tissue Sarcoma; Fibrous Histiocytoma; Liposarcoma; Leiomyosarcoma; Fibrosarcoma; Synovial Sarcoma
  
• Bevacizumab and Retinal Vascular Occlusions
  ClinicalTrials.gov Identifier: NCT00347711 - Recruiting
  Edema Macular; Vascular Occlusion
  
• Bevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00387751 - Recruiting
  Melanoma (Skin)
  
• Bevacizumab and Sunitinib in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00357318 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Bevacizumab and Trastuzumab (Herceptin®) in Treating Women With Relapsed or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00093535 - Recruiting
  recurrent breast cancer; stage IIIC breast cancer; stage IV breast cancer; stage IIIB breast cancer
  
• Bevacizumab as an Adjuvant for Resectable Ductal Adenocarcinoma of the Pancreas
  ClinicalTrials.gov Identifier: NCT00158392 - Recruiting
  
  
• Bevacizumab Combined With Either Docetaxel or Erlotinib Compared With Docetaxel Alone in Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00098410 - Recruiting
  recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; Adenocarcinoma of the Lung; ...
  
• Bevacizumab Erlotinib Study in Advanced Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00130520 - Recruiting
  Ovarian Neoplasms
  
• Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00405938 - Recruiting
  Breast Cancer; Breast Neoplasms
  
• Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00501891 - Recruiting
  Glioblastoma Multiforme; Brain and Central Nervous System Tumors; Recurrent Malignant Glioma; Recurrent Glioblastoma Multiforme
  
• Bevacizumab in Combination with Temozolomide in Patients with Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00137774 - Active, not recruiting
  Metastatic Neuroendocrine Tumor; Neuroendocrine Tumor
  
• Bevacizumab in Combination With Verteporfin Reduced and Standard Fluence in the Treatment of Hemorrhaged Lesions in Neovascular AMD
  ClinicalTrials.gov Identifier: NCT00403442 - Recruiting
  Macular Degeneration
  
• Bevacizumab in Multiple Phase I Combinations
  ClinicalTrials.gov Identifier: NCT00543504 - Recruiting
  Advanced Cancer
  
• Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00492089 - Recruiting
  Brain and Central Nervous System Tumors; Head and Neck Cancer; Radiation Toxicity; Sarcoma
  
• Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00544700 - Recruiting
  Colorectal Cancer
  
• Bevacizumab in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00416637 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Bevacizumab in Treating Patients With Angiosarcoma
  ClinicalTrials.gov Identifier: NCT00288015 - Suspended
  Sarcoma
  
• Bevacizumab in Treating Patients With Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00058136 - Recruiting
  Sarcoma
  
• Bevacizumab in Treating Patients With Metastatic Breast or Colorectal Cancer Who Received Bevacizumab on a Phase II or Phase III Clinical Trial
  ClinicalTrials.gov Identifier: NCT00066560 - Completed
  stage IV breast cancer; recurrent breast cancer; stage IV colon cancer; Stage IV rectal cancer
  
• Bevacizumab in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00022048 - Completed
  atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes
  
• Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00016094 - Active, not recruiting
  recurrent adult diffuse large cell lymphoma; recurrent adult Burkitt's lymphoma; recurrent mantle cell lymphoma; anaplastic large cell lymphoma
  
• Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix
  ClinicalTrials.gov Identifier: NCT00025233 - Active, not recruiting
  recurrent cervical cancer; cervical squamous cell carcinoma
  
• Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00022659 - Active, not recruiting
  stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Bevacizumab in Treating Patients With Recurrent Glioma
  ClinicalTrials.gov Identifier: NCT00290797 - Recruiting
  Brain and Central Nervous System Tumors
  
• Bevacizumab in Treating Patients With Recurrent or Persistent Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00301964 - Recruiting
  Endometrial Cancer
  
• Bevacizumab in Treating Patients With Recurrent or Progressive Glioma
  ClinicalTrials.gov Identifier: NCT00337207 - Recruiting
  Brain and Central Nervous System Tumors
  
• Bevacizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00290810 - Recruiting
  Leukemia
  
• Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00482495 - Suspended
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00478413 - Recruiting
  Prostate Cancer
  
• Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer
  ClinicalTrials.gov Identifier: NCT00055692 - Active, not recruiting
  adult primary hepatocellular carcinoma; recurrent adult primary liver cancer; localized unresectable adult primary liver cancer
  
• Bevacizumab in Treating Young Patients With Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00085111 - Completed
  unspecified childhood solid tumor, protocol specific
  
• Bevacizumab or Cetuximab Combined With Gemcitabine, Capecitabine, and Radiation Therapy in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00305877 - Recruiting
  Pancreatic Cancer
  
• Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00203411 - Recruiting
  Colorectal Cancer
  
• Bevacizumab Plus Docetaxel and Doxorubicin in Treating Patients With Previously Untreated Inflammatory or Locally Advanced Stage IIB or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00021086 - Completed
  Breast Cancer
  
• Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy
  ClinicalTrials.gov Identifier: NCT00066846 - Completed
  adenocarcinoma of the colon; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients
  ClinicalTrials.gov Identifier: NCT00583622 - Recruiting
  Ovarian Cancer
  
• Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00017394 - Completed
  Male Breast Cancer; stage IV breast cancer; recurrent breast cancer
  
• Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00016549 - No longer recruiting
  Breast Cancer
  
• Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients
  ClinicalTrials.gov Identifier: NCT00055237 - Recruiting
  Kaposi's Sarcoma; HIV Infections; HIV Seronegativity
  
• Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical Trial
  ClinicalTrials.gov Identifier: NCT00370422 - Active, not recruiting
  Diabetic Macular Edema
  
• Bevacizumab Versus Ranibizumab for Diabetic Retinopathy
  ClinicalTrials.gov Identifier: NCT00545870 - Recruiting
  Diabetic Retinopathy; Diabetic Macula Edema; Proliferative Diabetic Retinopathy
  
• Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00407563 - Recruiting
  Epithelial Ovarian Cancer; Primary Peritoneal Carcinoma
  
• Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00349557 - Recruiting
  Prostate Cancer
  
• Bevacizumab with Or Without Cyclophosphamide and Methotrexate: a Pilot Study in Women with Operable Breast Cancer
  ClinicalTrials.gov Identifier: NCT00121134 - Recruiting
  Breast Cancer
  
• Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00066677 - Active, not recruiting
  adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Bevacizumab With or Without Interferon alfa in Treating Patients With Metastatic Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00026221 - Recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00022607 - Completed
  refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Bevacizumab(Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma
  ClinicalTrials.gov Identifier: NCT00323739 - Active, not recruiting
  Kidney Cancer
  
• Bevacizumab(Avastin) Induced Hypertension and Correlation With Tumor Response, a Chart Review
  ClinicalTrials.gov Identifier: NCT00322725 - Active, not recruiting
  Cancer
  
• Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00387699 - Suspended
  Lung Cancer
  
• Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
  ClinicalTrials.gov Identifier: NCT00408694 - Recruiting
  Head and Neck Cancer
  
• Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers
  ClinicalTrials.gov Identifier: NCT00015951 - Active, not recruiting
  recurrent adult acute myeloid leukemia; relapsing chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; ...
  
• Bevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00308607 - Recruiting
  Metastatic Melanoma
  
• Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00281840 - Recruiting
  Head and Neck Cancer
  
• Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer
  ClinicalTrials.gov Identifier: NCT00436709 - Active, not recruiting
  Breast Cancer
  
• Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00307736 - Recruiting
  Rectal Cancer; Adenocarcinoma of the Rectum
  
• Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00543842 - Recruiting
  Rectal Cancer
  
• Bevacizumab, Erlotinib, and Imatinib in the Treatment of Advanced Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00193258 - Active, not recruiting
  Prostate Cancer
  
• Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00276575 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00052559 - Recruiting
  stage II rectal cancer; stage III rectal cancer; adenocarcinoma of the rectum
  
• Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00023959 - Active, not recruiting
  Head and Neck Cancer
  
• Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00112528 - Active, not recruiting
  duct cell adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
  
• Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00348998 - Recruiting
  Prostate Cancer
  
• Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00023920 - Completed
  blastic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
  
• Bevacizumab, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Stage II or Stage III Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00410605 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer
  ClinicalTrials.gov Identifier: NCT00217581 - Recruiting
  Esophageal Cancer; Gastric Cancer
  
• Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00025389 - Completed
  stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer
  
• Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00369551 - Active, not recruiting
  Lung Cancer
  
• Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00369122 - Recruiting
  Cervical Cancer
  
• Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00321685 - Recruiting
  Colorectal Cancer
  
• Bevacizumab, Sorafenib, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00378703 - Recruiting
  Kidney Cancer
  
• Bevacizumab, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma Previously Treated With Radiation Therapy and Temozolomide
  ClinicalTrials.gov Identifier: NCT00535249 - Recruiting
  Brain and Central Nervous System Tumors
  
• Bevacizumab/Docetaxel/Carboplatin in Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00271505 - Recruiting
  Non-Small Cell Lung Cancer; Lung Cancer
  
• Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00392665 - Recruiting
  Squamous Cell Carcinoma of the Head and Neck (SCCHN)
  
• Bevicizumab (Avastin) Infusion for CNV Not Associated With AMD
  ClinicalTrials.gov Identifier: NCT00407719 - Active, not recruiting
  Choroidal Neovascularization; Degenerative Myopia; Pathological Myopia
  
• Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients
  ClinicalTrials.gov Identifier: NCT00534898 - Not yet recruiting
  Schizophrenia; Schizoaffective Disorder; Cognition
  
• Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00425477 - Recruiting
  Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Bexarotene and Interferon alfa in Treating Patients With Cutaneous T-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00030849 - Active, not recruiting
  stage I cutaneous T-cell lymphoma; stage II cutaneous T-cell lymphoma; stage III cutaneous T-cell lymphoma; stage IV cutaneous T-cell lymphoma; ...
  
• Bexarotene Augmentation of Antipsychotic Treatment for Chronic Schizophrenia
  ClinicalTrials.gov Identifier: NCT00535574 - Not yet recruiting
  Schizophrenia
  
• Bexarotene in Preventing Breast Cancer in Women at Genetic Risk
  ClinicalTrials.gov Identifier: NCT00055991 - Active, not recruiting
  Breast Cancer
  
• Bexarotene in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003752 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Bexarotene Treatment in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00141947 - Recruiting
  Schizophrenia
  
• Bexarotene with Narrow-Band UVB for Psoriasis
  ClinicalTrials.gov Identifier: NCT00151008 - Active, not recruiting
  Psoriasis
  
• Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00514293 - Recruiting
  Lung Cancer
  
• Beyond Ageing: A Study for the Prevention of Depression, Cognitive Impairment and the Improvement of Knowledge About Mental Health
  ClinicalTrials.gov Identifier: NCT00214682 - Recruiting
  Depression; Depressive Disorder; Cognition
  
• BEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New Dose
  ClinicalTrials.gov Identifier: NCT00459667 - Active, not recruiting
  Multiple Sclerosis
  
• BEYOND Study - Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
  ClinicalTrials.gov Identifier: NCT00099502 - Active, not recruiting
  Multiple Sclerosis
  
• Bezafibrate Trial in CPT2 Deficiency
  ClinicalTrials.gov Identifier: NCT00336167 - Recruiting
  Carnitine Palmitoyl Transferase 2 Deficiency
  
• BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis
  ClinicalTrials.gov Identifier: NCT00001789 - Completed
  Glomerulonephritis, Membranoproliferative; Lupus Nephritis
  
• BG9924 in Combination With Methotrexate Extension of Study 104RA203
  ClinicalTrials.gov Identifier: NCT00523328 - Recruiting
  Rheumatoid Arthritis
  
• BG9924 in Combination With Methotrexate for Subjects With Active Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00458861 - Recruiting
  Rheumatoid Arthritis
  
• BHS4 - Bone/Muscle Changes Following Hip Fracture in Older White Women
  ClinicalTrials.gov Identifier: NCT00390741 - Active, not recruiting
  Hip Fracture
  
• BHS5 - Testing the Effectiveness of the Exercise Plus Program
  ClinicalTrials.gov Identifier: NCT00389844 - Active, not recruiting
  Hip Fracture
  
• BHT-3009 Immunotherapy in Relapsing Remitting Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00382629 - Active, not recruiting
  Relapsing Remitting Multiple Sclerosis
  
• BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00526149 - Recruiting
  Breast Cancer; Head and Neck Cancer; Melanoma (Skin); Ovarian Cancer; Sarcoma
  
• BI 2536 in Treating Patients With Refractory or Relapsed Advanced Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00243087 - Recruiting
  Lymphoma
  
• BI 2536 Second Line Monotherapy in SCLC
  ClinicalTrials.gov Identifier: NCT00412880 - Recruiting
  Carcinoma, Small Cell
  
• Bi-Axial Rotating Magnetic Field Therapy in Refractory Neuropathic Foot Pain Secondary to Diabetic Peripheral Neuropathy
  ClinicalTrials.gov Identifier: NCT00123136 - Recruiting
  diabetic peripheral neuropathic pain; sleep benefit; diabetic peripheral neuropathic functioning
  
• Bi-Ventricular Pacing in Patients With Atrial Fibrillation and Heart Failure (BIFF-Study)
  ClinicalTrials.gov Identifier: NCT00457834 - Recruiting
  Heart Failure
  
• Bi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00215709 - Completed
  Prostate Cancer
  
• Bi-Weekly Docetaxel Plus 24-Hour Infusion of HDFL and for Inoperable Advanced or Metastatic Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00155883 - Recruiting
  Gastric Cancer
  
• Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00006481 - Completed
  stage IV squamous cell carcinoma of the lip and oral cavity; stage III squamous cell carcinoma of the hypopharynx; ...
  
• Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma
  ClinicalTrials.gov Identifier: NCT00461084 - Recruiting
  Lymphoma
  
• BIBF 1120 in Treating Patients With Relapsed Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00370175 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• BIBW 2992 in Head&Neck Cancer
  ClinicalTrials.gov Identifier: NCT00514943 - Recruiting
  Head and Neck Neoplasms; Carcinoma, Squamous Cell
  
• BIBX 1382 in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003980 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum
  ClinicalTrials.gov Identifier: NCT00012090 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
  
• Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00014586 - Active, not recruiting
  stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Bicalutamide in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00468715 - Recruiting
  Breast Cancer
  
• Bicalutamide Monotherapy Has Significant Quality of Life Benefits for Men With Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00551044 - Completed
  Prostatic Neoplasms
  
• Bicarbonate v Saline to Prevent Contrast Nephropathy
  ClinicalTrials.gov Identifier: NCT00384995 - Recruiting
  Kidney Failure, Acute; Contrast Media
  
• Bicillin L-A vs Placebo for the Treatment of Chronic, Plaque-Type Psoriasis Unresponsive to Topical Medications
  ClinicalTrials.gov Identifier: NCT00427609 - Recruiting
  Psoriasis
  
• Bifeprunox in the Treatment of Schizophrenia
  ClinicalTrials.gov Identifier: NCT00193687 - Completed
  Schizophrenia
  
• Bifeprunox in the Treatment of Schizophrenia
  ClinicalTrials.gov Identifier: NCT00193713 - Completed
  Schizophrenia
  
• Bifocal Soft Contact Lenses and Their Effect on Myopia Progression in Children and Adolescents.
  ClinicalTrials.gov Identifier: NCT00214487 - Active, not recruiting
  Myopia; Esophoria; Fixation Disparity
  
• Bifurcated Stent-Graft for Endovascular Repair of Aneurysms Involving the Proximal Aortic Arch
  ClinicalTrials.gov Identifier: NCT00488696 - Recruiting
  Aortic Aneurysm of the Proximal Arch
  
• BIG 02/98 Docetaxel - Breast Cancer
  ClinicalTrials.gov Identifier: NCT00174655 - Active, not recruiting
  Breast Neoplasms
  
• Bikram Yoga and Asthma
  ClinicalTrials.gov Identifier: NCT00410098 - Not yet recruiting
  Asthmatics
  
• Bilateral Benefit in Adult Users of the HiRes 90K Bionic Ear System
  ClinicalTrials.gov Identifier: NCT00205881 - Recruiting
  Hearing Loss
  
• Bilateral Cochlear Implant Benefit in Young Children
  ClinicalTrials.gov Identifier: NCT00424307 - Recruiting
  Hearing Loss
  
• Bilateral Internal Pallidum Stimulation in Primary Generalized Dystonia
  ClinicalTrials.gov Identifier: NCT00272246 - Recruiting
  Dystonia; Primary Generalized Dystonia
  
• Bilateral Laryngeal Paralysis Reinnervation
  ClinicalTrials.gov Identifier: NCT00213616 - Recruiting
  Vocal Cord Paralysis
  
• Bilateral Recession or Unilateral Recession-Resection as Surgery for Infantile Esotropia
  ClinicalTrials.gov Identifier: NCT00304577 - Completed
  Strabismus
  
• Bilateral Refractive Amblyopia Treatment Study
  ClinicalTrials.gov Identifier: NCT00305955 - Completed
  Bilateral Refractive Amblyopia
  
• Bilateral Sinus Floor Augmentation in Conjunction With Immediate Implant Loading – Study on 3i Dental Implants
  ClinicalTrials.gov Identifier: NCT00318487 - Recruiting
  Mouth, Edentulous
  
• Biliary Atresia Research Consortium
  ClinicalTrials.gov Identifier: NCT00061828 - Recruiting
  Biliary Atresia; Cholestasis
  
• Biliary Atresia Study in Infants and Children
  ClinicalTrials.gov Identifier: NCT00345553 - Recruiting
  Biliary Atresia
  
• Biliary Cancers: EGFR INhibitor, Gemcitabine and Oxaliplatin
  ClinicalTrials.gov Identifier: NCT00552149 - Recruiting
  Advanced Biliary Cancer
  
• Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary Obstruction
  ClinicalTrials.gov Identifier: NCT00280709 - Recruiting
  Bile Duct Obstruction; Pancreatic Cancer; Gallbladder Cancer; Bile Duct Cancer
  
• Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00513539 - Not yet recruiting
  Extrahepatic Bile Duct Cancer; Gallbladder Cancer
  
• Biliary Tissue Sampling Using a Cytology Brush or the GIUM Catheter
  ClinicalTrials.gov Identifier: NCT00160836 - Recruiting
  Pancreatic Neoplasms; Cholangiocarcinoma; Pancreatitis
  
• Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%
  ClinicalTrials.gov Identifier: NCT00440011 - Recruiting
  Glaucoma; Ocular Hypertension
  
• Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00348023 - Completed
  Glaucoma
  
• Bimetric-10: Investigation of Patients Who Have Underwent Total Hip Arthroplasty With a Cemented Bi-Metric Stem
  ClinicalTrials.gov Identifier: NCT00192699 - Active, not recruiting
  Osteoarthrosis
  
• Bimodal Analgesia as Form of Pain Control Post Long Bone Fracture
  ClinicalTrials.gov Identifier: NCT00240396 - Recruiting
  Tibia Fracture; Femur Fracture; Humerus Fracture
  
• Bio-Availability of a New Liquid Tumeric Extract
  ClinicalTrials.gov Identifier: NCT00542711 - Not yet recruiting
  Healthy
  
• Bio-Behavioral Lung Cancer Prevention Program
  ClinicalTrials.gov Identifier: NCT00322205 - Completed
  Smoking Cessation
  
• Bio-Behavioral Predictors of the Efficacy of Nicotine Replacement Therapy (NRT)
  ClinicalTrials.gov Identifier: NCT00326781 - Active, not recruiting
  Smoking
  
• BIO-SEAL Biopsy Track Plug for Reducing Pneumothorax Rates Post Lung Biopsy Procedure
  ClinicalTrials.gov Identifier: NCT00562302 - Recruiting
  Pneumothorax
  
• Bioavailability and Effectiveness of Transdermally Administered Morphine
  ClinicalTrials.gov Identifier: NCT00125684 - Recruiting
  Cancer related pain; Stable Baseline Pain; Currently Taking Opioids
  
• Bioavailability and Metabolism of Voriconazole in Relation to Its Modulation by the CYP2C19 Genetic Polymorphism
  ClinicalTrials.gov Identifier: NCT00175994 - Completed
  Healthy
  
• Bioavailability of Aliskiren and Valsartan as a Single Tablet vs. the Same Doses of the Two Drugs Given Separately to Healthy Subjects.
  ClinicalTrials.gov Identifier: NCT00416728 - Completed
  Healthy
  
• Bioavailability of Aliskiren and Valsartan Combined as a Single Tablet vs. the Same Medications Given Separately to Healthy Subjects.
  ClinicalTrials.gov Identifier: NCT00416468 - Completed
  Healthy
  
• Bioavailability of Bimatoprost Ophthalmic Solution in Human Aqueous.
  ClinicalTrials.gov Identifier: NCT00355446 - Completed
  Cataract
  
• Bioavailability Of Flucloxacillin Capsules (250 Mg and 500 Mg)
  ClinicalTrials.gov Identifier: NCT00358371 - Completed
  Healthy
  
• Bioavailability of Folate from a Mixed Diet Using a Stable Isotope Method
  ClinicalTrials.gov Identifier: NCT00130585 - Completed
  Folate Bioavailability
  
• Bioavailability of Insulin Administered in Duodenum
  ClinicalTrials.gov Identifier: NCT00353990 - Completed
  Diabetes Mellitus
  
• Bioavailability of the Fixed Combination of Amodiaquine and Artesunate Under Fed & Fasted Conditions
  ClinicalTrials.gov Identifier: NCT00386503 - Completed
  Malaria
  
• Bioavailability Study Comparing Two New Nilotinib Tablet Formulations to an Established Nilotinib Capsule Formulation in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00418769 - Completed
  Healthy
  
• Bioavailability Study of a New Pediatric Formulation of Zidovudine/Lamivudine in Adult Volunteers
  ClinicalTrials.gov Identifier: NCT00470041 - Recruiting
  Healthy
  
• Bioavailability, Pharmacokinetics and Pharmacodynamics of IAsp Following Continuous Subcutaneous Insulin Infusion (CSII)
  ClinicalTrials.gov Identifier: NCT00497536 - Recruiting
  Type 1 Diabetes Mellitus
  
• Biobank Anus Carcinoma
  ClinicalTrials.gov Identifier: NCT00157417 - Recruiting
  Anus Cancer
  
• Biobank Bladder Carcinoma
  ClinicalTrials.gov Identifier: NCT00157365 - Recruiting
  Bladder Cancer
  
• Biobank Cervix Carcinoma
  ClinicalTrials.gov Identifier: NCT00157443 - Recruiting
  Cervix Cancer
  
• Biobank Endometrial Carcinoma
  ClinicalTrials.gov Identifier: NCT00157495 - Recruiting
  Endometrial Cancer
  
• Biobank Esophagus Cancer: Storing Blood and Protein of Patients With Esophagus Cancer
  ClinicalTrials.gov Identifier: NCT00181337 - Recruiting
  Esophagus Cancer
  
• Biobank For MS And Other Demyelinating Diseases
  ClinicalTrials.gov Identifier: NCT00445367 - Recruiting
  Multiple Sclerosis; Transverse Myelitis; Neuromyelitis Optica; Acute Disseminated Encephalomyelitis; Optic Neuritis
  
• Biobank Glioma: Storing Blood for Analysis of DNA and Protein of Patients With Glioma
  ClinicalTrials.gov Identifier: NCT00181493 - Recruiting
  Glioma
  
• Biobank Head and Neck Cancer: Storing Blood for Analysis of DNA and Protein of Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00181428 - Recruiting
  Head and Neck Cancer
  
• Biobank Hodgkin Lymphoma: Storing Blood and Protein of Patients With Hodgkin Lymphoma
  ClinicalTrials.gov Identifier: NCT00181467 - Recruiting
  Hodgkin Lymphoma
  
• Biobank Lung Cancer: Storing Blood and Protein of Patients With Lung Cancer
  ClinicalTrials.gov Identifier: NCT00181519 - Recruiting
  Lung Cancer
  
• Biobank Mammary Cancer: Storing Blood and Protein of Patients With Mammary Cancer
  ClinicalTrials.gov Identifier: NCT00181389 - Recruiting
  Mammary Carcinoma; Cancer
  
• Biobank Meningioma: Storing Blood for Analysis of DNA and Protein of Patients With Meningioma
  ClinicalTrials.gov Identifier: NCT00181454 - Recruiting
  Meningioma
  
• Biobank Non-Hodgkin Lymphoma: Storing Blood for Analysis of DNA and Protein of Patients With Non-Hodgkin Lymphoma
  ClinicalTrials.gov Identifier: NCT00181415 - Recruiting
  Non-Hodgkin Lymphoma
  
• Biobank Ovary Carcinoma
  ClinicalTrials.gov Identifier: NCT00157391 - Recruiting
  Ovary Cancer
  
• Biobank Pancreas Carcinoma
  ClinicalTrials.gov Identifier: NCT00157404 - Recruiting
  Pancreas Cancer
  
• Biobank Penis Carcinoma
  ClinicalTrials.gov Identifier: NCT00157352 - Recruiting
  Penis Cancer
  
• Biobank Prostate Cancer: Storing Blood and Protein of Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00181402 - Recruiting
  Prostate Cancer
  
• Biobank Sarcoma: Storing Blood for Analysis of DNA and Protein of Patients With Sarcoma
  ClinicalTrials.gov Identifier: NCT00181480 - Recruiting
  Sarcoma
  
• Biobank Skin Cancer: Storing Blood and Protein of Patients With Skin Cancer
  ClinicalTrials.gov Identifier: NCT00181441 - Recruiting
  Skin Cancer
  
• Biobank Testis Cancer: Storing Blood for Analysis of Patients With Testis Cancer
  ClinicalTrials.gov Identifier: NCT00181376 - Recruiting
  Testis Cancer
  
• Biobank Uterus Carcinoma
  ClinicalTrials.gov Identifier: NCT00157469 - Recruiting
  Uterus Cancer
  
• Biobank Vagina Carcinoma
  ClinicalTrials.gov Identifier: NCT00157456 - Recruiting
  Vagina Cancer
  
• Biobank Vulva Carcinoma
  ClinicalTrials.gov Identifier: NCT00157430 - Recruiting
  Vulva Cancer
  
• Biobehavioral Determinants of Obesity in Black Women
  ClinicalTrials.gov Identifier: NCT00005386 - Completed
  Cardiovascular Diseases; Heart Diseases; Obesity; Telangiectasis
  
• Biobehavioral Mechanisms of Blood Pressure Regulation
  ClinicalTrials.gov Identifier: NCT00005366 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Biobehavioral Predictors of Coronary Angioplasty Outcome
  ClinicalTrials.gov Identifier: NCT00005554 - Completed
  Cardiovascular Diseases; Heart Diseases; Coronary Disease
  
• Biobehavioral Recovery From Surgery and Anesthesia
  ClinicalTrials.gov Identifier: NCT00176696 - Recruiting
  Pain, Postoperative
  
• Biochemical and Genetic Markers of Hypertension in Women
  ClinicalTrials.gov Identifier: NCT00090467 - Active, not recruiting
  Cardiovascular Diseases; Hypertension; Heart Diseases; Inflammation
  
• Biochemical and Radiological Indicators of Cardiovascular Morbidity in Children With Premature Pubarche
  ClinicalTrials.gov Identifier: NCT00581490 - Recruiting
  Evidence of Cardiovascular Morbidity
  
• Biochemical Brain Changes Correlated With The Antidepressant Effect Of Thyroid Hormones
  ClinicalTrials.gov Identifier: NCT00562367 - Completed
  Major Depressive Disorder
  
• Biochemical Factors for a Dry Eyed Population
  ClinicalTrials.gov Identifier: NCT00522847 - Recruiting
  Postmenopausal; Dry Eye; Non Dry Eye
  
• Biochemical Marker to Predict the Recurrence of Atrial Fibrillation After Surgical Maze Procedure
  ClinicalTrials.gov Identifier: NCT00542659 - Recruiting
  Atrial Fibrillation
  
• Biochemical Markers of Growth Response to GH Treatment in Children With Idiopathic Short Stature
  ClinicalTrials.gov Identifier: NCT00458263 - Recruiting
  Idiopathic Short Stature
  
• Biochemotherapy With Temozolomide for Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00505635 - Recruiting
  Melanoma
  
• Biodegradable Biliary Stent for Post Operative Cystic Duct Leakage
  ClinicalTrials.gov Identifier: NCT00493675 - Recruiting
  Cystic Duct Leakage
  
• Biodistribution and Safety of a Radiopharmaceutical in Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00316797 - Recruiting
  Healthy Control
  
• Biodistribution Study of CMD-193 in Patients With Advanced Tumours Expressing the Lewis-Y Antigen
  ClinicalTrials.gov Identifier: NCT00293215 - Completed
  Neoplasms
  
• Bioelectric Field Imaging Near Human Skin Wounds
  ClinicalTrials.gov Identifier: NCT00355823 - Recruiting
  Wounds
  
• Bioengineered Skin and Wound Healing
  ClinicalTrials.gov Identifier: NCT00007280 - Active, not recruiting
  Leg Ulcers
  
• Bioequipotency Study of SSR126517E and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs (EQUINOX)
  ClinicalTrials.gov Identifier: NCT00311090 - Active, not recruiting
  Deep Venous Thrombosis
  
• Bioequivalence And Effect Of Food And Water On Lamotrigine in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00449774 - Completed
  Healthy Volunteers
  
• Bioequivalence and Food Effect Study in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00495274 - Not yet recruiting
  Insomnia
  
• Bioequivalence And Lack Of Food Effects Of 300mg Lamotrigine XR
  ClinicalTrials.gov Identifier: NCT00412191 - Completed
  Epilepsy
  
• Bioequivalence of Vildagliptin Tablet Manufactured in China Compared to Imported Vildagliptin Tablet in Chinese Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00414947 - Completed
  Healthy
  
• Bioequivalence Study in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00387985 - Completed
  Healthy
  
• Bioequivalence Study of 3 New Formulations of Premarin/MPA Compared With Premarin/MPA (Prempro)
  ClinicalTrials.gov Identifier: NCT00472927 - Completed
  Postmenopause
  
• Bioequivalence Study of Atazanavir 300 mg Capsule
  ClinicalTrials.gov Identifier: NCT00393328 - Completed
  HIV Infections
  
• Bioequivalence Study Of Bazedoxifene/Conjugated Estrogen Tablets In Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00396799 - Completed
  Menopause
  
• Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00415740 - Completed
  Healthy
  
• Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00415831 - Completed
  Healthy
  
• Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00415922 - Completed
  Healthy
  
• Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone Under Fasting Conditions in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00415844 - Completed
  Healthy
  
• Bioequivalence Study of Generic GPO Ritonavir Versus Norvir®
  ClinicalTrials.gov Identifier: NCT00477126 - Completed
  Healthy
  
• Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets
  ClinicalTrials.gov Identifier: NCT00550329 - Completed
  Diabetes Mellitus, Non-Insulin-Dependent; Hyperglycemia
  
• Bioequivalence Study of SB797620 in Healthy Japanese Volunteers
  ClinicalTrials.gov Identifier: NCT00549263 - Not yet recruiting
  Healthy Subjects
  
• Bioequivalence Trial of a New Opioid Combination Compared to Reference
  ClinicalTrials.gov Identifier: NCT00460785 - Completed
  Healthy
  
• Biofeedback and EMG-Triggered Stimulation in Fecal Incontinence
  ClinicalTrials.gov Identifier: NCT00525291 - Recruiting
  Fecal Incontinence; Therapy; EMG - Biofeedback; EMG - Triggered Stimulation; Augmented Biofeedback
  
• Biofeedback for Dyssynergic Constipation
  ClinicalTrials.gov Identifier: NCT00127257 - Completed
  Constipation
  
• Biofeedback for Fecal Incontinence
  ClinicalTrials.gov Identifier: NCT00124904 - Completed
  Fecal Incontinence
  
• Biofeedback Treatment for Functional Constipation
  ClinicalTrials.gov Identifier: NCT00502957 - Active, not recruiting
  Constipation
  
• Bioidentical 'Natural' Hormone Evaluation in Early Menopause
  ClinicalTrials.gov Identifier: NCT00302731 - Recruiting
  Menopause
  
• Biologic Correlative Taxotere/AC
  ClinicalTrials.gov Identifier: NCT00206466 - Active, not recruiting
  Breast Cancer
  
• Biologic Effects of Dehydroepiandrosterone (DHEA) in Humans
  ClinicalTrials.gov Identifier: NCT00099697 - Completed
  Aging; Obesity; Insulin Resistance
  
• Biological Aspects of Depression and Antidepressant Drugs
  ClinicalTrials.gov Identifier: NCT00018733 - Completed
  Depression
  
• Biological CVD Risk Factors in Older Depressed Patients
  ClinicalTrials.gov Identifier: NCT00318864 - Completed
  Depression; Hypertension; Hypercholesterolemia
  
• Biological Effects of Dehydroepiandrosterone (DHEA) in the Elderly
  ClinicalTrials.gov Identifier: NCT00111930 - Completed
  Healthy
  
• Biological Efficacy of Clopidogrel After Implantation of Drug-Eluting Stents (SPACE)
  ClinicalTrials.gov Identifier: NCT00298428 - Recruiting
  Coronary Artery Disease; Atherosclerosis; Diabetes Mellitus; Metabolic Syndrome X
  
• Biological Functions of Carotenoids in Humans
  ClinicalTrials.gov Identifier: NCT00356252 - Completed
  Oxidative DNA Damage
  
• Biological Imaging for Optimising CTV and GTV Contouring in Prostate Cancer to Improve the Possibilities for IMRT Dose Escalation
  ClinicalTrials.gov Identifier: NCT00122252 - Terminated
  -prostate cancer
  
• Biological Imaging Guided Antalgic Radiotherapy of Bone Metastases (Phase II Trial)
  ClinicalTrials.gov Identifier: NCT00503178 - Recruiting
  Bone Metastases
  
• Biological Markers in Attention Deficit/Hyperactivity Disorder (ADHD)
  ClinicalTrials.gov Identifier: NCT00001206 - Recruiting
  Attention Deficit and Disruptive Behavior Disorder; Attention Deficit Disorder with Hyperactivity
  
• Biological Markers in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00088335 - Completed
  Parkinson Disease
  
• Biological Markers in Retinal Vasculitis
  ClinicalTrials.gov Identifier: NCT00050492 - Completed
  Retinal Vasculitis
  
• Biological Markers of Disease in the Prediction of Preterm Delivery, Preeclampsia and Intra-Uterine Growth Retardation: A Longtitudinal Study
  ClinicalTrials.gov Identifier: NCT00340899 - Recruiting
  Maternal Fetal Factors
  
• Biological Markers of Response to Treatment in Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00361218 - Recruiting
  Major Depressive Disorder
  
• Biological significance of the Bloom's syndrome protein
  ClinicalTrials.gov Identifier: NCT00021437 - Completed
  Bloom Syndrome
  
• Biological Specifications for Denture Designs
  ClinicalTrials.gov Identifier: NCT00018512 - Completed
  Tooth Loss
  
• Biological Specimen Collection for Laboratory Methods Development and Training Purposes
  ClinicalTrials.gov Identifier: NCT00025831 - Completed
  Healthy
  
• Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005993 - Active, not recruiting
  Lymphoma; Breast Cancer
  
• Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00012207 - Recruiting
  recurrent grade 1 follicular lymphoma; recurrent grade 2 follicular lymphoma; recurrent grade 3 follicular lymphoma
  
• Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00030342 - Recruiting
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; Stage IV Renal Cell Cancer; ...
  
• Biological Therapy and Combination Chemotherapy in Treating Patients With Lymphomatoid Granulomatosis
  ClinicalTrials.gov Identifier: NCT00018993 - Recruiting
  Lymphoma; Precancerous/Nonmalignant Condition
  
• Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00006480 - Active, not recruiting
  disseminated neuroblastoma; Drug Toxicity; recurrent neuroblastoma
  
• Biological Therapy and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00052715 - Active, not recruiting
  adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
  
• Biological Therapy and Temozolomide in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00016055 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00003408 - Active, not recruiting
  Leukemia; Testicular Cancer; ovarian epithelial cancer; Lymphoma; Breast Cancer; Multiple Myeloma; kidney tumor
  
• Biological Therapy Following Surgery and Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Lung Cancer
  ClinicalTrials.gov Identifier: NCT00004019 - Suspended
  extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer; limited stage small cell lung cancer; stage IV non-small cell lung cancer; ...
  
• Biological Therapy Following Surgery and Chemotherapy in Treating Patients With Stage III or Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00004018 - Active, not recruiting
  stage IIIB breast cancer; stage IV breast cancer; stage IIIA breast cancer; recurrent breast cancer
  
• Biological Therapy Following Surgery and Chemotherapy in Treating Patients With Stage III or Stage IV Colon Cancer
  ClinicalTrials.gov Identifier: NCT00004020 - Suspended
  recurrent colon cancer; stage III colon cancer; stage IV colon cancer
  
• Biological Therapy Following Surgery and Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00004021 - Suspended
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian germ cell tumor; recurrent ovarian epithelial cancer; ...
  
• Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma
  ClinicalTrials.gov Identifier: NCT00004024 - Active, not recruiting
  adult brain tumor
  
• Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00004023 - Suspended
  stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00004022 - Suspended
  Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
  
• Biological Therapy in Previously Treated Patients With Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003090 - Active, not recruiting
  recurrent non-small cell lung cancer
  
• Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors
  ClinicalTrials.gov Identifier: NCT00003750 - Active, not recruiting
  childhood soft tissue sarcoma; childhood solid tumor; Melanoma; Neuroblastoma; Osteosarcoma
  
• Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00004061 - Active, not recruiting
  Leukemia; Lymphoma
  
• Biological Therapy in Treating Patients With Advanced Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00052520 - Recruiting
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; ...
  
• Biological Therapy in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00005956 - Active, not recruiting
  stage III gastric cancer; stage IIIB breast cancer; stage II gastric cancer; stage IIIA breast cancer; stage III ovarian epithelial cancer; ...
  
• Biological Therapy in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00003779 - Active, not recruiting
  stage I bladder cancer; stage 0 bladder cancer
  
• Biological Therapy in Treating Patients With Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00003185 - Active, not recruiting
  adult glioblastoma multiforme; adult anaplastic astrocytoma
  
• Biological Therapy in Treating Patients With Lymphoma or Lymphoproliferative Disease
  ClinicalTrials.gov Identifier: NCT00002663 - Recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma
  
• Biological Therapy in Treating Patients With Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00002733 - Active, not recruiting
  Stage IV Melanoma; Stage IV Renal Cell Cancer; unspecified adult solid tumor, protocol specific
  
• Biological Therapy in Treating Patients With Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00004604 - Active, not recruiting
  Lung Cancer; Testicular Cancer; ovarian epithelial cancer; Pancreatic Cancer; Colon Cancer; Thyroid Cancer; Gastric Cancer; Salivary Gland Cancer; ...
  
• Biological Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00002786 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Biological Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00045149 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Biological Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00045357 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00020540 - Completed
  Stage IV Melanoma; Stage IV Renal Cell Cancer; recurrent renal cell cancer; Recurrent Melanoma
  
• Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transplantation
  ClinicalTrials.gov Identifier: NCT00003153 - Active, not recruiting
  refractory plasma cell neoplasm
  
• Biological Therapy in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00005853 - Active, not recruiting
  Myelodysplastic Syndromes
  
• Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment
  ClinicalTrials.gov Identifier: NCT00089258 - Completed
  localized unresectable neuroblastoma; disseminated neuroblastoma; regional neuroblastoma; stage 4S neuroblastoma; recurrent neuroblastoma
  
• Biological Therapy in Treating Patients With Primary or Advanced Glioma
  ClinicalTrials.gov Identifier: NCT00003067 - Suspended
  recurrent adult brain tumor; adult glioblastoma multiforme; adult anaplastic astrocytoma; Mixed Gliomas
  
• Biological Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002637 - Completed
  recurrent prostate cancer
  
• Biological Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00039299 - Completed
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Biological Therapy in Treating Patients With Stage I, Stage II, or Stage III Pancreatic Cancer That Has Been Surgically Removed
  ClinicalTrials.gov Identifier: NCT00003434 - Active, not recruiting
  stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
  
• Biological Therapy in Treating Women With Breast Cancer That Has Spread to the Liver
  ClinicalTrials.gov Identifier: NCT00301106 - Recruiting
  Breast Cancer; Metastatic Cancer
  
• Biological Therapy in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002780 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; stage IIIB breast cancer
  
• Biological Therapy in Treating Women With Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00027807 - Recruiting
  stage IV breast cancer; recurrent breast cancer; ductal breast carcinoma
  
• Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00003585 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00040950 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002616 - Active, not recruiting
  stage IIIB breast cancer; stage IV breast cancer; inflammatory breast cancer; recurrent breast cancer
  
• Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003063 - Active, not recruiting
  stage II colon cancer; stage III colon cancer; stage II rectal cancer; stage III rectal cancer
  
• Biology and Treatment Strategy of AML in Its Subgroups: Multicenter Randomized Trial by the German Acute Myeloid Leukemia Cooperative Group (AMLCG)
  ClinicalTrials.gov Identifier: NCT00266136 - Recruiting
  Acute Myeloid Leukemia
  
• Biomagnetic Characterization of Gastric Dysrhythmias:Study 2
  ClinicalTrials.gov Identifier: NCT00178984 - Recruiting
  Ischemia
  
• Biomagnetic Signals of Intestinal Ischemia
  ClinicalTrials.gov Identifier: NCT00285545 - Recruiting
  Ischemia
  
• Biomagnetic Signals of Intestinal Ischemia II
  ClinicalTrials.gov Identifier: NCT00179036 - Recruiting
  Ischemia
  
• Biomarker Analysis of Stress
  ClinicalTrials.gov Identifier: NCT00527384 - Not yet recruiting
  Sepsis
  
• Biomarker Study for Heart Failure in Children With Single Ventricle Physiology
  ClinicalTrials.gov Identifier: NCT00571233 - Recruiting
  Tricuspid Atresia; Hypoplastic Left Heart Syndrome; Unbalanced AV Canal
  
• Biomarkers and Early Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00094952 - Recruiting
  Alzheimer's Disease
  
• Biomarkers and Radiation Side Effects in Patients Undergoing Radiation Therapy for Gastrointestinal Cancer
  ClinicalTrials.gov Identifier: NCT00452946 - Recruiting
  Colorectal Cancer; Esophageal Cancer; Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastric Cancer; Gastrointestinal Complications; Liver Cancer; Pancreatic Cancer; Radiation Toxicity
  
• Biomarkers for Detection of Brain Ischemia
  ClinicalTrials.gov Identifier: NCT00490295 - Not yet recruiting
  Congenital Disorders
  
• Biomarkers for Oral Cancer
  ClinicalTrials.gov Identifier: NCT00341497 - Active, not recruiting
  Oral Cancer
  
• Biomarkers in Acute Heart Failure
  ClinicalTrials.gov Identifier: NCT00537628 - Recruiting
  Shortness of Breath; Heart Failure
  
• Biomarkers in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00325988 - Recruiting
  Multiple Sclerosis
  
• Biomarkers in Obstructive Sleep Apnea Surgery
  ClinicalTrials.gov Identifier: NCT00507078 - Completed
  Obstructive Sleep Apnea
  
• Biomarkers in Patients Undergoing Transrectal Ultrasound Prostate Biopsy
  ClinicalTrials.gov Identifier: NCT00373035 - Active, not recruiting
  Prostate Cancer
  
• Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00280761 - Recruiting
  Colorectal Cancer
  
• Biomarkers in Screening Participants For Lung Cancer
  ClinicalTrials.gov Identifier: NCT00301119 - Recruiting
  Lung Cancer
  
• Biomarkers in the Diagnosis and Assessment of PAH
  ClinicalTrials.gov Identifier: NCT00566423 - Recruiting
  Pulmonary Arterial Hypertension
  
• Biomarkers in Women at High Risk for Developing Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00558389 - Recruiting
  Cervical Cancer; Precancerous/Nonmalignant Condition
  
• Biomarkers of Benzene Exposure in Inner City Residents
  ClinicalTrials.gov Identifier: NCT00014963 - Completed
  Lung Disease; Cancer
  
• Biomarkers of Homeopathy in Fibromyalgia
  ClinicalTrials.gov Identifier: NCT00065702 - Completed
  Fibromyalgia
  
• Biomarkers of iNOS Activity in COPD, Asthma, Healthy Control
  ClinicalTrials.gov Identifier: NCT00159302 - Completed
  Healthy smokers; Healthy non-smokers; Patients with mild asthma; Patints with COPD (GOLD II)
  
• Biomarkers of Insomnia and Fatigue in HIV/AIDS (Symptoms and Genetics Study)
  ClinicalTrials.gov Identifier: NCT00503633 - Recruiting
  HIV Infections
  
• Biomarkers of Oxidative Stress in LOOK AHEAD - Ancillary to LOOK AHEAD
  ClinicalTrials.gov Identifier: NCT00031226 - Active, not recruiting
  Heart Diseases; Myocardial Infarction; Obesity; Diabetes Mellitus, non-insulin dependent; Cardiovascular Diseases; Diabetes Mellitus
  
• Biomechanical Analysis of Gait in Individuals With Duchenne Muscular Dystrophy
  ClinicalTrials.gov Identifier: NCT00312247 - Recruiting
  Duchenne Muscular Dystrophy
  
• Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress Incontinence
  ClinicalTrials.gov Identifier: NCT00190853 - Completed
  Urinary Stress Incontinence
  
• Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress Incontinence
  ClinicalTrials.gov Identifier: NCT00190567 - Completed
  Urinary Stress Incontinence
  
• Biomechanical Parameters of Gait in Patients with Parkinson''s Disease and Parkinsonian Syndromes
  ClinicalTrials.gov Identifier: NCT00139321 - Recruiting
  Gait initiation; Parkinson''s Disease; Parkinsonian Syndrome; Adults
  
• Biomed 101 and Interleukin-2 in Treating Patients With Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00004890 - Active, not recruiting
  stage III renal cell cancer; Stage IV Renal Cell Cancer; drug extravasation; recurrent renal cell cancer; stage I renal cell cancer; ...
  
• Biomet Humeral Stem Data Collection
  ClinicalTrials.gov Identifier: NCT00553527 - Recruiting
  Humeral Stem Replacement
  
• Biomodel in Tetralogy of Fallot
  ClinicalTrials.gov Identifier: NCT00155428 - Recruiting
  Tetralogy of Fallot
  
• Bion for Occipital Nerve Stimulation
  ClinicalTrials.gov Identifier: NCT00205829 - Active, not recruiting
  Chronic Headaches
  
• BIONs, for Improved Tissue Health and Pressure Sore Prevention
  ClinicalTrials.gov Identifier: NCT00262457 - Not yet recruiting
  Spinal Cord Injury; Pressure Ulcers
  
• Biopace Study: Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization
  ClinicalTrials.gov Identifier: NCT00187278 - Recruiting
  Atrioventricular Block; Ventricular Dysfunction
  
• Biopsychosocial Factors' Influence on Shoulder Pain
  ClinicalTrials.gov Identifier: NCT00187863 - Active, not recruiting
  Pain Assessment
  
• Bioresorbable Membrane to Reduce Postoperative Small Bowel Obstruction
  ClinicalTrials.gov Identifier: NCT00529412 - Completed
  Gastric Cancer
  
• BiPAP for Cardiomyopathy With Central Sleep Apnea
  ClinicalTrials.gov Identifier: NCT00282789 - Completed
  Dilated Cardiomyopathy
  
• Biphasic Defibrillation Study: Trial to Compare Fixed Versus Escalating Energy
  ClinicalTrials.gov Identifier: NCT00212992 - Completed
  Cardiac Arrest
  
• Biphasic Extrathoracic Cuirass Ventilation During Dental Treatment
  ClinicalTrials.gov Identifier: NCT00420069 - Not yet recruiting
  Blood Gas Monitoring, Transcutaneous
  
• Bipolar Depression Research Study
  ClinicalTrials.gov Identifier: NCT00376220 - Recruiting
  Bipolar Disorder
  
• Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response
  ClinicalTrials.gov Identifier: NCT00191399 - Completed
  Depression, Bipolar
  
• Bipolar Disorder in Epilepsy
  ClinicalTrials.gov Identifier: NCT00365482 - Recruiting
  Epilepsy; Bipolar Disorder
  
• Bipolar Disorder in Pregnancy and the Postpartum Period: Predictors of Morbidity
  ClinicalTrials.gov Identifier: NCT00580268 - Recruiting
  Bipolar Disorder; Psychiatric Morbidity; Neonatal Outcome
  
• Bipolar Disorder Research Study for Ages 12 and Older
  ClinicalTrials.gov Identifier: NCT00211263 - Completed
  Bipolar Disorder
  
• Bipolar Disorder Study
  ClinicalTrials.gov Identifier: NCT00056277 - Completed
  Bipolar Disorder
  
• Bipolar II Depression: Lithium, SSRI, or the Combination
  ClinicalTrials.gov Identifier: NCT00276965 - Recruiting
  Bipolar II Depression
  
• Bipolar Radiofrequency Ablation of Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00560885 - Recruiting
  Atrial Fibrillation
  
• Bipolar Research And Innovation Network - BRAIN
  ClinicalTrials.gov Identifier: NCT00201526 - Recruiting
  Bipolar Disorder
  
• Bipolar Study
  ClinicalTrials.gov Identifier: NCT00067938 - Completed
  Bipolar Disorder
  
• Bipolar Versus Unipolar Hemiarthroplasty for Patients With a Hip Fracture
  ClinicalTrials.gov Identifier: NCT00317837 - Recruiting
  Femoral Neck Fractures
  
• Bipolar vs Monopolar Transurethral Resection of the Prostate (TURP)
  ClinicalTrials.gov Identifier: NCT00199550 - Active, not recruiting
  BPH; Benign Prostatatic Hyperplasia
  
• Birmingham Biventricular Pacing in Patients With Heart Failure Unselected for Dyssynchrony
  ClinicalTrials.gov Identifier: NCT00480051 - Recruiting
  Heart Failure, Congestive
  
• Birmingham Hip Resurfacing (BHR) Study: Implantation of a Hip Resurfacing Endoprosthesis
  ClinicalTrials.gov Identifier: NCT00180206 - Recruiting
  Arthritis
  
• Birth Control Pill vs Birth Control Patch Study
  ClinicalTrials.gov Identifier: NCT00554632 - Completed
  Venous Thrombosis
  
• Birth Defects Treatment and Prevention Program: Tertiary Prevention by Systematic Pediatric Care
  ClinicalTrials.gov Identifier: NCT00097149 - Completed
  Cleft Lip; Cleft Palate; Congenital Defects
  
• Birth Weight Effect on Blood Pressure in Late Childhood
  ClinicalTrials.gov Identifier: NCT00006322 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00005813 - Active, not recruiting
  adult glioblastoma multiforme
  
• Bispectral Index as an Analgesia Monitoring in Severely Ill Patient: Effect of Remifentanyl
  ClinicalTrials.gov Identifier: NCT00162591 - Recruiting
  Nociceptive stimuli; Sedated patient; BIS variation
  
• Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment
  ClinicalTrials.gov Identifier: NCT00122356 - Recruiting
  Breast Cancer
  
• Bisphosphonate Therapy for HIV Infected Adults with Decreased Bone Mineral Density
  ClinicalTrials.gov Identifier: NCT00102908 - Active, not recruiting
  HIV Infections; Osteopenia; Osteoporosis
  
• Bisphosphonate Treatment of Osteogenesis Imperfecta
  ClinicalTrials.gov Identifier: NCT00063479 - Completed
  Osteogenesis Imperfecta
  
• Bivalirudin as a Procedural Anticoagulant in Pediatrics
  ClinicalTrials.gov Identifier: NCT00503126 - Not yet recruiting
  Cardiology
  
• Bivalirudin in Patients with Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI)
  ClinicalTrials.gov Identifier: NCT00093184 - Completed
  Myocardial Infarction
  
• Biventricular Alternative Pacing
  ClinicalTrials.gov Identifier: NCT00559143 - Recruiting
  Atrioventricular Block
  
• Biventricular Pacing After Cardiopulmonary Bypass
  ClinicalTrials.gov Identifier: NCT00498940 - Recruiting
  Heart Failure
  
• Biventricular Pacing After Coronary Artery Bypass Grafting (BIVAC)
  ClinicalTrials.gov Identifier: NCT00417092 - Completed
  Cardiac Pacing,Artificial; Coronary Artery Bypass; Ventricular Function, Left
  
• Biventricular Pacing in Hypertrophic Cardiomyopathy
  ClinicalTrials.gov Identifier: NCT00504647 - Recruiting
  Hypertrophic Cardiomyopathy
  
• Biventricular Pacing In Patients With Left Ventricular Dysfunction After Cardiovascular Surgery
  ClinicalTrials.gov Identifier: NCT00321295 - Active, not recruiting
  Cardiomyopathy; Heart Failure, Congestive; Thoracic Surgery
  
• Biventricular Pacing in the Pediatric Population
  ClinicalTrials.gov Identifier: NCT00267423 - Terminated
  Congenital Disorders
  
• Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
  ClinicalTrials.gov Identifier: NCT00267098 - Recruiting
  Atrioventricular Block; Heart Diseases
  
• Biweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma
  ClinicalTrials.gov Identifier: NCT00561301 - Recruiting
  Lymphoma
  
• Bizelesin in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00003021 - Completed
  unspecified adult solid tumor, protocol specific
  
• BL-1020 Dose Finding Study
  ClinicalTrials.gov Identifier: NCT00567710 - Not yet recruiting
  Schizophrenia
  
• BL22 Immunotoxin in Treating Patients Previously Treated With Cladribine for Hairy Cell Leukemia
  ClinicalTrials.gov Identifier: NCT00074048 - Recruiting
  Leukemia
  
• BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin''s Lymphoma
  ClinicalTrials.gov Identifier: NCT00126646 - Active, not recruiting
  adult non-Hodgkin''s lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin''s lymphoma; Prolymphocytic Leukemia
  
• BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00077493 - Suspended
  Leukemia; Lymphoma
  
• BL22 Immunotoxin to Treat Hairy Cell Leukemia
  ClinicalTrials.gov Identifier: NCT00071318 - Recruiting
  Leukemia, Hairy Cell
  
• Black Cohosh As Alternative Therapy for Treating Menopause-Related Anxiety
  ClinicalTrials.gov Identifier: NCT00120458 - Recruiting
  Generalized Anxiety Disorder; Menopause
  
• Black Cohosh Extract in Postmenopausal Breast Health
  ClinicalTrials.gov Identifier: NCT00064831 - Completed
  Menopause; Hot Flashes
  
• Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
  ClinicalTrials.gov Identifier: NCT00060320 - Completed
  Breast Cancer; Hot Flashes
  
• Black Pooling Project
  ClinicalTrials.gov Identifier: NCT00064480 - Active, not recruiting
  Cardiovascular Diseases; Coronary Disease; Heart Diseases
  
• Bladder Cancer Case Control Study of Arsenic in Water
  ClinicalTrials.gov Identifier: NCT00011518 - Completed
  Bladder Cancer
  
• Bladder Cancer Chemoradiation Using Intensity Modulated Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00350688 - Recruiting
  Bladder Cancer
  
• BLADE: Comparison of Once Daily Lopinavir/Ritonavir to Lopinavir/Ritonavir BID Dosing in HIV-Infected Subjects
  ClinicalTrials.gov Identifier: NCT00388492 - Not yet recruiting
  HIV Infections
  
• Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal Combinations
  ClinicalTrials.gov Identifier: NCT00184795 - Completed
  Hormone Replacement Therapy, Post-Menopausal
  
• Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia
  ClinicalTrials.gov Identifier: NCT00393198 - Active, not recruiting
  Contraception; Menorrhagia
  
• Bleeding Pattern Study
  ClinicalTrials.gov Identifier: NCT00302666 - Completed
  Contraception, Bleeding Pattern
  
• Bleeding Risk in CVCs
  ClinicalTrials.gov Identifier: NCT00448188 - Recruiting
  Bleeding
  
• Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003110 - Active, not recruiting
  Lymphoma
  
• Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00006035 - Active, not recruiting
  Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
  
• Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions
  ClinicalTrials.gov Identifier: NCT00002872 - Active, not recruiting
  Quality of Life; Malignant Pleural Effusion
  
• Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles
  ClinicalTrials.gov Identifier: NCT00324298 - Recruiting
  Drug Toxicity; Testicular Germ Cell Tumor
  
• Blepharospasm Short Interval
  ClinicalTrials.gov Identifier: NCT00507637 - Not yet recruiting
  Blepharospasm
  
• BLI-800-301: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy
  ClinicalTrials.gov Identifier: NCT00503607 - Completed
  Colonoscopy
  
• BLI-800-302: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy
  ClinicalTrials.gov Identifier: NCT00503815 - Completed
  Colonoscopy
  
• Block-Replacement Therapy During Radioiodine Therapy
  ClinicalTrials.gov Identifier: NCT00150124 - Recruiting
  toxic nodular goitre; Graves'' disease
  
• Blockade of Vascular Potassium Channels During Human Endotoxemia
  ClinicalTrials.gov Identifier: NCT00185003 - Completed
  Endotoxemia
  
• Blocking Tumor Necrosis Factor in Ankylosing Spondylitis
  ClinicalTrials.gov Identifier: NCT00000433 - Completed
  Spondylitis, Ankylosing
  
• Blood and Marrow Transplant Clinical Research Network
  ClinicalTrials.gov Identifier: NCT00023530 - Completed
  Bone Marrow Transplantation; Blood Disease; Hematopoietic Stem Cell Transplantation; Leukemia; Multiple Myeloma; Myelodysplastic Syndromes; ...
  
• Blood and Tissue Collection for Cutaneous Lymphoma Research
  ClinicalTrials.gov Identifier: NCT00177268 - Recruiting
  Cutaneous T-Cell Lymphoma; Sezary Syndrome; Mycosis Fungoides
  
• Blood Cell Collection for Future Use in Individuals With Fanconi Anemia
  ClinicalTrials.gov Identifier: NCT00271089 - Completed
  Fanconi Anemia
  
• Blood Collection for Use in Serological Assay Development From Healthy Adult Volunteers
  ClinicalTrials.gov Identifier: NCT00500032 - Recruiting
  Healthy
  
• Blood Collection From Individuals With Lung Disease for Genetic Studies
  ClinicalTrials.gov Identifier: NCT00362739 - Recruiting
  Asthma; COPD; Interstitial Lung Disease; Cystic Fibrosis; Lung Cancer
  
• Blood Collection From Individuals With Lung Disease for Genetic Studies (Qatar)
  ClinicalTrials.gov Identifier: NCT00504361 - Recruiting
  Asthma; COPD; Interstitial Lung Disease; Cystic Fibrosis; Lung Cancer
  
• Blood Component Collection from Patients with Rheumatic Disease and Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00031174 - Recruiting
  Rheumatic Diseases; Healthy
  
• Blood Donation--Immune Sequelae and Recruitment
  ClinicalTrials.gov Identifier: NCT00005341 - Completed
  Blood Disease; Blood donors
  
• Blood Endothelium Progenitor Cells and Dendritic Cells as Predictive Biomarkers of in-Stent Restenosis
  ClinicalTrials.gov Identifier: NCT00493597 - Not yet recruiting
  Atherosclerosis; Restenosis
  
• Blood Factors and Diabetic Retinopathy
  ClinicalTrials.gov Identifier: NCT00005761 - Recruiting
  Diabetic Retinopathy
  
• Blood Factors and Peripheral Arterial Disease Outcomes
  ClinicalTrials.gov Identifier: NCT00035776 - Completed
  Arterial Occlusive Diseases; Cardiovascular Diseases; Peripheral Vascular Diseases; Coronary Disease
  
• Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing
  ClinicalTrials.gov Identifier: NCT00047918 - Completed
  Mastocytosis; Anaphylaxis
  
• Blood Flow and Bone Density in Healthy Adult Women
  ClinicalTrials.gov Identifier: NCT00397462 - Recruiting
  Bone Loss; Muscle Tone Poor
  
• Blood Folate and Homocysteine Levels Following Administration of Folic Acid According to Different Daily Dosing Schedules:a Simulation of Food Fortification
  ClinicalTrials.gov Identifier: NCT00207558 - Completed
  Neural Tube Defects - Spina Bifida and Anencephaly
  
• Blood Glucose Awareness Training for Parents
  ClinicalTrials.gov Identifier: NCT00315991 - Recruiting
  Diabetes Mellitus, Type 1
  
• Blood Glucose Response to Meals of Varying Glycemic Index in Youth With Type 1 & 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00545727 - Completed
  Type 1 Diabetes; Type 2 Diabetes; Impaired Glucose Metabolism
  
• Blood Levels of Abacavir after One Dose in HIV-Infected Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00011479 - Completed
  HIV Infections
  
• Blood Levels of Abacavir in HIV Infected Adolescents
  ClinicalTrials.gov Identifier: NCT00087945 - Completed
  HIV Infections
  
• Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected Children
  ClinicalTrials.gov Identifier: NCT00260078 - Active, not recruiting
  HIV Infections
  
• Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean Delivery
  ClinicalTrials.gov Identifier: NCT00540605 - Not yet recruiting
  HIV Infections
  
• Blood Neurotrophic Factors in Adults
  ClinicalTrials.gov Identifier: NCT00505349 - Recruiting
  Healthy
  
• Blood Pressure and Diurnal Variation in Sodium, Potassium, and Water Excretion
  ClinicalTrials.gov Identifier: NCT00005204 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in High Risk Patients with Type 2 Diabetes.
  ClinicalTrials.gov Identifier: NCT00145925 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Blood Pressure Control in African Americans
  ClinicalTrials.gov Identifier: NCT00233220 - Recruiting
  Cardiovascular Diseases; Hypertension
  
• Blood Pressure Control in Hypertensive Smokers
  ClinicalTrials.gov Identifier: NCT00113074 - Recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Blood Pressure Control in Juveniles - Longitudinal Study
  ClinicalTrials.gov Identifier: NCT00005181 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Blood Pressure Control--Racial and Psychosocial Influences
  ClinicalTrials.gov Identifier: NCT00005685 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Blood Pressure Interaction Between Sildenafil and Sublingual Glyceryl Trinitrate (GTN) in Men With Angina
  ClinicalTrials.gov Identifier: NCT00479908 - Completed
  Angina Pectoris
  
• Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension
  ClinicalTrials.gov Identifier: NCT00527514 - Recruiting
  Hypertension
  
• Blood Pressure Lowering Effects of Grape Juice
  ClinicalTrials.gov Identifier: NCT00302809 - Recruiting
  Hypertension
  
• Blood Pressure Reduction in Danish General Practice (BRIDGE)
  ClinicalTrials.gov Identifier: NCT00244660 - Recruiting
  Hypertension
  
• Blood Pressure Tracking--Childhood to Young Adulthood
  ClinicalTrials.gov Identifier: NCT00005421 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract Cancer
  ClinicalTrials.gov Identifier: NCT00559598 - Not yet recruiting
  Extrahepatic Bile Duct Cancer; Pancreatic Cancer
  
• Blood Sample Collection and Health Information Collection From Patients With Invasive Breast Cancer and Their Brothers and Sisters
  ClinicalTrials.gov Identifier: NCT00445562 - Recruiting
  Breast Cancer
  
• Blood Sample Donations to Study the Role of Genes in Pain
  ClinicalTrials.gov Identifier: NCT00341367 - Active, not recruiting
  Pain
  
• Blood Sampling for Neurochemical and Genetic Testing
  ClinicalTrials.gov Identifier: NCT00001147 - Completed
  Autonomic Nervous System Disease; Healthy; Hypertension; Pheochromocytoma
  
• Blood Sugars in Children With Idiopathic Seizures.
  ClinicalTrials.gov Identifier: NCT00279851 - Recruiting
  Seizures; Hypoglycemia; Hyperammonemia
  
• Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients
  ClinicalTrials.gov Identifier: NCT00085930 - Recruiting
  Neuroblastoma
  
• Blood Test for Ovarian Cancer Associated Antibodies (CAAb)
  ClinicalTrials.gov Identifier: NCT00327925 - Recruiting
  Ovarian Cancer
  
• Blood Test to Measure DNA Damage in Blood
  ClinicalTrials.gov Identifier: NCT00523471 - Recruiting
  Prostate Cancer
  
• Blood Transplantation for Patients with Hematologic Malignancies or Bone Marrow Failure States
  ClinicalTrials.gov Identifier: NCT00038779 - Terminated
  Leukemia; Non Hodgkin's Lymphoma; Aplastic Anemia
  
• Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00050908 - Completed
  HIV Infections
  
• BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management
  ClinicalTrials.gov Identifier: NCT00395135 - Active, not recruiting
  Obesity
  
• Blown Nasal Secretion Measurements in Rhinosinusitis: Repeatability and Validity Compared to Nasal Lavage
  ClinicalTrials.gov Identifier: NCT00292851 - Completed
  Rhinosinusitis
  
• BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1.
  ClinicalTrials.gov Identifier: NCT00326963 - Active, not recruiting
  HIV Infections
  
• BLSA: The Baltimore Longitudinal Study of Aging
  ClinicalTrials.gov Identifier: NCT00233272 - Recruiting
  Aging
  
• Blue-Blocking IOLs in Combined Surgery
  ClinicalTrials.gov Identifier: NCT00537992 - Completed
  Epiretinal Membranes; Macular Holes; Cataract
  
• BlueCQ Bioavailability
  ClinicalTrials.gov Identifier: NCT00176072 - Completed
  Methylene Blue; Chloroquine; Pharmacokinetics; Bioavailability
  
• Blunt Needles do Not Reduce Needlestick Injuries to Doctors During Suturing After Child-Birth
  ClinicalTrials.gov Identifier: NCT00536289 - Completed
  Needlestick Injuries
  
• BMI and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine.
  ClinicalTrials.gov Identifier: NCT00312598 - Recruiting
  Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder; Mood Disorders With Psychotic Features
  
• BMS 247550 in Treating Patients With Recurrent Glioma
  ClinicalTrials.gov Identifier: NCT00045708 - Completed
  adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; adult brain tumor; adult glioblastoma; Mixed Gliomas
  
• BMS 247550 to Treat Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00030992 - Recruiting
  Renal Cell Carcinoma
  
• BMS-184476 in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003705 - Completed
  unspecified adult solid tumor, protocol specific
  
• BMS-188667 in Children and Adolescents with Juvenile Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00095173 - Completed
  Juvenile Rheumatoid Arthritis
  
• BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic Cancer
  ClinicalTrials.gov Identifier: NCT00006086 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• BMS-188797 in Treating Patients With Advanced Solid Tumors That Have not Responded to Previous Treatment
  ClinicalTrials.gov Identifier: NCT00005611 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00006213 - Completed
  relapsing chronic myelogenous leukemia; recurrent adult acute myeloid leukemia; refractory anemia with excess blasts in transformation; ...
  
• BMS-214662 in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00006242 - Completed
  unspecified adult solid tumor, protocol specific
  
• BMS-214662 in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00004877 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• BMS-214662 in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00005973 - Completed
  unspecified childhood solid tumor, protocol specific; unspecified adult solid tumor, protocol specific
  
• BMS-214662 Plus Trastuzumab in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00022529 - Completed
  unspecified adult solid tumor, protocol specific
  
• BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00043095 - Completed
  unspecified adult solid tumor, protocol specific
  
• BMS-247550 in Treating Patients With Advanced Cancers
  ClinicalTrials.gov Identifier: NCT00006221 - Active, not recruiting
  adult solid tumor; Leukemia; Lymphoma; small intestine cancer
  
• BMS-247550 in Treating Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00016965 - Completed
  stage II pancreatic cancer; stage III pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; ...
  
• BMS-247550 in Treating Patients With Advanced Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00022542 - Completed
  stage IVB adult soft tissue sarcoma; recurrent adult soft tissue sarcoma; stage IVA adult soft tissue sarcoma; stage III adult soft tissue sarcoma
  
• BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
  ClinicalTrials.gov Identifier: NCT00004927 - Completed
  unspecified adult solid tumor, protocol specific
  
• BMS-247550 in Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00005807 - Completed
  adult solid tumor; Breast Cancer; Endocrine Cancer; female reproductive cancer
  
• BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy
  ClinicalTrials.gov Identifier: NCT00020371 - Completed
  Unspecified Adult Solid Tumor, Protocol Specific; Neutropenia
  
• BMS-247550 in Treating Patients With Liver or Gallbladder Cancer
  ClinicalTrials.gov Identifier: NCT00023946 - Active, not recruiting
  adult primary liver cancer; extrahepatic bile duct cancer; Gallbladder Cancer
  
• BMS-247550 in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00033306 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy
  ClinicalTrials.gov Identifier: NCT00017043 - Active, not recruiting
  stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ...
  
• BMS-247550 in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer That Has Not Responded to Previous Chemotherapy
  ClinicalTrials.gov Identifier: NCT00025155 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00016393 - Completed
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With Chemotherapy
  ClinicalTrials.gov Identifier: NCT00017056 - Completed
  stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ...
  
• BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00022477 - Completed
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• BMS-247550 in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00058019 - Recruiting
  recurrent grade 3 follicular lymphoma; recurrent adult diffuse large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ...
  
• BMS-247550 in Treating Patients With Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00036764 - Completed
  Stage IV Melanoma; Recurrent Melanoma
  
• BMS-247550 in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00020904 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• BMS-247550 Plus Capecitabine in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00049244 - Active, not recruiting
  recurrent breast cancer; stage IV breast cancer
  
• BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00028561 - Completed
  unspecified adult solid tumor, protocol specific
  
• BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00057850 - Completed
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ...
  
• BMS-247550 to Treat Children with Solid Tumors
  ClinicalTrials.gov Identifier: NCT00025961 - Recruiting
  Neoplasms; Neoplasm by Histologic Type; Optic Glioma; Brainstem Tumor
  
• BMS-247550 With or Without Estramustine in Treating Patients With Progressive Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00025194 - Completed
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• BMS-275291 in Treating Patients With HIV-Related Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00024024 - Completed
  epidemic Kaposi's sarcoma; recurrent Kaposi's sarcoma
  
• BMS-275291 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00040755 - Completed
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• BMS-354825 in Patients with Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00103701 - Completed
  Leukemia, Myeloid, Chronic-Phase; Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
  
• BMS-354825 in Subjects with Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00101595 - Active, not recruiting
  Chronic Myeloid Leukemia; Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
  
• BMS-354825 in Subjects with Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate
  ClinicalTrials.gov Identifier: NCT00101816 - Active, not recruiting
  Chronic Myeloid Leukemia; Blast Crisis
  
• BMS-354825 in Treating Patients With Accelerated Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate
  ClinicalTrials.gov Identifier: NCT00108693 - Active, not recruiting
  accelerated phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; relapsing chronic myelogenous leukemia
  
• BMS-354825 in Treating Patients With Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia That Did Not Respond to Previous Imatinib Mesylate
  ClinicalTrials.gov Identifier: NCT00110097 - Active, not recruiting
  blastic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; relapsing chronic myelogenous leukemia; ...
  
• BMS-354825 in Treating Patients With Blastic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate
  ClinicalTrials.gov Identifier: NCT00108719 - Active, not recruiting
  blastic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; relapsing chronic myelogenous leukemia
  
• BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate
  ClinicalTrials.gov Identifier: NCT00112801 - Active, not recruiting
  chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; relapsing chronic myelogenous leukemia
  
• BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate
  ClinicalTrials.gov Identifier: NCT00064233 - Active, not recruiting
  chronic phase chronic myelogenous leukemia; relapsing chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
  
• BMS-354825 or Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate
  ClinicalTrials.gov Identifier: NCT00112775 - Active, not recruiting
  chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; relapsing chronic myelogenous leukemia
  
• BMS-354835 versus Imatinib Mesylate in Subjects with Chronic Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00103844 - Active, not recruiting
  Chronic Myeloid Leukemia; Philadelphia-Positive Myeloid Leukemia
  
• BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery
  ClinicalTrials.gov Identifier: NCT00097357 - Completed
  Venous Thrombosis; Pulmonary Embolism; Preventive therapy
  
• BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies
  ClinicalTrials.gov Identifier: NCT00207051 - Recruiting
  Colorectal Cancer
  
• BMS-599626 in Patients with Advanced Solid Malignancies
  ClinicalTrials.gov Identifier: NCT00095537 - Completed
  Cancer; Metastases
  
• BMS-599626 in Treating Patients With Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00093730 - Recruiting
  unspecified adult solid tumor, protocol specific
  
• BMS-646256 in Obese and Overweight Type 2 Diabetics
  ClinicalTrials.gov Identifier: NCT00541567 - Not yet recruiting
  Obesity and Type 2 Diabetes
  
• BNP (Nesiritide) Vs. Placebo to Protect Kidney Function in Patients Undergoing Heart Bypass Surgery.
  ClinicalTrials.gov Identifier: NCT00252200 - Active, not recruiting
  Acute Kidney Failure
  
• BNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS)
  ClinicalTrials.gov Identifier: NCT00186329 - Completed
  Congestive Heart Failure Exacerbation; Renal Insufficiency
  
• BNP Guided Care in Addition to Multidisciplinary Care
  ClinicalTrials.gov Identifier: NCT00355017 - Terminated
  Decompensated Heart Failure
  
• BNP Testing in Patients With SOB on Presentation to ED
  ClinicalTrials.gov Identifier: NCT00163709 - Recruiting
  Heart Failure, Congestive
  
• BNP Therapy Observation Unit Outcomes STudy (BOOST)
  ClinicalTrials.gov Identifier: NCT00453453 - Recruiting
  Congestive Heart Failure
  
• BNP-Guided Diagnostic Strategy in ICU Patients with Respiratory Failure
  ClinicalTrials.gov Identifier: NCT00130559 - Active, not recruiting
  Respiratory Insufficiency
  
• BOAT: Beta Blocker Uptitration With OptiVol After CRT.
  ClinicalTrials.gov Identifier: NCT00433043 - Recruiting
  Congestive Heart Failure
  
• Body Composition, Bone Mineral Density, Insulin Sensitivity and Echocardiographic Measurements in Klinefelter Syndrome
  ClinicalTrials.gov Identifier: NCT00523835 - Completed
  Klinefelter Syndrome; Diabetes; Osteoporosis; Metabolic Syndrome; Cardiovascular Disease
  
• Body Composition, Glucose Metabolism, Insulin Resistance Adn Gene Expression in Muscle Cells in Healthy Overweight Women
  ClinicalTrials.gov Identifier: NCT00145392 - Active, not recruiting
  Obesity; Type 2 Diabetes; Polycystic Ovary Syndrome
  
• Body Cooling for Birth Asphyxia in Term Infants
  ClinicalTrials.gov Identifier: NCT00005772 - Active, not recruiting
  Hypoxic-Ischemic Encephalopathy; Asphyxia; Brain Ischemia; Hypoxia, Brain
  
• Body Fat Distribution and Fat Metabolism
  ClinicalTrials.gov Identifier: NCT00475774 - Recruiting
  Obesity; Metabolic Disease
  
• Body Heat Content and Dissipation in Obese and Normal Weight Adults
  ClinicalTrials.gov Identifier: NCT00266500 - Recruiting
  Obesity
  
• Body Image and Psychosocial Functioning in Women With Breast Cancer: Can We Fix What We've Broken?
  ClinicalTrials.gov Identifier: NCT00418444 - Recruiting
  Breast Neoplasms
  
• Body Plethysmograph Measurements Before and After Methacholine Challenge in Early Childhood
  ClinicalTrials.gov Identifier: NCT00458627 - Completed
  Asthma
  
• Body Water Content in Cyanotic Congenital Heart Disease
  ClinicalTrials.gov Identifier: NCT00000107 - Completed
  Heart Defects, Congenital
  
• Body Weight Gain, Parkinson, Subthalamic Stimulation
  ClinicalTrials.gov Identifier: NCT00529724 - Recruiting
  Parkinson's Disease
  
• Body Weight Regulation in Patients With Narcolepsy
  ClinicalTrials.gov Identifier: NCT00283894 - Not yet recruiting
  Narcolepsy
  
• Body Weight Supported Treadmill Training Following Hip Fracture
  ClinicalTrials.gov Identifier: NCT00197496 - Not yet recruiting
  Hip Fracture
  
• Body-Oriented Therapy for Sexual Abuse Recovery
  ClinicalTrials.gov Identifier: NCT00097305 - Completed
  Child Abuse, Sexual; Post-Traumatic Stress Disorder; Dissociation
  
• Bogalusa Heart Study
  ClinicalTrials.gov Identifier: NCT00005129 - Completed
  Atherosclerosis; Cardiovascular Diseases; Heart Diseases; Coronary Disease; Hypertension
  
• BONAMI (BOne Marrow in Acute Myocardial Infarction)
  ClinicalTrials.gov Identifier: NCT00200707 - Recruiting
  Acute and Severe Myocardial Infarction
  
• BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.
  ClinicalTrials.gov Identifier: NCT00545779 - Recruiting
  Post-Menopausal Osteoporosis
  
• BONDIR Study: A Study of Intravenous Bonviva (Ibandronate) After Recent Vertebral Osteoporotic Fracture in Patients With Osteoporosis.
  ClinicalTrials.gov Identifier: NCT00493623 - Recruiting
  Osteoporosis
  
• Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
  ClinicalTrials.gov Identifier: NCT00261950 - Recruiting
  Secondary Hyperparathyroidism
  
• Bone Cancer: Treatment Outcome Based on Tumor Response
  ClinicalTrials.gov Identifier: NCT00001821 - Recruiting
  Osteosarcoma
  
• Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98
  ClinicalTrials.gov Identifier: NCT00369850 - Active, not recruiting
  Breast Cancer; Osteoporosis
  
• Bone Density and Serum Testosterone in Male Methadone Maintained Patients
  ClinicalTrials.gov Identifier: NCT00170339 - Completed
  Opiate Dependence; Osteoporosis; Erectile Dysfunction; Hypogonadism
  
• Bone Density in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00540267 - Not yet recruiting
  Schizophrenia; Alcohol Abuse
  
• Bone Development in Adolescent Girls: Effects of Calcium and Exercise
  ClinicalTrials.gov Identifier: NCT00063011 - Active, not recruiting
  Osteoporosis
  
• Bone Effects of Teriparatide Following Alendronate
  ClinicalTrials.gov Identifier: NCT00191893 - Completed
  Osteoporosis
  
• Bone Estrogen Strength Training
  ClinicalTrials.gov Identifier: NCT00000399 - Completed
  Osteoporosis
  
• Bone Geometry and Muscle Density Changes in Postmenopausal Women and Breast Cancer Patients Prescribed Anastrozole
  ClinicalTrials.gov Identifier: NCT00421447 - Recruiting
  Breast Cancer
  
• Bone Health in Pediatric Crohn's Disease: A Low Magnitude Mechanical Stimulus Trial
  ClinicalTrials.gov Identifier: NCT00364130 - Recruiting
  Crohn Disease
  
• Bone Health of People with Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00008762 - Completed
  Cystic Fibrosis
  
• Bone Lead Levels and College Achievement Scores
  ClinicalTrials.gov Identifier: NCT00014885 - Completed
  Lead Poisoning
  
• Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00199537 - Active, not recruiting
  Prostate Cancer; Bone Loss
  
• Bone Loss in Premenopausal Women with Depression
  ClinicalTrials.gov Identifier: NCT00006180 - Completed
  Depression; Healthy; Osteopenia; Osteoporosis
  
• Bone Loss in Women with Anorexia Nervosa
  ClinicalTrials.gov Identifier: NCT00089843 - Recruiting
  Anorexia Nervosa
  
• Bone Loss, Fractures, and Management of Bone Health in People With Stroke in Managed Rehabilitation Settings
  ClinicalTrials.gov Identifier: NCT00462683 - Not yet recruiting
  Stroke; Anoxia; Brain Injury
  
• Bone Marker Assessment of Multiple Myeloma Patients Treated With Aminobisphosphonates
  ClinicalTrials.gov Identifier: NCT00577642 - Recruiting
  Multiple Myeloma
  
• Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis
  ClinicalTrials.gov Identifier: NCT00532545 - Completed
  Osteoporosis, Post-Menopausal
  
• Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00004232 - Completed
  Leukemia; Lymphoma; Multiple Myeloma
  
• Bone Marrow Angiogenesis in Acute Myeloid Leukemia - Evaluated by Dynamic Contrast Enhanced Magnetic Resonance (MR) Image
  ClinicalTrials.gov Identifier: NCT00172562 - Recruiting
  Acute Myeloid Leukemia
  
• Bone Marrow Cell Gene Transfer in Individuals With Fanconi Anemia
  ClinicalTrials.gov Identifier: NCT00272857 - Completed
  Fanconi Anemia
  
• Bone Marrow Cell Transplantation to Improve Heart Function in Individuals With End-Stage Heart Failure
  ClinicalTrials.gov Identifier: NCT00383630 - Recruiting
  Heart Failure, Congestive
  
• Bone Marrow Cells in Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00363324 - Recruiting
  Acute Myocardial Infarction
  
• Bone Marrow Grafting for Leukemia and Lymphoma
  ClinicalTrials.gov Identifier: NCT00186147 - Recruiting
  Hematologic Malignancies; Leukemia; Lymphoma
  
• Bone Marrow Injection to Replace Diseased Bone in Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome
  ClinicalTrials.gov Identifier: NCT00001851 - Recruiting
  Polyostotic Fibrous Dysplasia
  
• Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002942 - Completed
  stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; stage II breast cancer
  
• Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00002789 - Active, not recruiting
  accelerated phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
  
• Bone Marrow Stem Cell Infusion Following a Heart Attack
  ClinicalTrials.gov Identifier: NCT00268307 - Recruiting
  Acute Myocardial Infarction
  
• Bone Marrow Stem Cell Mobilisation Therapy for AMI
  ClinicalTrials.gov Identifier: NCT00126100 - Completed
  Myocardial Infarction
  
• Bone Marrow Stem Cells as a Source of Allogenic Hepatocyte Transplantation in Homozygous Familial Hypercholesterolemia
  ClinicalTrials.gov Identifier: NCT00515307 - Recruiting
  Hypercholesterolemia, Familial
  
• Bone Marrow Transfer to Enhance ST-Elevation Infarct Regeneration
  ClinicalTrials.gov Identifier: NCT00224536 - Completed
  Coronary Artery Disease
  
• Bone marrow transplant from donor using less toxic conditioning for patient with high risk hemoglobinopathies
  ClinicalTrials.gov Identifier: NCT00040417 - Terminated
  Sickle Cell Anemia; Hemoglobinopathy; Thalassemia
  
• Bone Marrow transplant from related donor for patients with high risk hemoglobinopathies
  ClinicalTrials.gov Identifier: NCT00040469 - Terminated
  Sickle Cell Anemia; Hemoglobinopathy; Thalassemia
  
• Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia
  ClinicalTrials.gov Identifier: NCT00001623 - Active, not recruiting
  Graft vs Host Disease; Hematologic Neoplasm; Leukemia; Multiple Myeloma; Myelodysplastic Syndrome
  
• Bone Marrow Transplant to Induce Tolerance in Heart Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00497757 - Recruiting
  Cardiac Transplant Recipients
  
• Bone Marrow Transplant to Induce Tolerance in Kidney Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00498160 - Recruiting
  Deceased Donor Kidney Transplant
  
• Bone Marrow Transplant to Induce Tolerance in Kidney Transplant Recipients From Living Donors
  ClinicalTrials.gov Identifier: NCT00497926 - Recruiting
  Living Donor Kidney Transplant
  
• Bone Marrow Transplantation in Treating Children With Sickle Cell Disease
  ClinicalTrials.gov Identifier: NCT00004485 - Active, not recruiting
  Sickle Cell Anemia
  
• Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission
  ClinicalTrials.gov Identifier: NCT00002534 - Active, not recruiting
  childhood acute myeloid leukemia in remission; adult acute lymphoblastic leukemia in remission; recurrent adult acute myeloid leukemia; ...
  
• Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002844 - Active, not recruiting
  refractory chronic lymphocytic leukemia
  
• Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002592 - Active, not recruiting
  accelerated phase chronic myelogenous leukemia; refractory chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia
  
• Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00005854 - Completed
  Leukemia; Lymphoma; Multiple Myeloma
  
• Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003398 - Active, not recruiting
  Lymphoma; Leukemia; Multiple Myeloma
  
• Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00005804 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma; Eye Cancer
  
• Bone Marrow Transplantation in Treating Patients With Hematologic Cancers
  ClinicalTrials.gov Identifier: NCT00005797 - Active, not recruiting
  acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; chronic myeloproliferative disorders; ...
  
• Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma
  ClinicalTrials.gov Identifier: NCT00003187 - Active, not recruiting
  Lymphoma; Leukemia
  
• Bone Marrow Transplantation in Treating Patients With Lymphoma
  ClinicalTrials.gov Identifier: NCT00002829 - Active, not recruiting
  recurrent diffuse small lymphocytic/marginal zone lymphoma; Waldenstrom's Macroglobulinemia; recurrent grade I follicular small cleaved cell lymphoma; ...
  
• Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia
  ClinicalTrials.gov Identifier: NCT00004181 - Completed
  chronic idiopathic myelofibrosis; Chronic Myelogenous Leukemia; Multiple Myeloma; refractory plasma cell neoplasm
  
• Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant
  ClinicalTrials.gov Identifier: NCT00005852 - Active, not recruiting
  Lymphoma; Multiple Myeloma; Leukemia
  
• Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00011934 - Active, not recruiting
  Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; ...
  
• Bone Marrow Transplantation Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00002809 - Active, not recruiting
  Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; atypical chronic myeloid leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia; ...
  
• Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy
  ClinicalTrials.gov Identifier: NCT00005988 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma
  
• Bone Marrow-Derived Cells' Contribution to Tumor Formation and Inflammation
  ClinicalTrials.gov Identifier: NCT00452205 - Recruiting
  Gastrointestinal Neoplasms
  
• Bone Marrow-Derived Stem Cell Transfer in Acute Myocardial Infarctions
  ClinicalTrials.gov Identifier: NCT00264316 - Completed
  Myocardial Infarction
  
• Bone Metabolism and PTHrP Lactation Study
  ClinicalTrials.gov Identifier: NCT00430417 - Recruiting
  Pregnancy; Lactation; Bone Diseases, Endocrine
  
• Bone Microarchitecture in Osteopenic Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00577395 - Recruiting
  Osteoporosis
  
• Bone Microstructure in Nasal Salmon Calcitonin Treated Postmenopausal Women (a Pilot Study)
  ClinicalTrials.gov Identifier: NCT00372099 - Recruiting
  Bone Microarchitecture
  
• Bone Mineral Content and Bone Metabolism in Adolescents on Antipsychotic Therapy
  ClinicalTrials.gov Identifier: NCT00399776 - Recruiting
  Adolescent Depression
  
• Bone Mineral Density (BMD) in Adolescents with Growth Hormone Deficiency (GHD)
  ClinicalTrials.gov Identifier: NCT00097526 - Recruiting
  Dwarfism, Pituitary; Turner Syndrome
  
• Bone Mineral Density (BMD) in HIV Infection
  ClinicalTrials.gov Identifier: NCT00146094 - Recruiting
  Osteopenia; Osteoporosis
  
• Bone Mineral Density and Subsequent Cancer Risk
  ClinicalTrials.gov Identifier: NCT00340262 - Active, not recruiting
  Bone Mineral Density; Cancer
  
• Bone Mineral Density as a Risk Factor in Patients With Early Stage Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00176579 - Recruiting
  Osteoporosis; Prostate Cancer
  
• Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00213980 - Recruiting
  Breast Cancer
  
• Bone Mineral Density in Pediatric Epilepsy
  ClinicalTrials.gov Identifier: NCT00204815 - Completed
  Epilepsy
  
• Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial CAN-NCIC-MA27
  ClinicalTrials.gov Identifier: NCT00354302 - Recruiting
  Breast Cancer; Osteoporosis
  
• Bone Mineral Density in Women with Major Depression
  ClinicalTrials.gov Identifier: NCT00001413 - Completed
  Healthy; Involutional Depression; Osteoporosis
  
• Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00355342 - Active, not recruiting
  Chronic Obstructive Pulmonary Disease; Osteoporosis; Osteopenia
  
• Bone Mineral Density, Body Composition and Growth Following Severe Burn Injury
  ClinicalTrials.gov Identifier: NCT00285090 - Recruiting
  Burn; Growth; Malnutrition
  
• Bone Physiology & Mechanics in Osteomyoplasty Amputation Rehabilitation
  ClinicalTrials.gov Identifier: NCT00271362 - Not yet recruiting
  Amputation; Osteoporosis; Fracture; Inflammation
  
• Bone Properties in Hypoparathyroidism: Effects of PTH
  ClinicalTrials.gov Identifier: NCT00473265 - Recruiting
  Hypoparathyroidism
  
• Bone Regeneration Using Stromal Cells
  ClinicalTrials.gov Identifier: NCT00001391 - Recruiting
  Bone Disease; Craniofacial Abnormality; Healthy
  
• Bone Remodeling Around HA-Coated Acetabular Cups.
  ClinicalTrials.gov Identifier: NCT00159497 - Active, not recruiting
  Coxarthrosis
  
• Bone Repair Cell (BRC) Treatment of Patients With Osteonecrosis of the Femoral Head
  ClinicalTrials.gov Identifier: NCT00505219 - Recruiting
  Osteonecrosis
  
• Bone Response in Metastatic Breast Cancer Involving Bones
  ClinicalTrials.gov Identifier: NCT00420433 - Recruiting
  Breast Cancer; Bone Metastases
  
• Bone Response to Enzyme Replacement in Gaucher's Disease
  ClinicalTrials.gov Identifier: NCT00001416 - Completed
  Gaucher's Disease
  
• Bone Response to Soy Isoflavones in Women
  ClinicalTrials.gov Identifier: NCT00043745 - Active, not recruiting
  Osteopenia; Osteoporosis
  
• Bone Status and Insulin Resistance in Hirsutism
  ClinicalTrials.gov Identifier: NCT00143052 - Active, not recruiting
  Hirsutism
  
• Bone Tunnel Widening Following ACL Reconstruction
  ClinicalTrials.gov Identifier: NCT00198042 - Recruiting
  Anterior Cruciate Ligament Injury; Knee Injuries
  
• BONSAI: Biomarkers of Nonsteroidal Anti-Inflammatories
  ClinicalTrials.gov Identifier: NCT00239746 - Recruiting
  Alzheimer's Disease
  
• Boost Use in Breast Conservation Radiotherapy
  ClinicalTrials.gov Identifier: NCT00138814 - Recruiting
  Breast Neoplasm; Mastectomy, segmental
  
• BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)
  ClinicalTrials.gov Identifier: NCT00414284 - Completed
  HIV Infections
  
• Boosted Atazanavir and Truvada Given Once-Daily - BATON Study
  ClinicalTrials.gov Identifier: NCT00224445 - Completed
  HIV Infections
  
• Booster Study to Evaluate the Immunological Memory Induced by GSK Biologicals'' MenC-TT and 2 Formulations of GSK Biologicals'' Hib-MenC-TT or Meningitec™ in Healthy Toddlers Aged 12-15 Months Primed in Study 711202/001.
  ClinicalTrials.gov Identifier: NCT00135564 - Completed
  Prophylaxis meningococcal serogroup C disease, Hib diseases
  
• Booster Vaccination Study to Assess Immune Response & Safety of a Dose of GSK Biologicals’ Mencevax™ ACWY at 24-30 Mths Age & to Assess Immune Response & Safety of 1/5th of a Dose of Mencevax™ ACWY at 30-36 Mths Age in Subjects Primed in
  ClinicalTrials.gov Identifier: NCT00291343 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Hib Diseases; Neisseria Meningitidis Serogroups A & C Diseases
  
• Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine
  ClinicalTrials.gov Identifier: NCT00463476 - Recruiting
  Japanese Encephalitis
  
• Borage Oil and Ginkgo Biloba (EGb 761) in Asthma
  ClinicalTrials.gov Identifier: NCT00029679 - Completed
  Asthma
  
• Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma
  ClinicalTrials.gov Identifier: NCT00115453 - Recruiting
  Glioblastoma
  
• Boron Neutron Capture Therapy (BNCT) to Treat Anaplastic Astrocytoma or Glioblastoma that has Progressed Following Radiotherapy
  ClinicalTrials.gov Identifier: NCT00115440 - Recruiting
  Glioblastoma; Anaplastic Astrocytoma
  
• Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00004015 - Active, not recruiting
  adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
  
• Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain
  ClinicalTrials.gov Identifier: NCT00039572 - Active, not recruiting
  adult glioblastoma; Stage IV Melanoma; brain metastases; adult giant cell glioblastoma; adult gliosarcoma
  
• Boron Neutron Capture Therapy in Treating Patients With Melanoma
  ClinicalTrials.gov Identifier: NCT00059800 - Active, not recruiting
  Recurrent Melanoma; stage 0 melanoma; stage I melanoma; stage II melanoma; stage III melanoma; Stage IV Melanoma
  
• Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma
  ClinicalTrials.gov Identifier: NCT00002781 - Active, not recruiting
  stage III melanoma; Recurrent Melanoma
  
• Boron Neutron Capture Therapy Using Boronophenylalanine-Fructose Complex in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00085059 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Boronophenylalanine (BPA)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment Head and Neck Tumors
  ClinicalTrials.gov Identifier: NCT00114790 - Recruiting
  Head and Neck Cancer
  
• Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases
  ClinicalTrials.gov Identifier: NCT00062348 - Recruiting
  Endocrine Cancer; Gastrointestinal Cancer; Head and Neck Cancer; metastatic cancer
  
• Borrelia Species in Cutaneous Lyme Borreliosis
  ClinicalTrials.gov Identifier: NCT00576082 - Not yet recruiting
  Lyme Borreliosis
  
• Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC
  ClinicalTrials.gov Identifier: NCT00516100 - Recruiting
  Non-Small Cell Lung Cancer
  
• Bortezomib (Velcade) and Rituximab-HyperCVAD in Patients With Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00477412 - Recruiting
  Mantle Cell Lymphoma; Lymphoma
  
• Bortezomib (Velcade) in Patients with Untreated Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00153920 - Active, not recruiting
  Multiple Myeloma
  
• Bortezomib (Velcade) in Waldenstrom''s Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00142129 - Completed
  Waldenstrom''s Macroglobulinemia; Lymphoplasmacytic lymphoma
  
• Bortezomib (Velcade) Post Allo for Myeloma
  ClinicalTrials.gov Identifier: NCT00504634 - Recruiting
  Multiple Myeloma
  
• Bortezomib (Velcade) With Standard Chemotherapy for Relapsed or Refractory Follicular Lymphoma
  ClinicalTrials.gov Identifier: NCT00510887 - Recruiting
  Lymphoma, Follicular
  
• Bortezomib After Combination Chemotherapy, Rituximab, and an Autologous Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00310037 - Recruiting
  Lymphoma
  
• Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma
  ClinicalTrials.gov Identifier: NCT00217503 - Completed
  Lymphoma
  
• Bortezomib and Bevacizumab (“BB-Mib-Mab”) in Patients With Advanced or Recurrent Renal Cell Cancer (RCC)
  ClinicalTrials.gov Identifier: NCT00184015 - Recruiting
  Renal Cell Cancer
  
• Bortezomib and Carboplatin in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00416793 - Recruiting
  Pancreatic Cancer
  
• Bortezomib and Carboplatin in Treating Patients With Recurrent or Progressive Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00028912 - Completed
  recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
  
• Bortezomib and Celecoxib in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00290680 - Suspended
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas
  ClinicalTrials.gov Identifier: NCT00374699 - Recruiting
  Peripheral T-Cell Lymphomas; Non-Hodgkin Lymphoma
  
• Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma
  ClinicalTrials.gov Identifier: NCT00458913 - Recruiting
  Malignant Mesothelioma
  
• Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00027898 - Completed
  unspecified adult solid tumor, protocol specific
  
• Bortezomib and Dexamethasone as Treatment and Maintenance for Multiple Myeloma Relapse
  ClinicalTrials.gov Identifier: NCT00335348 - Recruiting
  Multiple Myeloma
  
• Bortezomib and Dexamethasone in Treating Patients With Multiple Myeloma That Has Relapsed or Has Not Responded to Treatment
  ClinicalTrials.gov Identifier: NCT00389701 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
  ClinicalTrials.gov Identifier: NCT00522392 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Bortezomib and Docetaxel in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00049088 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Bortezomib and Docetaxel in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00425750 - Recruiting
  Head and Neck Cancer
  
• Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms
  ClinicalTrials.gov Identifier: NCT00082784 - Recruiting
  adult non-Hodgkin's lymphoma; indolent or aggressive adult non-Hodgkin's lymphoma; refractory plasma cell neoplasm
  
• Bortezomib and Fludarabine in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00068315 - Recruiting
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma
  ClinicalTrials.gov Identifier: NCT00093704 - Recruiting
  recurrent adult Hodgkin's lymphoma; recurrent adult Burkitt's lymphoma; post-transplant lymphoproliferative disorder; ...
  
• Bortezomib and Gemcitabine Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00262860 - Active, not recruiting
  Lymphoma
  
• Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer
  ClinicalTrials.gov Identifier: NCT00305734 - Active, not recruiting
  Head and Neck Cancer
  
• Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00377052 - Recruiting
  Lymphoma
  
• Bortezomib and High-Dose Melphalan at Myeloma Relapse
  ClinicalTrials.gov Identifier: NCT00508209 - Recruiting
  Multiple Myeloma
  
• Bortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00553644 - Recruiting
  Lymphoma
  
• Bortezomib and Liposomal Doxorubicin in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00088855 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Bortezomib and Low Dose Cytarabine in the Treatment of High-Risk Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00411905 - Recruiting
  Myelodysplastic Syndromes
  
• Bortezomib and Mitoxantrone in Treating Patients With Advanced or Metastatic Androgen-Independent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00082680 - Active, not recruiting
  recurrent prostate cancer; stage III prostate cancer; stage IV prostate cancer
  
• Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00030368 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
  ClinicalTrials.gov Identifier: NCT00389805 - Completed
  Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Bortezomib and Radiation Therapy in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00016003 - Recruiting
  Head and Neck Cancer
  
• Bortezomib and Reduced Intensity Allo SCT for Lymphoid Malignancies
  ClinicalTrials.gov Identifier: NCT00439556 - Recruiting
  Leukemia; Lymphoma
  
• Bortezomib and Rituxan for Patients With Waldenstrom's Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00492050 - Recruiting
  Waldenstrom's Macroglobulinemia
  
• Bortezomib and Rituximab as First-Line Therapy in Treating Patients With Low-Grade B-Cell Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00369707 - Recruiting
  Lymphoma
  
• Bortezomib and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00093769 - Active, not recruiting
  grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma; marginal zone lymphoma
  
• Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin''s Lymphoma
  ClinicalTrials.gov Identifier: NCT00265928 - Recruiting
  Adult Non-Hodgkin''s Lymphoma; Indolent or Aggressive Adult Non-Hodgkin''s Lymphoma
  
• Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma
  ClinicalTrials.gov Identifier: NCT00512798 - Recruiting
  Brain and Central Nervous System Tumors; Melanoma (Skin); Unspecified Adult Solid Tumor, Protocol Specific
  
• Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment
  ClinicalTrials.gov Identifier: NCT00544284 - Recruiting
  Brain and Central Nervous System Tumors; Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific
  
• Bortezomib and Thalidomide in Treating Patients With Newly Diagnosed Stage II or Stage III Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00287872 - Completed
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00388089 - Recruiting
  Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00541359 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Bortezomib as Consolidation Therapy in Patients With Multiple Myeloma Age < 60 Years.
  ClinicalTrials.gov Identifier: NCT00416273 - Recruiting
  Multiple Myeloma
  
• Bortezomib as First-Line Systemic Therapy in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder
  ClinicalTrials.gov Identifier: NCT00085410 - Recruiting
  adult primary liver cancer; extrahepatic bile duct cancer; Gallbladder Cancer
  
• Bortezomib Compared With Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00052260 - No longer recruiting
  refractory plasma cell neoplasm
  
• Bortezomib Followed by High-Dose Melphalan and Bortezomib as Conditioning Regimen for Tandem Stem Cell Transplants
  ClinicalTrials.gov Identifier: NCT00307086 - Recruiting
  Multiple Myeloma; Plasma Cell Leukemia
  
• Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00077428 - Completed
  lip and oral cavity cancer; Salivary Gland Cancer
  
• Bortezomib in Combination with CC-5013 in Patients with Relapsed/Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00153933 - Active, not recruiting
  Refractory Multiple Myeloma; Relapsed Multiple Myeloma; Multiple Myeloma
  
• Bortezomib in Combination With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors
  ClinicalTrials.gov Identifier: NCT00479128 - Recruiting
  Solid Tumor; Urethral Cancer
  
• Bortezomib in Treating Children With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00021216 - Active, not recruiting
  unspecified childhood solid tumor, protocol specific
  
• Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction
  ClinicalTrials.gov Identifier: NCT00054483 - Recruiting
  adult non-Hodgkin's lymphoma; adult solid tumor; Multiple Myeloma; refractory plasma cell neoplasm
  
• Bortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction
  ClinicalTrials.gov Identifier: NCT00091117 - Recruiting
  adult non-Hodgkin's lymphoma; adult primary liver cancer; adult solid tumor
  
• Bortezomib in Treating Patients With Advanced Myeloproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00437086 - Active, not recruiting
  Chronic Myeloproliferative Disorders; Leukemia
  
• Bortezomib in Treating Patients With Advanced Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00040768 - Completed
  recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Bortezomib in Treating Patients With Advanced or Metastatic Sarcoma
  ClinicalTrials.gov Identifier: NCT00027716 - Active, not recruiting
  adult soft tissue sarcoma; metastatic osteosarcoma; metastatic tumors of the Ewing's family; Osteosarcoma; tumors of the Ewing's family
  
• Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter
  ClinicalTrials.gov Identifier: NCT00066352 - Completed
  recurrent bladder cancer; stage IV bladder cancer; metastatic transitional cell cancer of the renal pelvis and ureter; ...
  
• Bortezomib in Treating Patients With Advanced Transitional Cell Carcinoma of the Urothelium
  ClinicalTrials.gov Identifier: NCT00072150 - Active, not recruiting
  Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
  
• Bortezomib in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00023881 - Completed
  relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; accelerated phase chronic myelogenous leukemia; ...
  
• Bortezomib in Treating Patients With Diffuse Large B-Cell Lymphoma That Is Refractory To Chemotherapy
  ClinicalTrials.gov Identifier: NCT00066508 - Completed
  recurrent adult diffuse large cell lymphoma
  
• Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)
  ClinicalTrials.gov Identifier: NCT00077441 - Active, not recruiting
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
  
• Bortezomib in Treating Patients With Lymphoproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00023764 - Recruiting
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Bortezomib in Treating Patients With Malignant Pleural Mesothelioma
  ClinicalTrials.gov Identifier: NCT00513877 - Recruiting
  Malignant Mesothelioma
  
• Bortezomib in Treating Patients With Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00030875 - Active, not recruiting
  stage I mantle cell lymphoma; contiguous stage II mantle cell lymphoma; noncontiguous stage II mantle cell lymphoma; stage III mantle cell lymphoma; ...
  
• Bortezomib in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00276614 - Recruiting
  Kidney Cancer
  
• Bortezomib in Treating Patients With Metastatic or Recurrent Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00052507 - Completed
  stage IV colon cancer; Stage IV rectal cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent colon cancer; ...
  
• Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
  ClinicalTrials.gov Identifier: NCT00104871 - Recruiting
  stage II follicular thyroid cancer; stage IV follicular thyroid cancer; stage II papillary thyroid cancer; stage IV papillary thyroid cancer; ...
  
• Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00288028 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Bortezomib in Treating Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00262873 - Recruiting
  Myelodysplastic Syndromes
  
• Bortezomib in Treating Patients With Newly Diagnosed High-Risk Stage III Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00075881 - Active, not recruiting
  stage III multiple myeloma
  
• Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00023712 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Bortezomib in Treating Patients With Recurrent Glioma
  ClinicalTrials.gov Identifier: NCT00006773 - Completed
  recurrent adult brain tumor; adult glioblastoma; adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; adult giant cell glioblastoma; ...
  
• Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
  ClinicalTrials.gov Identifier: NCT00068289 - Completed
  extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer
  
• Bortezomib in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00182637 - Recruiting
  Cutaneous T-Cell Lymphoma; Mycosis Fungoides and Sezary Syndrome
  
• Bortezomib in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00082966 - Recruiting
  recurrent adult Hodgkin's lymphoma; adult nodular sclerosis Hodgkin's lymphoma; adult mixed cellularity Hodgkin's lymphoma; ...
  
• Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma
  ClinicalTrials.gov Identifier: NCT00084851 - Completed
  recurrent mantle cell lymphoma
  
• Bortezomib in Treating Patients with Stage III Or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00119223 - Recruiting
  Bronchoalveolar Cell Lung Cancer; Adenocarcinoma of the Lung; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; ...
  
• Bortezomib in Treating Patients with Stage IIIB Or Stage IV Lung Cancer
  ClinicalTrials.gov Identifier: NCT00118144 - Recruiting
  stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer; Bronchoalveolar Cell Lung Cancer; ...
  
• Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00074009 - Active, not recruiting
  recurrent gastric cancer; stage III gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach
  
• Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00045695 - Active, not recruiting
  Waldenstrom's Macroglobulinemia
  
• Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia
  ClinicalTrials.gov Identifier: NCT00077467 - Completed
  recurrent childhood acute lymphoblastic leukemia; recurrent childhood acute myeloid leukemia; blastic phase chronic myelogenous leukemia; ...
  
• Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCL
  ClinicalTrials.gov Identifier: NCT00379574 - Recruiting
  Lymphoma, Large-Cell, Diffuse; Lymphoma, B-Cell
  
• Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00052338 - Completed
  recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; Malignant Pleural Effusion
  
• Bortezomib Plus Tacrolimus and Methotrexate to Prevent GVHD After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00369226 - Recruiting
  Hematologic Malignancies
  
• Bortezomib Retreatment in Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00431769 - Recruiting
  Multiple Myeloma
  
• Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)
  ClinicalTrials.gov Identifier: NCT00440726 - Recruiting
  Acute Lymphoblastic Leukemia
  
• Bortezomib With or Without Combination Chemotherapy in Treating Patients With Relapsed or Refractory Lymphoma
  ClinicalTrials.gov Identifier: NCT00057902 - Active, not recruiting
  recurrent adult diffuse large cell lymphoma; recurrent grade 3 follicular lymphoma
  
• Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00064012 - Active, not recruiting
  stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer
  
• Bortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00052689 - Completed
  stage IVA pancreatic cancer; duct cell adenocarcinoma of the pancreas; stage IVB pancreatic cancer
  
• Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00103376 - Recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach
  ClinicalTrials.gov Identifier: NCT00061932 - Recruiting
  adenocarcinoma of the stomach; recurrent gastric cancer; stage III gastric cancer; stage IV gastric cancer
  
• Bortezomib With or Without Irinotecan in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00103259 - Recruiting
  Head and Neck Cancer
  
• Bortezomib, Arsenic Trioxide, and Melphalan in Treating Patients Undergoing an Autologous Stem Cell Transplant For Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00504101 - Suspended
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00317811 - Active, not recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00428142 - Recruiting
  Lymphoma
  
• Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00438841 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00458705 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Bortezomib, Doxorubicin Hydrochloride Liposome, and Thalidomide as First-Line Therapy in Treating Patients With Previously Untreated Stage I, II, or III Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00523848 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00280176 - Recruiting
  Colorectal Cancer
  
• Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00103103 - Active, not recruiting
  recurrent gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach
  
• Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00098982 - Active, not recruiting
  stage III colon cancer; stage IV colon cancer; stage III rectal cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer
  
• Bortezomib, Ifosfamide, and Vinorelbine in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy
  ClinicalTrials.gov Identifier: NCT00381940 - Recruiting
  Lymphoma
  
• Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00378105 - Recruiting
  Multiple Myeloma
  
• Bortezomib, Lenalidomide, and Dexamethasone Combination Therapy for Patients With Relapsed or Relapsed and Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00378209 - Recruiting
  Multiple Myeloma
  
• Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease
  ClinicalTrials.gov Identifier: NCT00520767 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Bortezomib, Paclitaxel, and Carboplatin Combined With Radiation Therapy in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00093756 - Recruiting
  recurrent non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00288041 - Active, not recruiting
  Intraocular Melanoma; Melanoma (Skin)
  
• Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction
  ClinicalTrials.gov Identifier: NCT00107341 - Active, not recruiting
  Adenocarcinoma of the Esophagus; stage IV esophageal cancer; recurrent esophageal cancer
  
• Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00261612 - Active, not recruiting
  Lymphoma, Mantle-Cell
  
• Bortezomib, Rituximab, and Combination Chemotherapy in Treating Patients With Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00131976 - Recruiting
  stage I mantle cell lymphoma; contiguous stage II mantle cell lymphoma; noncontiguous stage II mantle cell lymphoma; stage III mantle cell lymphoma; ...
  
• Bortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00372905 - Recruiting
  Lymphoma
  
• Bortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00334438 - Recruiting
  Lymphoma
  
• Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00295932 - Recruiting
  Leukemia; Lymphoma
  
• Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00124579 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Bortezomib-Dexamethasone-Doxorubicin-Study
  ClinicalTrials.gov Identifier: NCT00401804 - Recruiting
  Multiple Myeloma; Renal Insuficiency
  
• BOSCOT : A Randomised Controlled Trial of Cognitive Behavioural Therapy in Borderline Personality Disorder
  ClinicalTrials.gov Identifier: NCT00538135 - Completed
  Borderline Personality Disorder
  
• Bosentan Effects in Inoperable Forms of Chronic Thromboembolic Pulmonary Hypertension
  ClinicalTrials.gov Identifier: NCT00313222 - Completed
  Chronic Thromboembolic Pulmonary Hypertension
  
• Bosentan in Children With Pulmonary Arterial Hypertension
  ClinicalTrials.gov Identifier: NCT00319267 - Completed
  Pulmonary Hypertension
  
• Bosentan in Children With Pulmonary Arterial Hypertension Extension Study
  ClinicalTrials.gov Identifier: NCT00319020 - Active, not recruiting
  Pulmonary Hypertension
  
• Bosentan in Digital Ulcers
  ClinicalTrials.gov Identifier: NCT00319696 - Active, not recruiting
  Systemic Sclerosis; Digital Ulcers
  
• Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
  ClinicalTrials.gov Identifier: NCT00319111 - Active, not recruiting
  Pulmonary Hypertension
  
• Bosentan in Treatment of Pulmonary Arterial Hypertension
  ClinicalTrials.gov Identifier: NCT00266162 - Active, not recruiting
  Eisenmenger Syndrome
  
• BOSS Study: A Study of Fuzeon Using the Needle-Free Biojector 2000 in Patients With HIV-1 Infection
  ClinicalTrials.gov Identifier: NCT00337701 - Completed
  HIV Infections
  
• Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)
  ClinicalTrials.gov Identifier: NCT00000517 - Completed
  Arrhythmia; Atrial Fibrillation; Cardiovascular Diseases; Cerebral Embolism and Thrombosis; Cerebrovascular Disorders; Heart Diseases; ...
  
• Boston Scientific Embolic Protection, Inc. (EPI): A Carotid Stenting Trial for High-Risk Surgical Patients (BEACH)
  ClinicalTrials.gov Identifier: NCT00316108 - Active, not recruiting
  Carotid Artery Diseases; Stroke; Cerebral Arteriosclerosis
  
• Botanical/Drug Interactions in HIV: Glucuronidation
  ClinicalTrials.gov Identifier: NCT00065741 - Completed
  HIV Seronegativity
  
• Both Exercise and Adenosine Stress Testing
  ClinicalTrials.gov Identifier: NCT00200629 - Recruiting
  Coronary Artery Disease
  
• Botox as a Treatment for Chronic Male Pelvic Pain Syndrome
  ClinicalTrials.gov Identifier: NCT00194623 - Terminated
  Chronic Male Pelvic Pain Syndrome
  
• Botox as a Treatment for Interstitial Cystitis in Women
  ClinicalTrials.gov Identifier: NCT00194610 - Recruiting
  Painful Bladder Syndrome; Interstitial Cystitis
  
• Botox for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
  ClinicalTrials.gov Identifier: NCT00529386 - Recruiting
  Chronic Prostatitis; Chronic Pevlic Pain Syndrome
  
• Botox for Non-Surgical Lateral Release in Patellofemoral Pain
  ClinicalTrials.gov Identifier: NCT00496964 - Recruiting
  Patellofemoral Pain Syndrome
  
• Botox Injection for Lower Extremity Lengthening and Deformity Correction Surgery
  ClinicalTrials.gov Identifier: NCT00412035 - Recruiting
  Lower Limb Length Discrepancy; Lower Limb Angular Deformity
  
• Botox On Vulvar Vestibulitis
  ClinicalTrials.gov Identifier: NCT00119886 - Recruiting
  Vulvar vestibulitis; Vulvar Diseases
  
• Botox vs. Baclofen for Upper Limb Spasticity
  ClinicalTrials.gov Identifier: NCT00280280 - Recruiting
  Spasticity
  
• BOTOX® Economic Spasticity Trial (BEST)
  ClinicalTrials.gov Identifier: NCT00549783 - Recruiting
  Muscle Spasticity
  
• BOTOX® Versus Zanaflex® for the Treatment of Post-Stroke or Traumatic Brain Injury Upper Limb Spasticity
  ClinicalTrials.gov Identifier: NCT00430196 - Completed
  Upper Limb Spasticity
  
• Botswana Diarrheal Diseases Study
  ClinicalTrials.gov Identifier: NCT00197652 - Recruiting
  HIV Infections
  
• Botswana Pediatric Respiratory Disease and Bloodstream Infection Study
  ClinicalTrials.gov Identifier: NCT00197691 - Recruiting
  HIV Infections; Respiratory Tract Diseases; Sepsis
  
• Botswana Study of UC-781 Vaginal Microbicide
  ClinicalTrials.gov Identifier: NCT00385554 - Not yet recruiting
  HIV Infections
  
• Botswana TDF/FTC Oral HIV Prophylaxis Trial
  ClinicalTrials.gov Identifier: NCT00448669 - Recruiting
  HIV Infections
  
• Botswana Tenofovir Oral HIV Prophylaxis Trial
  ClinicalTrials.gov Identifier: NCT00111150 - Terminated
  HIV Infection
  
• Botulinum Toxin (BOTOX) for Cerebral Palsy
  ClinicalTrials.gov Identifier: NCT00060957 - Active, not recruiting
  Cerebral Palsy; Muscle Spasticity
  
• Botulinum Toxin A for the Treatment of Chronic Lumbar Back Pain
  ClinicalTrials.gov Identifier: NCT00404417 - Recruiting
  Chronic Low Back Pain
  
• Botulinum Toxin Efficiency on Spasticity of Rectus Femoris and Semitendinosus Muscles as Functional Agonist and Antagonist Muscles.
  ClinicalTrials.gov Identifier: NCT00133861 - Recruiting
  Cerebral palsy children
  
• Botulinum Toxin for the Treatment of Involuntary Movement Disorders
  ClinicalTrials.gov Identifier: NCT00001208 - Recruiting
  Chorea; Drug Induced Dyskinesia; Movement Disorder; Muscular Disease; Tic Disorder
  
• Botulinum Toxin Injection for the Management of BPH
  ClinicalTrials.gov Identifier: NCT00451191 - Recruiting
  Benign Prostatic Hyperplasia
  
• Botulinum Toxin Injection in Neck Muscles in Cervicogenic Headache
  ClinicalTrials.gov Identifier: NCT00184197 - Recruiting
  Cervicogenic Headache
  
• Botulinum Toxin to Treat Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00479154 - Recruiting
  Restless Legs Syndrome
  
• Botulinum Toxin Type A (Botox) for the Treatment of Cervical Dystonia and Upper Thoracic Muscular Pain
  ClinicalTrials.gov Identifier: NCT00178945 - Completed
  Refractory Cervicothoracic Myofascial Pain Syndrome (CMPS); Cervical Dystonia
  
• Botulinum Toxin Type A (BOTOX) in the Management of Levodopa-Induced Peak-Dose Dyskinesias in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00477802 - Recruiting
  Parkinson Disease
  
• Botulinum Toxin Type A (Dysport) Associated with Rehabilitation Treatment in Patients with Primary Myofascial Pain Syndrome
  ClinicalTrials.gov Identifier: NCT00149240 - Completed
  Myofascial Pain Syndromes
  
• Botulinum Toxin Type A for the Treatment of Male Chronic Pelvic Pain Syndrome
  ClinicalTrials.gov Identifier: NCT00464373 - Recruiting
  Chronic Prostatitis With Chronic Pelvic Pain Syndrome; Prostatitis
  
• Botulinum Toxin Type A Preparation Free of Complexing Proteins for Upper Limb Spasticity (Arm Tightness)
  ClinicalTrials.gov Identifier: NCT00465738 - Recruiting
  Upper Limb Spasticity
  
• Botulinum Toxin Type A Preparation Free of Complexing Proteins, in the Treatment of Arm Tightness After a Stroke
  ClinicalTrials.gov Identifier: NCT00432666 - Active, not recruiting
  Post-Stroke Upper Limb Spasticity
  
• Botulinum Type A Toxin in the Treatment of Lateral Canthal Lines (Crow's Feet)
  ClinicalTrials.gov Identifier: NCT00247559 - Completed
  Lateral Canthal Lines
  
• Botulism Outbreak in Thailand (Episode II)
  ClinicalTrials.gov Identifier: NCT00348426 - Completed
  Botulism
  
• Bovine Intestinal Alkaline Phosphatase for the Treatment of Patients With Sepsis
  ClinicalTrials.gov Identifier: NCT00430859 - Completed
  Sepsis; Multiple Organ Dysfunction Syndrome
  
• Bowel Disease Research Registry
  ClinicalTrials.gov Identifier: NCT00574028 - Active, not recruiting
  Inflammatory Bowel Disease
  
• Bowel Preparation and Prokinetics in Capsule Endoscopy
  ClinicalTrials.gov Identifier: NCT00275184 - Recruiting
  Small Bowel Disease; Gastrointestinal Hemorrhage; Refractory Anemia
  
• Bowel, Urinary and Sexual Function After Laparoscopic Colorectal Surgery
  ClinicalTrials.gov Identifier: NCT00451165 - Recruiting
  Surgery, Laparoscopic; Sexual Dysfunction, Physiological; Colorectal Surgery
  
• Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Healthy Men
  ClinicalTrials.gov Identifier: NCT00287833 - Completed
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia
  ClinicalTrials.gov Identifier: NCT00330382 - Recruiting
  Head and Neck Cancer; Precancerous/Nonmalignant Condition
  
• Brace Versus Casting in Pediatric Low Risk Ankle Fractures
  ClinicalTrials.gov Identifier: NCT00132964 - Active, not recruiting
  ankle fracture
  
• Brachytherapy for Prostatic Carcinoma Patients
  ClinicalTrials.gov Identifier: NCT00525720 - Recruiting
  Prostate Cancer
  
• Brachytherapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003312 - Completed
  stage II prostate cancer; stage I prostate cancer; Quality of Life
  
• Brachytherapy in Treating Patients With Recurrent Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00045474 - Completed
  adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; adult glioblastoma; recurrent adult brain tumor
  
• Brachytherapy in Treating Patients With Recurrent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00005939 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; recurrent prostate cancer
  
• Bracing in Adolescent Idiopathic Scoliosis Trial (BrAIST)
  ClinicalTrials.gov Identifier: NCT00448448 - Recruiting
  Adolescent Idiopathic Scoliosis
  
• Bracing in Patellofemoral Osteoarthritis: A Clinical Trial
  ClinicalTrials.gov Identifier: NCT00381563 - Recruiting
  Knee Osteoarthritis
  
• Bradykinin Receptor Antagonism During Cardiopulmonary Bypass- Specific Aim 3
  ClinicalTrials.gov Identifier: NCT00223704 - Recruiting
  Coronary Arteriosclerosis
  
• Bradykinin Receptors and Pain
  ClinicalTrials.gov Identifier: NCT00083356 - Completed
  Tooth, Impacted
  
• BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
  ClinicalTrials.gov Identifier: NCT00206908 - Completed
  Stroke; Stroke Mimic(Conditions Presenting With Stroke-Like Conditions)
  
• Brain Abnormalities in Late-Onset Major Depression
  ClinicalTrials.gov Identifier: NCT00260468 - Recruiting
  Major Depression
  
• Brain Activation During Simple Vocal Behaviors
  ClinicalTrials.gov Identifier: NCT00071734 - Completed
  
  
• Brain Activation During Thermal Stimulation in Neuropathic Pain
  ClinicalTrials.gov Identifier: NCT00525018 - Recruiting
  Neuropathic Pain
  
• Brain Activation in Vocal and Motor Tics
  ClinicalTrials.gov Identifier: NCT00026000 - Completed
  Tourette's Syndrome; Chronic Motor Tic Disorder; Chronic Motor Vocal Disorder
  
• Brain Activation Patterns in Schizophrenia After Computerized Cognitive Skills Training
  ClinicalTrials.gov Identifier: NCT00431223 - Recruiting
  Schizophrenia
  
• Brain Activities Associated with Different Facial Expressions Using Blood Oxygenation Level Dependent Functional MRI
  ClinicalTrials.gov Identifier: NCT00096564 - Active, not recruiting
  Healthy
  
• Brain Activity Changes and Treatment Response in Depressed People Who Are Receiving Antidepressant Medication
  ClinicalTrials.gov Identifier: NCT00375843 - Active, not recruiting
  Depression
  
• Brain Activity During Production of Movement
  ClinicalTrials.gov Identifier: NCT00029939 - Recruiting
  Healthy
  
• Brain Activity in People With Functional Movement Disorders
  ClinicalTrials.gov Identifier: NCT00448084 - Recruiting
  Functional Movement Disorders
  
• Brain Activity in Visual-Motor Behavior
  ClinicalTrials.gov Identifier: NCT00077038 - Completed
  Healthy
  
• Brain Aging Project--Kansas University
  ClinicalTrials.gov Identifier: NCT00267124 - Recruiting
  Alzheimer's Disease
  
• Brain Anatomy in Dystonia
  ClinicalTrials.gov Identifier: NCT00031369 - Recruiting
  Dystonia; Healthy
  
• Brain and Coordination Changes Induced By Robotics and FES Treatment Following Stroke
  ClinicalTrials.gov Identifier: NCT00237744 - Recruiting
  Cerebrovascular Accident; Stroke; Cerebral Stroke
  
• Brain Blood Flow Studies of Language and Memory
  ClinicalTrials.gov Identifier: NCT00001288 - Completed
  Cerebrovascular Disorder; Epilepsy
  
• Brain Cell Injury in Patients With A First Episode of Psychosis
  ClinicalTrials.gov Identifier: NCT00070889 - Completed
  Psychoses
  
• Brain Changes Associated with Learning a Motor Task
  ClinicalTrials.gov Identifier: NCT00076466 - Recruiting
  Healthy
  
• Brain Changes in Adolescents While Imagining and Observing Aggressive Behavior
  ClinicalTrials.gov Identifier: NCT00267891 - Recruiting
  Aggressive Behavior
  
• Brain Changes in Blepharospasm
  ClinicalTrials.gov Identifier: NCT00487383 - Recruiting
  Dystonia; Focal Dystonia; Cerebellar Disease
  
• Brain Changes in Blepharospasm
  ClinicalTrials.gov Identifier: NCT00500799 - Recruiting
  Blepharospasm
  
• Brain Changes in Children and Adolescents with Behavioral Problems
  ClinicalTrials.gov Identifier: NCT00104039 - Recruiting
  
  
• Brain Changes in Fear
  ClinicalTrials.gov Identifier: NCT00047853 - Recruiting
  Anxiety Disorders
  
• Brain Changes in Patients With Focal Hand Dystonia
  ClinicalTrials.gov Identifier: NCT00306865 - Recruiting
  Focal Dystonia
  
• Brain Changes in Stimulant Dependent Subjects - 8
  ClinicalTrials.gov Identifier: NCT00000343 - Active, not recruiting
  Substance-Related Disorders
  
• Brain Chemical Receptor Effects in Patients with Panic Disorder and Post-Traumatic Stress Disorder
  ClinicalTrials.gov Identifier: NCT00025974 - Recruiting
  Panic Disorder; Posttraumatic Stress Disorder; Major Depressive Disorder
  
• Brain Connectivity Between Visual Input and Movement
  ClinicalTrials.gov Identifier: NCT00376545 - Recruiting
  Occipital Cortex; Prefrontal Cortex; Healthy
  
• Brain Control of Bimanual (Both Hands) Movements
  ClinicalTrials.gov Identifier: NCT00029302 - Recruiting
  Healthy
  
• Brain Control of Blinking
  ClinicalTrials.gov Identifier: NCT00030199 - Completed
  Healthy
  
• Brain Control of Movements in Cerebral Palsy
  ClinicalTrials.gov Identifier: NCT00076596 - Completed
  Cerebral Palsy
  
• Brain Dopamine Function in Adults With ADHD
  ClinicalTrials.gov Identifier: NCT00580814 - Recruiting
  Attention Deficit Hyperactivity Disorder
  
• Brain Dynamics Involved in Generating Tics and Controlling Voluntary Movement
  ClinicalTrials.gov Identifier: NCT00056420 - Recruiting
  Tourette Syndrome; Tic Disorders
  
• Brain Electrical Stimulation to Enhance Recovery After Stroke
  ClinicalTrials.gov Identifier: NCT00085657 - Recruiting
  
  
• Brain Encoding for Memory
  ClinicalTrials.gov Identifier: NCT00051870 - Completed
  Healthy
  
• Brain Energy Metabolism in Individuals With Major Depressive Disorder Receiving Escitalopram
  ClinicalTrials.gov Identifier: NCT00183677 - Recruiting
  Depression
  
• Brain Energy Metabolism in Patients With Chronic Liver Disease and Impaired Central Nervous System
  ClinicalTrials.gov Identifier: NCT00424957 - Recruiting
  Cirrhosis; Hepatic Encephalopathy
  
• Brain Excitability During Self-Paced Voluntary Movements
  ClinicalTrials.gov Identifier: NCT00017966 - Completed
  Movement Disorder; Healthy
  
• Brain Function in Children Previously Treated on Clinical Trials POG-9605 and POG-9201
  ClinicalTrials.gov Identifier: NCT00028509 - Active, not recruiting
  neurotoxicity; long-term effects secondary to cancer therapy in children
  
• Brain Function in Focal Dystonia
  ClinicalTrials.gov Identifier: NCT00102999 - Recruiting
  
  
• Brain Function in Mentally Ill Adolescents
  ClinicalTrials.gov Identifier: NCT00025857 - Recruiting
  Healthy; Posttraumatic Stress Disorder; Major Depressive Disorder
  
• Brain Function in Performance of Motor Tasks
  ClinicalTrials.gov Identifier: NCT00498329 - Recruiting
  Brain Connectivity
  
• Brain Function in Primary Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00071435 - Completed
  Motor Neuron Disease
  
• Brain Function in Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00334516 - Recruiting
  Cerebral Cortex Dysfunction
  
• Brain Function in Response to Motivational Stimuli
  ClinicalTrials.gov Identifier: NCT00047866 - Recruiting
  Drug Dependence
  
• Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00437060 - Recruiting
  Cognitive/Functional Effects; Leukemia; Long-Term Effects Secondary to Cancer Therapy in Children; Neurotoxicity; Psychosocial Effects/Treatment
  
• Brain Function of Self-Regulation in Women With Bulimia Nervosa
  ClinicalTrials.gov Identifier: NCT00345943 - Recruiting
  Eating Disorders
  
• Brain Function, Marijuana Smoking and Treatment - 1
  ClinicalTrials.gov Identifier: NCT00158249 - Recruiting
  Marijuana Abuse
  
• Brain GABA Levels and Treatment Response in Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00464711 - Recruiting
  Major Depressive Disorder
  
• Brain Imaging and Mental Disorders of Aging Intervention
  ClinicalTrials.gov Identifier: NCT00267163 - Active, not recruiting
  Cognition Disorders
  
• Brain Imaging and Pain in Irritable Bowel Syndrome
  ClinicalTrials.gov Identifier: NCT00065754 - Active, not recruiting
  Irritable Bowel Syndrome
  
• Brain Imaging and Retreatment Study of Persistent Lyme Disease
  ClinicalTrials.gov Identifier: NCT00037479 - Completed
  Lyme Disease; Lyme Neuroborreliosis
  
• Brain Imaging in Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00039702 - Completed
  Alzheimer Disease
  
• Brain Imaging in Children With AD/HD
  ClinicalTrials.gov Identifier: NCT00008892 - Completed
  Attention Deficit Disorder with Hyperactivity; Healthy
  
• Brain Imaging in Depression
  ClinicalTrials.gov Identifier: NCT00050700 - Recruiting
  Depression; Bipolar Disorder
  
• Brain Imaging in Elderly People and Individuals with Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00001917 - Completed
  Alzheimer's Disease; Healthy
  
• Brain Imaging in Patients With Chronic Liver Disease and Functional Impairment.
  ClinicalTrials.gov Identifier: NCT00305591 - Recruiting
  Cirrhosis; Hepatic Encephalopathy
  
• Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Children
  ClinicalTrials.gov Identifier: NCT00001246 - Recruiting
  Autoimmune Disease; Congenital Adrenal Hyperplasia; Healthy; Mental Disorder Diagnosed in Childhood; Neurologic Manifestations
  
• Brain Imaging of Serotonin Transporters in the Brain
  ClinicalTrials.gov Identifier: NCT00059046 - Completed
  Healthy; Serotonin Transporter
  
• Brain Imaging of Tinnitus
  ClinicalTrials.gov Identifier: NCT00359931 - Recruiting
  Tinnitus; Hearing Loss
  
• Brain Imaging Studies of the Effects of Cocaine Abstinence
  ClinicalTrials.gov Identifier: NCT00581282 - Recruiting
  Substance Abuse Disorder
  
• Brain Imaging Study of Rosiglitazone Efficacy and Safety in Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00265148 - Recruiting
  Alzheimer's Disease
  
• Brain Imaging Technology to Examine the Effects of Meditation
  ClinicalTrials.gov Identifier: NCT00082160 - Completed
  Healthy
  
• Brain Imaging: Cocaine Effects & Medication Development - 5
  ClinicalTrials.gov Identifier: NCT00000270 - Completed
  Cocaine-Related Disorders
  
• Brain Infusion of Muscimol to Treat Epilepsy
  ClinicalTrials.gov Identifier: NCT00005925 - Recruiting
  Epilepsy
  
• Brain Inhibition of Muscle Movement in Normal Volunteers
  ClinicalTrials.gov Identifier: NCT00047957 - Completed
  Dystonic Disorders
  
• Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00057746 - Recruiting
  limited stage small cell lung cancer
  
• Brain Manganese Deposition in High Risk Neonates
  ClinicalTrials.gov Identifier: NCT00392977 - Recruiting
  Necrotizing Enterocolitis; Digestive System Abnormalities; Cholestasis
  
• Brain Mapping of Voice Control
  ClinicalTrials.gov Identifier: NCT00066911 - Recruiting
  Voice Disorders
  
• Brain Metastases In ErbB2-Positive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00263588 - Active, not recruiting
  Metastatic Breast Cancer
  
• Brain Metastases Study
  ClinicalTrials.gov Identifier: NCT00138788 - Recruiting
  Neoplasm metastasis of the brain
  
• Brain Mets - Capecitabine and WBRT
  ClinicalTrials.gov Identifier: NCT00570908 - Not yet recruiting
  Breast Cancer
  
• Brain Natriuretic Peptide (BNP) Levels in Patients in Non Invasive Mechanical Ventilation
  ClinicalTrials.gov Identifier: NCT00453726 - Recruiting
  Respiratory Insufficiency
  
• Brain Natriuretic Peptide (BNP) to Preserve Renal Function in Hospitalized Patients With Heart Failure
  ClinicalTrials.gov Identifier: NCT00170183 - Recruiting
  Kidney Diseases; Congestive Heart Failure; Cardiomyopathy
  
• Brain Neoplasms, Leukemia and Petrochemical Exposures
  ClinicalTrials.gov Identifier: NCT00042445 - Completed
  Leukemia; Brain Neoplasm
  
• Brain Networks Responsible for Self-Agency
  ClinicalTrials.gov Identifier: NCT00246831 - Recruiting
  Brain
  
• Brain Networks Responsible for Sense of Agency
  ClinicalTrials.gov Identifier: NCT00283907 - Recruiting
  Spatiotemporal Patterns
  
• Brain Oxygenation Monitoring in Patients Undergoing Coronary Artery Bypass Surgery
  ClinicalTrials.gov Identifier: NCT00137527 - Active, not recruiting
  Coronary Artery Bypass; Cardiopulmonary bypass; Neurological Manifestations
  
• Brain Peripheral Benzodiazepine Receptors in Patients With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00432900 - Recruiting
  Multiple Sclerosis
  
• Brain Physiology in Polio Survivors
  ClinicalTrials.gov Identifier: NCT00080600 - Completed
  Postpoliomyelitis
  
• Brain Plasticity of Verbal Memory in the Blind
  ClinicalTrials.gov Identifier: NCT00059189 - Completed
  Blindness
  
• Brain Power: Resistance Training and Cognitive Function
  ClinicalTrials.gov Identifier: NCT00426881 - Active, not recruiting
  Healthy
  
• Brain Processing of Language Meanings
  ClinicalTrials.gov Identifier: NCT00005004 - Completed
  Central Nervous System Disease; Cerebrovascular Accident; Craniocerebral Trauma; Head Injury; Healthy; Stroke
  
• Brain Reaction to Treatment of Nicotine Dependence
  ClinicalTrials.gov Identifier: NCT00108173 - Completed
  Nicotine Dependence
  
• Brain Receptor Function in Post-Traumatic Stress Disorder
  ClinicalTrials.gov Identifier: NCT00046553 - Completed
  Post-Traumatic Stress Disorder
  
• Brain Receptors in Sympathetic Nervous System Regulation
  ClinicalTrials.gov Identifier: NCT00029627 - Completed
  Healthy
  
• Brain Regulation of Emotions in People with Depression and Anhedonia
  ClinicalTrials.gov Identifier: NCT00059579 - Recruiting
  Major Depressive Disorder
  
• Brain Reorganization Following Constraint-Induced Therapy in Children with Cerebral Palsy
  ClinicalTrials.gov Identifier: NCT00100503 - Completed
  Cerebral Palsy
  
• Brain Stimulation to Treat Blepharospasm or Meige Syndrome
  ClinicalTrials.gov Identifier: NCT00411255 - Recruiting
  Blepharospasm; Focal Dystonia
  
• Brain Structure and Function Before and After Treatment for Post-Traumatic Stress Disorder
  ClinicalTrials.gov Identifier: NCT00069225 - Completed
  Stress Disorders, Post-Traumatic
  
• Brain Study of Patients with Frontal Lobe Dementia and Parkinsonian Disorders
  ClinicalTrials.gov Identifier: NCT00001178 - Recruiting
  Alzheimer's Disease; Dementia; Down's Syndrome
  
• Brain Tissue Collection for Neuropathological Studies
  ClinicalTrials.gov Identifier: NCT00001260 - Recruiting
  Bipolar Disorder; Huntington Disease; Schizophrenia; Tourette Syndrome; Dementia
  
• Brain Tissue Swelling and Seizure Activity in Inactive Cysticercosis
  ClinicalTrials.gov Identifier: NCT00001912 - Active, not recruiting
  Cysticercosis; Cysts; Seizures
  
• Brain Tumor Caregivers
  ClinicalTrials.gov Identifier: NCT00352820 - Terminated
  Brain Cancer; Glioma
  
• Brain Tumor Treatment Satisfaction Survey
  ClinicalTrials.gov Identifier: NCT00557375 - Recruiting
  Brain Tumors
  
• Brain Use of Sensory Information to Generate Movement
  ClinicalTrials.gov Identifier: NCT00055289 - Completed
  Healthy
  
• Brain, Biology and Mood Study
  ClinicalTrials.gov Identifier: NCT00285935 - Recruiting
  Major Depressive Disorder
  
• Brain, Gut and Kidney Blood Flow During Medical Closure of PDA
  ClinicalTrials.gov Identifier: NCT00554307 - Not yet recruiting
  Patent Ductus Arteriosus
  
• Branch Vein Occlusion Study
  ClinicalTrials.gov Identifier: NCT00000162 - Completed
  Macular Degeneration; Neovascularization, Pathologic; Vitreous Hemorrhage
  
• Breaking Down Barriers to Diabetes Self-Care
  ClinicalTrials.gov Identifier: NCT00142922 - Completed
  Type 1 Diabetes; Type 2 Diabetes
  
• Breast Cancer Associated Antibodies
  ClinicalTrials.gov Identifier: NCT00331942 - Recruiting
  Breast Cancer
  
• Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With Genetics
  ClinicalTrials.gov Identifier: NCT00341458 - Active, not recruiting
  Endometrial Cancer; Ovarian Cancer; Breast Cancer
  
• Breast Cancer in Pregnancy
  ClinicalTrials.gov Identifier: NCT00196833 - Recruiting
  Breast Cancer
  
• Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2
  ClinicalTrials.gov Identifier: NCT00383604 - Recruiting
  Lymphedema; Breast Cancer
  
• Breast Cancer Screening Via Computer V. Phone
  ClinicalTrials.gov Identifier: NCT00287040 - Recruiting
  Breast Cancer Screening
  
• Breast Cancer Treated by Neoadjuvant Chemotherapy
  ClinicalTrials.gov Identifier: NCT00425516 - Recruiting
  Breast Cancer
  
• Breast Cancer Trial of an Investigational Drug versus Capecitabine in Male or Female Patients with Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00081796 - Completed
  Breast Cancer; Metastases
  
• Breast Cancer, Breast Disease, and Pesticides
  ClinicalTrials.gov Identifier: NCT00341315 - Active, not recruiting
  Breast Cancer
  
• Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole
  ClinicalTrials.gov Identifier: NCT00316836 - Recruiting
  Breast Cancer
  
• Breast Duct Lavage and Breast Duct Endoscopy for Detecting Breast Cancer
  ClinicalTrials.gov Identifier: NCT00028340 - Recruiting
  Breast Neoplasms; Healthy
  
• Breast Duct Lavage, Breast Duct Endoscopy, and Gene Expression Profiling in Women With Breast Cancer Compared With Healthy Women Who Are and Are Not at High Risk for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00070460 - Recruiting
  Breast Cancer
  
• Breast Feeding Analgesia in Preterm Infants
  ClinicalTrials.gov Identifier: NCT00175409 - Recruiting
  Pain
  
• Breast Imaging and Time of Menstrual Cycle in Women With a Genetic Risk of Breast Cancer
  ClinicalTrials.gov Identifier: NCT00012402 - Active, not recruiting
  Breast Cancer
  
• Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up Study
  ClinicalTrials.gov Identifier: NCT00006421 - Recruiting
  Breast Neoplasm
  
• Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Study
  ClinicalTrials.gov Identifier: NCT00006425 - Recruiting
  Breast Cancer; Healthy; Ovarian Cancer
  
• Breast Imaging Using Indium In 111 CHX-A DTPA Trastuzumab in Women With Stage I, Stage II, Stage III, or Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00474578 - Recruiting
  Breast Cancer
  
• Breast Mammogram and Tissue Study
  ClinicalTrials.gov Identifier: NCT00475761 - Recruiting
  Cancer; Breast, Neoplasms
  
• Breast MRI in Women With Known or Suspected Breast Cancer and in Healthy Participants
  ClinicalTrials.gov Identifier: NCT00474604 - Recruiting
  Breast Cancer
  
• Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00165412 - Recruiting
  Breast Cancer; Hodgkin's Disease
  
• Breast MRI Spectroscopy Scan
  ClinicalTrials.gov Identifier: NCT00577915 - Recruiting
  Suspicion of, or Known Breast Cancer
  
• Breast MRI Spectroscopy, Department of Defense (DOD)
  ClinicalTrials.gov Identifier: NCT00582569 - Recruiting
  Breast Lesion
  
• Breast Neoplasms Study
  ClinicalTrials.gov Identifier: NCT00062751 - Active, not recruiting
  Breast Neoplasms
  
• Breast Reconstruction and Augmentation With Brava Enhanced Autologous Fat Mico Grafting
  ClinicalTrials.gov Identifier: NCT00466765 - Recruiting
  Mammaplasty; Mastectomy; Lumpectomy
  
• Breast Study Investigating a New Light Technique to Monitor Changes in Breast Tissue Density
  ClinicalTrials.gov Identifier: NCT00188760 - Active, not recruiting
  Breast Cancer
  
• Breast Study to Determine the Ability of Non-Invasive Optical Transillumination Spectroscopy to Predict Breast Density.
  ClinicalTrials.gov Identifier: NCT00188682 - Completed
  Breast Cancer
  
• Breast Study to Learn More About the Application of Optical Transillumination Measurements to Assess Breast Cancer Risk and to Potentially Detect the Presence of Breast Cancer.
  ClinicalTrials.gov Identifier: NCT00188721 - Recruiting
  Breast Cancer
  
• Breast Ultrasound and Mammography in Screening Women at High Risk for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00072501 - Active, not recruiting
  Breast Cancer
  
• BREAST-10: Three-Weekly Versus Weekly First-Line Chemotherapy for Metastatic or Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00540800 - Recruiting
  Breast Cancer
  
• Breast-Conserving Therapy Compared With Mastectomy Followed By Radiation Therapy in Treating Women With Locally Advanced Breast Cancer Previously Treated With Chemotherapy
  ClinicalTrials.gov Identifier: NCT00028704 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; inflammatory breast cancer
  
• Breastfeeding, Antiretroviral, and Nutrition Study
  ClinicalTrials.gov Identifier: NCT00164736 - Recruiting
  HIV Infections
  
• Breath Actuated Nebulizer Study Protocol
  ClinicalTrials.gov Identifier: NCT00382447 - Recruiting
  Asthma; COPD
  
• Breath Ammonia Method for H. Pylori Detection: Phase II
  ClinicalTrials.gov Identifier: NCT00194688 - Active, not recruiting
  Helicobacter Infections
  
• Breath Analysis Technique to Diagnose Pulmonary Embolism
  ClinicalTrials.gov Identifier: NCT00368836 - Recruiting
  Pulmonary Embolism
  
• Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Cirrhotics
  ClinicalTrials.gov Identifier: NCT00375011 - Not yet recruiting
  Cirrhosis
  
• BREATHE 5-OL: Tracleer (Bosentan) in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger Physiology
  ClinicalTrials.gov Identifier: NCT00367770 - Completed
  Pulmonary Arterial Hypertension
  
• Breathe: Slow Paced Breathing to Lower Blood Pressure
  ClinicalTrials.gov Identifier: NCT00328016 - Recruiting
  High Blood Pressure
  
• BreathID Multi-Center HCV Liver Breath Test Study
  ClinicalTrials.gov Identifier: NCT00350714 - Suspended
  Hepatitis C
  
• Breathing and Relaxation Exercises for Asthma: a Randomised Controlled Trial
  ClinicalTrials.gov Identifier: NCT00400270 - Completed
  Asthma
  
• Breathing Cycle Biofeedback During Computed Tomography Procedures
  ClinicalTrials.gov Identifier: NCT00059137 - Completed
  Needle Biopsy; CAT Scan; X-Ray
  
• Breathing Meditation With Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00310986 - Recruiting
  Attention Deficit Disorder With Hyperactivity
  
• Breathing Regulation Training for Individuals With Panic Disorder
  ClinicalTrials.gov Identifier: NCT00183521 - Recruiting
  Panic Disorder
  
• Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1
  ClinicalTrials.gov Identifier: NCT00249574 - Active, not recruiting
  Hepatitis C; Heroin Dependence
  
• Bridging Barriers to Diabetes Care With Telemedicine
  ClinicalTrials.gov Identifier: NCT00288132 - Recruiting
  Diabetes
  
• Brief Alcohol Intervention in General Hospitals
  ClinicalTrials.gov Identifier: NCT00423904 - Completed
  Alcohol Dependence; Alcohol Abuse; At-Risk-Drinking; Heavy Episodic Drinking
  
• Brief Behavioral Weight Loss Treatment vs. Weight Watchers
  ClinicalTrials.gov Identifier: NCT00249340 - Completed
  Obesity; Overweight
  
• Brief Cognitive-Behavioral Treatment for Victims of Mass Violence
  ClinicalTrials.gov Identifier: NCT00495027 - Completed
  Post-Traumatic Stress Disorder
  
• Brief Counseling to Reduce Injuries Among Emergency Department Patients Who Report Alcohol and Substance Use
  ClinicalTrials.gov Identifier: NCT00547963 - Active, not recruiting
  Alcohol Drinking; Marijuana Smoking
  
• Brief Eclectic Psychotherapy for PTSD – a Randomized Controlled Trial
  ClinicalTrials.gov Identifier: NCT00329992 - Recruiting
  Chronic Posttraumatic Stress Disorder
  
• Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome
  ClinicalTrials.gov Identifier: NCT00018837 - Completed
  Schizophrenia; Schizophrenic Disorder
  
• Brief Integrative Therapy for Post-Traumatic Stress Disorder
  ClinicalTrials.gov Identifier: NCT00047684 - Active, not recruiting
  Stress Disorders, Post-Traumatic
  
• Brief Intervention for Alcohol Use Among Injured Patients
  ClinicalTrials.gov Identifier: NCT00278785 - Recruiting
  Alcohol Drinking; Wounds and Injuries
  
• Brief Intervention for Drug Abusing Adolescents
  ClinicalTrials.gov Identifier: NCT00350909 - Recruiting
  Drug Abuse
  
• Brief Intervention for Families of Teens Treated in the Emergency Department for an Alcohol-Related Event
  ClinicalTrials.gov Identifier: NCT00247221 - Recruiting
  Alcohol Abuse
  
• Brief Intervention for Prescription Drug Misuse in General Hospital
  ClinicalTrials.gov Identifier: NCT00514839 - Active, not recruiting
  Abuse of Prescription Drug; Dependence on Prescription Drugs; Regular Consumption of Prescription Drug
  
• BRIEF INTERVENTION IN AT-RISK FIRST-TIME MOTHERS - 3
  ClinicalTrials.gov Identifier: NCT00230009 - Recruiting
  Behavior Therapy
  
• Brief Intervention to Increase Safety Belt Use Among ED Patients
  ClinicalTrials.gov Identifier: NCT00300859 - Not yet recruiting
  Accidents, Traffic
  
• Brief Intervention to Reduce Drinking Among Batterers
  ClinicalTrials.gov Identifier: NCT00539955 - Recruiting
  Intimate Partner Violence; Alcohol Use
  
• Brief Intervention to Reduce Drinking and Intimate Partner Violence in Women
  ClinicalTrials.gov Identifier: NCT00539812 - Recruiting
  Intimate Partner Violence; Substance Use
  
• Brief Intervention to Reduce Injury in Minorities
  ClinicalTrials.gov Identifier: NCT00132262 - Active, not recruiting
  Injuries; Alcohol Related Disorders
  
• Brief Intervention to Reduce STDs in ER Drug Users - 1
  ClinicalTrials.gov Identifier: NCT00218400 - Recruiting
  Substance-Related Disorders; Sexual Risk Behaviors
  
• Brief Interventions for Drop-Out re-Engagement
  ClinicalTrials.gov Identifier: NCT00350571 - Recruiting
  Substance Abuse
  
• Brief Introductory Therapy for Opioid Dependence
  ClinicalTrials.gov Identifier: NCT00406484 - Recruiting
  Opiate Dependence; HIV Infections
  
• Brief Smoking Intervention for Women Undergoing Breast Cancer Surgery
  ClinicalTrials.gov Identifier: NCT00299117 - Recruiting
  Complication, Postoperative; Smoking; Smoking Cessation; Stress; Nicotine Dependence
  
• Brief Strategic Family Therapy for Adolescent Drug Abusers - 1
  ClinicalTrials.gov Identifier: NCT00095303 - Active, not recruiting
  Behavior Therapy
  
• Brief Therapy Intervention for Heavy/Hazardous Drinking in HIV-Positive Women
  ClinicalTrials.gov Identifier: NCT00127231 - Not yet recruiting
  Alcohol Consumption; Alcoholism
  
• Brief Treatment for Temporomandibular Pain
  ClinicalTrials.gov Identifier: NCT00067366 - Active, not recruiting
  Temporomandibular Joint Syndrome; Myofascial Pain Dysfunction Syndrome, Temporomandibular Joint; Orofacial Pain
  
• Brief Youth Substance Use Intervention for Primary Care
  ClinicalTrials.gov Identifier: NCT00292240 - Recruiting
  Alcohol Consumption; Drug Abuse
  
• Brief, Behavioral Intervention to Reduce Douching Among Adolescent and Young Women
  ClinicalTrials.gov Identifier: NCT00207480 - Suspended
  Vaginal Douching; Bacterial Vaginosis
  
• BRIEF-PCI: Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention
  ClinicalTrials.gov Identifier: NCT00111566 - Completed
  Coronary Artery Disease; Myocardial Infarction
  
• Bright Light Therapy for Weight Loss
  ClinicalTrials.gov Identifier: NCT00406770 - Completed
  Obesity
  
• Bright Start: Obesity Prevention in American Indian Children
  ClinicalTrials.gov Identifier: NCT00123032 - Recruiting
  Cardiovascular Diseases; Heart Diseases; Obesity
  
• Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005%
  ClinicalTrials.gov Identifier: NCT00440141 - Active, not recruiting
  Glaucoma; Ocular Hypertension
  
• Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost
  ClinicalTrials.gov Identifier: NCT00348400 - Completed
  Glaucoma
  
• Brimonidine vs ALTP in Progressing Human Glaucoma
  ClinicalTrials.gov Identifier: NCT00466479 - Completed
  Glaucoma
  
• Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
  ClinicalTrials.gov Identifier: NCT00504881 - Recruiting
  Epilepsy
  
• Brivaracetam as Add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults.
  ClinicalTrials.gov Identifier: NCT00357669 - Completed
  Unverricht-Lundborg Disease
  
• Brivaracetam as Add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults.
  ClinicalTrials.gov Identifier: NCT00368251 - Active, not recruiting
  Unverricht-Lundborg Disease
  
• BRL49653C In Type 2 Diabetes -Comparison Study With Pioglitazone And Placebo By Monotherapy-
  ClinicalTrials.gov Identifier: NCT00297063 - Completed
  Non-Insulin-Dependent Diabetes Mellitus
  
• Broad Effectiveness: Study with Aripiprazole
  ClinicalTrials.gov Identifier: NCT00036361 - Completed
  Schizophrenia; Schizoaffective Disorder
  
• Broad Spectrum HPV (Human Papillomavirus) Vaccine (V505) in 16 to 26 Year Old Women
  ClinicalTrials.gov Identifier: NCT00520598 - Recruiting
  Cervical Cancer; Vulvar Cancer; Vaginal Cancer; Genital Warts; Human Papillomavirus Infection
  
• Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women
  ClinicalTrials.gov Identifier: NCT00543543 - Recruiting
  Cervical Cancer; Vulvar Cancer; Vaginal Cancer; Genital Warts; Human Papillomavirus Infection
  
• Broad Spectrum HPV Vaccine Dose Ranging Study
  ClinicalTrials.gov Identifier: NCT00260039 - Active, not recruiting
  HPV; Cervical Cancer and Premalignancy; Anogenital Warts
  
• Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study
  ClinicalTrials.gov Identifier: NCT00365443 - Terminated
  Cervical Cancer; Condylomata Acuminata
  
• Broccoli Sprout Extract in Preventing Lung Cancer in Smokers
  ClinicalTrials.gov Identifier: NCT00255775 - Recruiting
  Lung Cancer
  
• Broccoli, Peas and PIN
  ClinicalTrials.gov Identifier: NCT00535977 - Completed
  Prostatic Intraepithelial Neoplasia
  
• Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase
  ClinicalTrials.gov Identifier: NCT00520260 - Recruiting
  Dry Eye Disease; Ocular Comfort
  
• Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus Prednisolone QID for the Prevention of Cystoid Macular Edema and Retinal Thickening
  ClinicalTrials.gov Identifier: NCT00469781 - Recruiting
  Cystoid Macular Edema,; Retinal Thickening
  
• Bronchial Response to Mannitol and Inflammation in Steroid Naive Asthmatics.
  ClinicalTrials.gov Identifier: NCT00206973 - Recruiting
  Asthma
  
• Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease
  ClinicalTrials.gov Identifier: NCT00241267 - Terminated
  Pulmonary Neoplasms
  
• Bronchiectasis and Long Term Azithromycin Treatment
  ClinicalTrials.gov Identifier: NCT00415350 - Not yet recruiting
  Bronchiectasis; Inflammation
  
• Bronchiectasis in COPD Patients:Role of Prophylaxis
  ClinicalTrials.gov Identifier: NCT00524095 - Recruiting
  Bronchiectasis; Pulmonary Disease; Chronic Bronchitis
  
• Bronchitis and Emphysema Advice and Training to Reduce Hospitalization
  ClinicalTrials.gov Identifier: NCT00395083 - Recruiting
  COPD; Emphysema
  
• Bronchodilatation Effects of a Small Volume Spacer Used With a Metered-Dose Inhaler
  ClinicalTrials.gov Identifier: NCT00465413 - Completed
  Asthma
  
• Bronchodilators and Oxygen Kinetics With Exercise in COPD Patients.
  ClinicalTrials.gov Identifier: NCT00354354 - Recruiting
  Chronic Obstructive Pulmonary Disease
  
• Bronchodilatory Efficacy of a Single Dose QMF149 Via a Multiple-Dose Dry Powder Inhaler (MDDPI) in Adult Asthma Patients
  ClinicalTrials.gov Identifier: NCT00556673 - Recruiting
  Asthma
  
• Bronchoprotection of Salbutamol in Asthma and COPD
  ClinicalTrials.gov Identifier: NCT00440245 - Active, not recruiting
  Asthma; COPD
  
• Bronchoscopy With Bronchial Biopsies.Sub-Study of: Persistence of Airway Inflammation and Remodeling in Asthma Remission
  ClinicalTrials.gov Identifier: NCT00526344 - Recruiting
  Remission of Asthma; Asthma
  
• Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00041249 - Active, not recruiting
  adult soft tissue sarcoma; gastrointestinal stromal tumor
  
• Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00060203 - Active, not recruiting
  stage III multiple myeloma; refractory plasma cell neoplasm
  
• Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00410462 - Recruiting
  Ovarian Cancer; Sarcoma; Small Intestine Cancer; Uterine Leiomyoma
  
• Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003832 - Completed
  stage II prostate cancer; stage I prostate cancer
  
• BrUOG-EG-203 Cetuximab, Paclitaxel, Carboplatin and Radiation for Esophageal, Gastroesophageal Junction and Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00439608 - Active, not recruiting
  Esophageal; Gastroesophageal; Gastric Cancer
  
• BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00447122 - Recruiting
  Metastatic Pancreatic Cancer
  
• Brushite Kidney Stones: A Registry and Database of Clinical and Laboratory Findings
  ClinicalTrials.gov Identifier: NCT00169663 - Recruiting
  Nephrolithiasis
  
• Bryophyllum vs. Nifedipine
  ClinicalTrials.gov Identifier: NCT00391339 - Not yet recruiting
  Tocolysis
  
• Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00006942 - Active, not recruiting
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; Fallopian Tube Cancer; ...
  
• Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00006389 - Active, not recruiting
  stage III gastric cancer; stage IV gastric cancer
  
• Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00017342 - Active, not recruiting
  recurrent adult acute myeloid leukemia; adult acute myeloid leukemia with t(8;21)(q22;q22); adult acute myeloid leukemia with t(16;16)(p13;q22); ...
  
• Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or Lymphoma
  ClinicalTrials.gov Identifier: NCT00003079 - Completed
  recurrent adult lymphoblastic lymphoma; recurrent adult acute lymphocytic leukemia; recurrent adult acute myeloid leukemia; ...
  
• Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma
  ClinicalTrials.gov Identifier: NCT00003993 - Active, not recruiting
  adult solid tumor; Leukemia; Lymphoma; small intestine cancer
  
• Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00087425 - Completed
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003220 - Completed
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00003968 - Completed
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003443 - Completed
  stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ...
  
• Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00003171 - Completed
  Refractory Anemia; Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; refractory anemia with ringed sideroblasts; ...
  
• Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00004008 - Completed
  recurrent ovarian epithelial cancer; stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; ...
  
• Bryostatin 1 In Treating Patients With Progressive Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00005056 - Completed
  stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer; stage I renal cell cancer; stage II renal cell cancer
  
• Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00003936 - Completed
  recurrent adult Hodgkin's disease
  
• Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00002907 - Completed
  refractory plasma cell neoplasm
  
• Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002908 - Completed
  recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
  
• Bryostatin 1 in Treating Patients With Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003205 - Completed
  stage IV breast cancer; recurrent breast cancer
  
• Bryostatin 1 Plus Cisplatin in Treating Patients With Metastatic or Unresectable Cancer
  ClinicalTrials.gov Identifier: NCT00003132 - Completed
  unspecified adult solid tumor, protocol specific
  
• Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003174 - Completed
  stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia; ...
  
• Bryostatin 1 Plus Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00005580 - Completed
  Leukemia; Lymphoma; plasma cell neoplasm
  
• Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00004144 - Completed
  unspecified adult solid tumor, protocol specific
  
• Bryostatin 1 Plus Paclitaxel and Cisplatin in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003242 - Completed
  unspecified adult solid tumor, protocol specific
  
• Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00005599 - Completed
  Esophageal Cancer; Gastric Cancer
  
• Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00005849 - Active, not recruiting
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer
  
• Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00058305 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Bryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related Lymphoma
  ClinicalTrials.gov Identifier: NCT00022555 - Completed
  AIDS-related peripheral/systemic lymphoma; AIDS-related diffuse large cell lymphoma; AIDS-related small noncleaved cell lymphoma; ...
  
• Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002725 - Completed
  recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
  
• Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the Cervix
  ClinicalTrials.gov Identifier: NCT00005965 - Active, not recruiting
  recurrent cervical cancer; cervical squamous cell carcinoma; cervical adenocarcinoma; stage III cervical cancer; ...
  
• BST-DERMON Versus Standard of Care in the Treatment of Diabetic Foot Ulcers
  ClinicalTrials.gov Identifier: NCT00434538 - Recruiting
  Diabetic Foot Ulcer
  
• Buccal estrogen in toothpaste study: Systemic absorption of estradiol when administered mixed with toothpaste in postmenopausal or surgically menopausal women
  ClinicalTrials.gov Identifier: NCT00029757 - Completed
  Menopause; Postmenopause
  
• Budesonide / Formoterol in Treatment of Exacerbations of COPD
  ClinicalTrials.gov Identifier: NCT00239278 - Active, not recruiting
  Chronic Obstructive Pulmonary Disease (COPD)
  
• Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis
  ClinicalTrials.gov Identifier: NCT00450086 - Recruiting
  Collagenous Colitis
  
• Budesonide for Eosinophilic Esophagitis: a Randomized, Placebo-Controlled, Double-Blind Treatment Study
  ClinicalTrials.gov Identifier: NCT00271349 - Recruiting
  Eosinophilic Esophagitis
  
• Budesonide for Maintenance Treatment of Collagenous Colitis
  ClinicalTrials.gov Identifier: NCT00180076 - Recruiting
  Collagenous Colitis
  
• Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00180089 - Recruiting
  Leukemia; Graft-Versus-Host Disease
  
• Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia
  ClinicalTrials.gov Identifier: NCT00005880 - Completed
  prevention of lung cancer
  
• Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer
  ClinicalTrials.gov Identifier: NCT00321893 - Active, not recruiting
  Lung Cancer
  
• Budesonide Inhalation Suspension for Acute Asthma in Children
  ClinicalTrials.gov Identifier: NCT00393367 - Recruiting
  Asthma; Acute Asthma; Reactive Airway Exacerbation
  
• Budesonide Treatment for Lymphocytic Colitis
  ClinicalTrials.gov Identifier: NCT00180050 - Recruiting
  Microscopic Colitis
  
• Budesonide Versus Placebo for the Treatment of Lymphocytic Colitis.
  ClinicalTrials.gov Identifier: NCT00217022 - Recruiting
  Positve Colon Biospsy for Lymphocytic Colitis Within Last Year.; Diarrhea
  
• BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women
  ClinicalTrials.gov Identifier: NCT00074425 - Active, not recruiting
  HIV Infections; HIV Seronegativity
  
• BUILD 3: Bosentan Use in Interstitial Lung Disease
  ClinicalTrials.gov Identifier: NCT00391443 - Recruiting
  Idiopathic Pulmonary Fibrosis
  
• Building Better Bones in Children
  ClinicalTrials.gov Identifier: NCT00063037 - Active, not recruiting
  Osteoporosis
  
• Building Futures for Youth - Phase III
  ClinicalTrials.gov Identifier: NCT00341471 - Recruiting
  Adolescent Pregnancy
  
• Building Healthy Teen Relationships and Reproductive Practices to Increase Intervals Between Pregnancies
  ClinicalTrials.gov Identifier: NCT00342706 - Recruiting
  Teen Pregnancy
  
• Bumetanide vs. Furosemide in Heart Failure
  ClinicalTrials.gov Identifier: NCT00372762 - Not yet recruiting
  Heart Failure
  
• Buprenorphine and Integrated HIV Care
  ClinicalTrials.gov Identifier: NCT00317460 - Recruiting
  Substance-Related Disorders; Drug Addiction; Human Immunodeficiency Virus; AIDS; HIV Infections
  
• Buprenorphine and Integrated HIV Care Evaluation
  ClinicalTrials.gov Identifier: NCT00124358 - Recruiting
  Substance-Related Disorders; Drug Addiction; HIV; AIDS
  
• Buprenorphine and Naloxone Combination Study - 10
  ClinicalTrials.gov Identifier: NCT00015288 - Completed
  Heroin Dependence; Opioid-Related Disorders
  
• Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1
  ClinicalTrials.gov Identifier: NCT00015171 - Completed
  Heroin Dependence; Substance-Related Disorders
  
• Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids
  ClinicalTrials.gov Identifier: NCT00218101 - Completed
  Opioid-Related Disorders
  
• Buprenorphine as a Treatment in Opiate Dependent Pain Patients
  ClinicalTrials.gov Identifier: NCT00552578 - Recruiting
  Opiate Addiction; Refractory Pain
  
• Buprenorphine Combination Tablet Feasibility - 1
  ClinicalTrials.gov Identifier: NCT00000298 - Completed
  Opioid-Related Disorders
  
• Buprenorphine Detox with Two Types of Treatment. BBD I - 10
  ClinicalTrials.gov Identifier: NCT00000228 - Completed
  Opioid-Related Disorders
  
• Buprenorphine Detox with Two Types of Treatment. BBD II - 11
  ClinicalTrials.gov Identifier: NCT00000229 - Completed
  Opioid-Related Disorders
  
• Buprenorphine Detoxification - BBDVI - 19
  ClinicalTrials.gov Identifier: NCT00000237 - Completed
  Opioid-Related Disorders
  
• Buprenorphine Detoxification with Two Types of Treatment. BBD III - 12
  ClinicalTrials.gov Identifier: NCT00000230 - Completed
  Opioid-Related Disorders
  
• Buprenorphine Detoxification with Two Types of Treatment. BBD IV - 13
  ClinicalTrials.gov Identifier: NCT00000231 - Completed
  Opioid-Related Disorders
  
• Buprenorphine Dose Alteration Study - 1
  ClinicalTrials.gov Identifier: NCT00000219 - Completed
  Opioid-Related Disorders
  
• Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2
  ClinicalTrials.gov Identifier: NCT00015041 - Completed
  Opioid-Related Disorders; Substance-Related Disorders
  
• Buprenorphine Dosing Interval - 5
  ClinicalTrials.gov Identifier: NCT00000209 - Completed
  Opioid-Related Disorders
  
• Buprenorphine for the Treatment of Neonatal Abstinence Syndrome
  ClinicalTrials.gov Identifier: NCT00521248 - Recruiting
  Neonatal Abstinence Syndrome
  
• Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1
  ClinicalTrials.gov Identifier: NCT00000320 - Active, not recruiting
  Opioid-Related Disorders
  
• Buprenorphine HIV Care Integration Project
  ClinicalTrials.gov Identifier: NCT00348868 - Recruiting
  HIV Infection; Opioid-Related Disorders
  
• Buprenorphine in the Treatment of Osteoarthritis (OA) in the Elderly
  ClinicalTrials.gov Identifier: NCT00324038 - Active, not recruiting
  Osteoarthritis
  
• Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1
  ClinicalTrials.gov Identifier: NCT00000318 - Active, not recruiting
  Opioid-Related Disorders; Substance-Related Disorders
  
• Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2
  ClinicalTrials.gov Identifier: NCT00000319 - Completed
  Opioid-Related Disorders; Substance-Related Disorders
  
• Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1
  ClinicalTrials.gov Identifier: NCT00000216 - Completed
  Cocaine-Related Disorders; Opioid-Related Disorders; Substance-Related Disorders
  
• Buprenorphine Maintenance for Opiate Dependence - 6
  ClinicalTrials.gov Identifier: NCT00000357 - Completed
  Opioid-Related Disorders; Substance-Related Disorders
  
• Buprenorphine Maintenance for Opioid Addicts - 1
  ClinicalTrials.gov Identifier: NCT00000202 - Completed
  Opioid-Related Disorders
  
• Buprenorphine Maintenance for Opioid Addicts - 2
  ClinicalTrials.gov Identifier: NCT00000203 - Completed
  Opioid-Related Disorders
  
• Buprenorphine Maintenance for Opioid Addicts - 3
  ClinicalTrials.gov Identifier: NCT00000204 - Completed
  Opioid-Related Disorders
  
• Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-Release
  ClinicalTrials.gov Identifier: NCT00367302 - Not yet recruiting
  Opiate Addiction
  
• Buprenorphine Maintenance Protocol - 1
  ClinicalTrials.gov Identifier: NCT00000205 - Completed
  Opioid-Related Disorders
  
• Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence
  ClinicalTrials.gov Identifier: NCT00555425 - Not yet recruiting
  Opiate Dependence
  
• Buprenorphine Pharmacology Related to Addiction Treatment - 18
  ClinicalTrials.gov Identifier: NCT00000236 - Completed
  Opioid-Related Disorders
  
• Buprenorphine Pharmacology Related to Addiction Treatment - 21
  ClinicalTrials.gov Identifier: NCT00000239 - Completed
  Opioid-Related Disorders
  
• Buprenorphine Versus Methadone Maintenance in Hepatitis C Patients Receiving Peg-Intron and Rebetol (Study P04279)(TERMINATED)
  ClinicalTrials.gov Identifier: NCT00279565 - Terminated
  Hepatitis C, Chronic
  
• Buprenorphine's Dose Response Curve
  ClinicalTrials.gov Identifier: NCT00460239 - Recruiting
  Opioid-Related Disorders
  
• Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1
  ClinicalTrials.gov Identifier: NCT00078130 - Active, not recruiting
  Opioid-Related Disorders
  
• Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1
  ClinicalTrials.gov Identifier: NCT00015028 - Completed
  Opioid-Related Disorders; Substance-Related Disorders
  
• Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9
  ClinicalTrials.gov Identifier: NCT00000344 - Active, not recruiting
  Opioid-Related Disorders
  
• Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14
  ClinicalTrials.gov Identifier: NCT00015340 - Active, not recruiting
  Heroin Dependence; Substance-Related Disorders
  
• Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1
  ClinicalTrials.gov Identifier: NCT00000326 - Completed
  Heroin Dependence; Opioid-Related Disorders
  
• Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2
  ClinicalTrials.gov Identifier: NCT00000327 - Completed
  Heroin Dependence; Opioid-Related Disorders
  
• Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4
  ClinicalTrials.gov Identifier: NCT00000329 - Completed
  Heroin Dependence; Opioid-Related Disorders
  
• Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5
  ClinicalTrials.gov Identifier: NCT00000330 - Terminated
  Heroin Dependence; Opioid-Related Disorders
  
• Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6
  ClinicalTrials.gov Identifier: NCT00000331 - Terminated
  Heroin Dependence; Opioid-Related Disorders
  
• Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3
  ClinicalTrials.gov Identifier: NCT00000328 - Completed
  Heroin Dependence; Opioid-Related Disorders
  
• Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1
  ClinicalTrials.gov Identifier: NCT00032955 - Active, not recruiting
  Heroin Dependence; Morphine Dependence; Substance Withdrawal Syndrome
  
• Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1
  ClinicalTrials.gov Identifier: NCT00032968 - Active, not recruiting
  Heroin Dependence; Morphine Dependence; Substance Withdrawal Syndrome
  
• Bupropion and Counseling With or Without Contingency Management to Enhance Smoking Cessation in Treating Cancer Survivors Who Continue to Smoke
  ClinicalTrials.gov Identifier: NCT00079469 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Bupropion and Weight Control for Smoking Cessation - 1
  ClinicalTrials.gov Identifier: NCT00006170 - Active, not recruiting
  Tobacco Use Disorder
  
• Bupropion as a Smoking Cessation Aid in Alcoholics
  ClinicalTrials.gov Identifier: NCT00044434 - Active, not recruiting
  Alcoholism; Smoking
  
• Bupropion for Hospital-Based Smoking Cessation
  ClinicalTrials.gov Identifier: NCT00261170 - Active, not recruiting
  Smoking
  
• Bupropion for Hospitalized Smokers With Acute Cardiovascular Disease
  ClinicalTrials.gov Identifier: NCT00181818 - Completed
  Smoking; Myocardial Infarction; Unstable Angina; Cardiovascular Disease
  
• Bupropion For Reducing High-Risk Behaviors in Depressed Men Who Have Sex With Men (MSM)
  ClinicalTrials.gov Identifier: NCT00285584 - Active, not recruiting
  HIV Infections; Depression
  
• Bupropion for the Treatment of Methamphetamine Dependence - 1
  ClinicalTrials.gov Identifier: NCT00069251 - Active, not recruiting
  Amphetamine-Related Disorders
  
• Bupropion in Helping Adults Stop Smoking
  ClinicalTrials.gov Identifier: NCT00534001 - Recruiting
  Bladder Cancer; Cervical Cancer; Esophageal Cancer; Gastric Cancer; Head and Neck Cancer; Kidney Cancer; Leukemia; Liver Cancer; Lung Cancer; Pancreatic Cancer; Tobacco Use Disorder
  
• Bupropion in the Treatment of Methamphetamine Dependence
  ClinicalTrials.gov Identifier: NCT00572234 - Recruiting
  Methamphetamine Use Disorder
  
• Bupropion SR for Major Depression and Depression NOS in Children and Adolescents With Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00181896 - Terminated
  Depression; Bipolar Disorder
  
• Bupropion SR for Treating Smokeless Tobacco Use
  ClinicalTrials.gov Identifier: NCT00414180 - Completed
  Smokeless Tobacco
  
• Bupropion Treatment for Youth Smoking Cessation
  ClinicalTrials.gov Identifier: NCT00344695 - Completed
  Nicotine Dependence
  
• Bupropion With Telephone-Based Counseling and/or Internet-Based Counseling in Helping Adults Stop Smoking
  ClinicalTrials.gov Identifier: NCT00301145 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Burden of Urinary Incontinence in Home Care Patients in the State of Geneva
  ClinicalTrials.gov Identifier: NCT00530036 - Active, not recruiting
  Urinary Incontinence
  
• Burning Mouth Disorder (BMD) – a Neuropathic Pain Disorder?
  ClinicalTrials.gov Identifier: NCT00504387 - Recruiting
  Burning Mouth Disorder; Burning Mouth Syndrome; Oral Burning; Taste Disorder; Neuropathic Orofacial Pain
  
• BURULICO Drug Trial Study Protocol: RCT SR8/SR4+CR4, GHANA
  ClinicalTrials.gov Identifier: NCT00321178 - Recruiting
  Buruli Ulcer; Mycobacterium Ulcerans
  
• Buspirone in Reducing Shortness of Breath in Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00053846 - Recruiting
  Pulmonary Complications; unspecified adult solid tumor, protocol specific
  
• Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00004896 - Completed
  adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; atypical chronic myeloid leukemia; ...
  
• Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantaion: a Pharmockinetic Study
  ClinicalTrials.gov Identifier: NCT00156858 - Recruiting
  Hematologic Malignancy
  
• Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00301912 - Recruiting
  Anemia; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Busulfan and Fludarabine in Patients With AML and MDS
  ClinicalTrials.gov Identifier: NCT00502905 - Active, not recruiting
  Leukemia
  
• Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
  ClinicalTrials.gov Identifier: NCT00448201 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
  
• Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00005866 - Active, not recruiting
  untreated adult acute myeloid leukemia; secondary myelodysplastic syndrome; de novo myelodysplastic syndrome; ...
  
• Busulfan in Treating Children and Adolescents With Refractory CNS Cancer
  ClinicalTrials.gov Identifier: NCT00006246 - Completed
  Leukemia; Brain Tumor; Lymphoma
  
• Busulfan Monotherapy as Conditioning for Autologous Hematopoietic Progenitor Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00363467 - Recruiting
  Acute Myeloid Leukemia (AML)
  
• Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00427765 - Recruiting
  Multiple Myeloma; Lymphoma
  
• Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)
  ClinicalTrials.gov Identifier: NCT00361140 - Recruiting
  Myelodysplastic Syndromes; Myeloproliferative Disorders; Leukemia, Lymphocytic; Myeloma; Lymphoma
  
• Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remi
  ClinicalTrials.gov Identifier: NCT00305708 - Completed
  Congenital Amegakaryocytic Thrombocytopenia; Diamond-Blackfan Anemia; Fanconi Anemia; Leukemia; Severe Congenital Neutropenia; Thrombocytopenia
  
• Busulfan, Cyclophosphamide, Melphalan, and Donor Stem Cell Transplant in Treating Young Patients For Juvenile Myelomonocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00262756 - Recruiting
  Leukemia
  
• Busulfan, Etoposide, and Total-Body Irradiation Followed by Autologous Stem Cell Transplant and Aldesleukin in Treating Patients With Acute Myeloid Leukemia in First Remission
  ClinicalTrials.gov Identifier: NCT00534469 - Active, not recruiting
  Leukemia
  
• Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00534430 - Active, not recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Busulfan, Etoposide, Intensity-Modulated Radiation Therapy, and Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer
  ClinicalTrials.gov Identifier: NCT00540995 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00245037 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00469014 - Recruiting
  Acute Myeloid Leukemia; Myelodysplastic Syndrome; Chronic Myeloid Leukemia
  
• Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors
  ClinicalTrials.gov Identifier: NCT00436761 - Active, not recruiting
  Unspecified Childhood Solid Tumor, Protocol Specific
  
• Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors
  ClinicalTrials.gov Identifier: NCT00357396 - Recruiting
  Sarcoma
  
• Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00238433 - Recruiting
  Lymphoma
  
• BVAIT: B-Vitamin Atherosclerosis Intervention Trial
  ClinicalTrials.gov Identifier: NCT00114400 - Completed
  Atherosclerosis
  
• Bypass Angioplasty Revascularization Investigation (BARI)
  ClinicalTrials.gov Identifier: NCT00000462 - Completed
  Angina Pectoris; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus; Heart Diseases; Myocardial Ischemia
  
• Bypass Angioplasty Revascularization Investigation in Type 2 Diabetics (BARI 2D)
  ClinicalTrials.gov Identifier: NCT00006305 - Active, not recruiting
  Coronary Disease; Cardiovascular Diseases; Heart Diseases; Insulin Resistance; Diabetes Mellitus; Diabetes Mellitus, non-insulin dependent
  
• Bypass Surgery and CD133 Marrow Cell Injection for Treatment of Ischemic Heart Failure
  ClinicalTrials.gov Identifier: NCT00462774 - Recruiting
  Coronary Artery Disease With Need for Bypass Surgery; Myocardial Ischemia, Angina Pectoris; Congestive Heart Failure; Previous Myocardial Infarction
  
• Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease
  ClinicalTrials.gov Identifier: NCT00422968 - Recruiting
  Coronary Artery Disease